UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended ~~September~~June 30, ~~2022~~2023

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from __________ to __________

Commission File Number: 001-41123

CHICAGO ATLANTIC REAL ESTATE FINANCE, INC.

(Exact name of registrant as specified in its charter)

Maryland		86-3125132
(State or other jurisdiction of incorporation or organization)		(I.R.S. Employer Identification Number)

~~420 North Wabash~~1680 Michigan Avenue, Suite ~~500,~~700,
~~Chicago, IL 60611~~Miami Beach, FL 33139

(Address of principal executive offices) (Zip Code)

(312) 809-7002

(Registrant’s telephone number, including area code)

N/A

(Former name, former address and former fiscal year, if changed since last report)

Securities registered pursuant to Section 12(b) of the Act:

Title of each class		Trading Symbol(s)		Name of each exchange on which registered
Common Stock, $0.01 par value per share		REFI		NASDAQ Global Market

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer	☐	Accelerated filer	☐
Non-accelerated Filer	☒	Smaller reporting company	☐☒
		Emerging growth company	☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒

Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date.

Class		Outstanding at ~~November 7, 2022~~August 4, 2023
Common stock, $0.01 par value		~~17,657,913~~18,175,393

CHICAGO ATLANTIC REAL ESTATE FINANCE, INC.

TABLE OF CONTENTS

INDEX

Part I.	Financial Information		1
Item 1.	Financial Statements		1
	Consolidated Balance Sheets as of ~~September~~June 30, ~~2022~~2023 (unaudited) and December 31, ~~2021~~2022		1
	Consolidated Statements of Income for the three and ~~nine~~six months ended ~~September~~June 30, 2023 and 2022 (unaudited) ~~and for the three months ended September 30, 2021 (unaudited) and the period from March 30, 2021 (inception) to September 30, 2021 (unaudited)~~		2
	Consolidated Statements of Equity for the three and ~~nine~~six months ended ~~September~~June 30, 2023 and 2022 (unaudited) ~~and for the three months ended September 30, 2021 (unaudited) and the period from March 30, 2021 (inception) to September 30, 2021 (unaudited)~~		3
	Consolidated Statements of Cash Flows for the ~~nine~~six months ended ~~September~~June 30, 2023 and 2022 (unaudited) ~~and for the period from March 30, 2021 (inception) to September 30, 2021 (unaudited)~~		4
	Notes to Consolidated Financial Statements (unaudited)		5
Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	18	24
Item 3.	Quantitative and Qualitative Disclosures About Market Risk	34	42
Item 4.	Controls and Procedures	38	45
Part II.	Other Information	39	46
Item 1.	Legal Proceedings	39	46
Item 1A.	Risk Factors	39	46
Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds	39	47
Item 3.	Defaults Upon Senior Securities	39	47
Item 4.	Mine Safety Disclosures	39	47
Item 5.	Other Information	39	47
Item 6.	Exhibits	39	47

PART I -– FINANCIAL INFORMATION

Item 1. Financial Statements

CHICAGO ATLANTIC REAL ESTATE FINANCE, INC.

CONSOLIDATED BALANCE SHEETS

							June 30, 2023			December 31, 2022
	September 30, 2022			December 31, 2021			(unaudited)
Assets	(unaudited)
Loans held for investment	$	331,075,547		$	196,984,566		$	314,536,900		$	339,273,538
Current expected credit loss reserve		(1,497,933	)		(134,542	)		(5,121,577	)		(3,940,939	)
Loans held for investment at carrying value, net		329,577,614			196,850,024			309,415,323			335,332,599
Cash		9,331,530			80,248,526
Cash and cash equivalents								18,020,688			5,715,827
Debt securities, at fair value								877,610			-
Interest receivable		727,279			197,735			994,812			1,204,412
Other receivables and assets, net		844,486			874,170			1,010,720			1,018,212
Related party receivables								237,885			-
Total Assets	$	340,480,909		$	278,170,455		$	330,557,038		$	343,271,050

Liabilities
Revolving Loan	$	53,000,000		$	-
Revolving loan							$	43,000,000		$	58,000,000
Dividend payable		8,435,222			4,537,924			8,708,161			13,618,591
Management and incentive fees payable								1,799,667			3,295,600
Related party payables								1,601,773			1,397,515
Accounts payable and other liabilities								1,415,612			1,058,128
Interest reserve		5,625,979			6,636,553			341,951			1,868,193
Management and incentive fees payable		1,347,421			802,294
Related party payable		1,203,030			1,902,829
Accounts payable and other liabilities		716,463			212,887
Total Liabilities		70,328,115			14,092,487			56,867,164			79,238,027
Commitments and contingencies (Note 8)

Stockholders’ equity
Common stock, par value $0.01 per share, 100,000,000 shares authorized at September 30, 2022 and December 31, 2021, respectively, and 17,742,915 and 17,453,553 shares issued and outstanding at September 30, 2022 and December 31, 2021, respectively		176,579			173,551
Common stock, par value $0.01 per share, 100,000,000 shares authorized and 18,175,393 and 17,766,936 shares issued and outstanding, respectively								181,754			176,859
Additional paid-in-capital		268,888,861			264,081,977			276,405,754			268,995,848
Accumulated earnings (deficit)		1,087,354			(177,560	)		(2,897,634	)		(5,139,684	)
Total stockholders’ equity		270,152,794			264,077,968			273,689,874			264,033,023

Total liabilities and stockholders’ equity	$	340,480,909		$	278,170,455		$	330,557,038		$	343,271,050

The accompanying notes are an integral part of these consolidated financial statements.

CHICAGO ATLANTIC REAL ESTATE FINANCE, INC.

CONSOLIDATED STATEMENTS OF INCOME

(UNAUDITED)

	For the three months ended			For the three months ended			For the nine months ended			Period from March 30, 2021 (inception) to			For the three months ended			For the three months ended			For the six months ended			For the six months ended
	September 30, 2022			September 30, 2021			September 30, 2022			September 30, 2021			June 30, 2023			June 30, 2022			June 30, 2023			June 30, 2022
Revenues
Interest income	$	13,795,097		$	4,141,323		$	35,478,178		$	5,295,812		$	14,659,222		$	11,850,028		$	31,186,526		$	21,683,081
Interest expense		(861,348	)		(25,206	)		(1,383,172	)		(41,918	)		(994,926	)		(449,556	)		(2,613,222	)		(521,824	)
Net interest income		12,933,749			4,116,117			34,095,006			5,253,894			13,664,296			11,400,472			28,573,304			21,161,257

Expenses
Management and incentive fees, net		1,347,421			-			3,266,487			-			1,799,667			1,247,561			3,937,672			1,919,066
General and administrative expense		1,076,798			13,531			2,410,151			13,531			1,280,401			777,212			2,555,226			1,333,353
Organizational expense		-			35,065			-			104,291
Provision for current expected credit losses		306,885			-			1,403,892			-
Professional fees		348,785			-			1,649,360			-			537,894			743,670			1,107,269			1,300,574
Stock based compensation		84,891			-			328,356			-			263,844			122,525			402,179			243,465
Provision for current expected credit losses														1,139,112			1,045,665			1,235,231			1,097,008
Total expenses		3,164,780			48,596			9,058,246			117,822			5,020,918			3,936,633			9,237,577			5,893,466

Net Income before income taxes		9,768,969			4,067,521			25,036,760			5,136,072			8,643,378			7,463,839			19,335,727			15,267,791
Income tax expense		-			-			-			-			-			-			-			-
Net Income	$	9,768,969		$	4,067,521		$	25,036,760		$	5,136,072		$	8,643,378		$	7,463,839		$	19,335,727		$	15,267,791

Earnings per common share:
Basic earnings per common share (in dollars per share)	$	0.55		$	0.83		$	1.42		$	1.40
Diluted earnings per common share (in dollars per share)	$	0.55		$	0.83		$	1.41		$	1.40
Basic earnings per common share													$	0.48		$	0.42		$	1.07		$	0.87
Diluted earnings per common share													$	0.47		$	0.42		$	1.07		$	0.86

Weighted average number of common shares outstanding:
Basic weighted average shares of common stock outstanding (in shares)		17,657,913			4,895,694			17,652,367			3,658,310
Diluted weighted average shares of common stock outstanding (in shares)		17,752,290			4,895,694			17,747,612			3,658,310
Basic weighted average shares of common stock outstanding														18,094,288			17,657,913			17,989,684			17,649,548
Diluted weighted average shares of common stock outstanding														18,273,512			17,752,413			18,117,919			17,745,234

The accompanying notes are an integral part of these consolidated financial statements.

CHICAGO ATLANTIC REAL ESTATE FINANCE, INC.

CONSOLIDATED STATEMENTS OF EQUITY

(UNAUDITED)

Three months ended June 30, 2023

Common Stock Additional
Paid- Accumulated Total Stockholders’
Shares Amount In-Capital Earnings Equity
Balance at March 30, 2021 (inception) - $ - $ - $ - $ -
Issuance of common stock in connection with sale of unregistered equity securities 6,427 64 99,936 - 100,000
Balance at March 31, 2021 6,427 $ 64 $ 99,936 $ - $ 100,000
Issuance of common stock in connection with sale of unregistered equity securities 3,618,401 36,184 56,263,560 - 56,299,744
Dividends declared on common shares - - - (1,068,551 ) (1,068,551 )
Net income - - - 1,068,551 1,068,551
Balance at June 30, 2021 3,624,828 $ 36,248 $ 56,363,496 $ - $ 56,399,744
Issuance of common stock in connection with sale of unregistered equity securities 4,415,594 44,156 68,179,213 - 68,223,369
Net income - - - 4,067,521 4,067,521
Balance at September 30, 2021 8,040,422 $ 80,404 $ 124,542,709 $ 4,067,521 $ 128,690,634

Balance at January 1, 2022 17,453,553 $ 173,551 $ 264,081,977 $ (177,560 ) $ 264,077,968
Issuance of common stock in connection with initial public offering and concurrent private placement, net of offering costs, underwriting discounts and commissions 302,800 3,028 4,478,528 - 4,481,556
Stock-based compensation (3,750 ) - 120,940 975 121,915
Dividends declared on common shares ($0.40 per share) - - - (7,100,875 ) (7,100,875 )
Net income - - - 7,803,952 7,803,952
Balance at March 31, 2022 17,752,603 $ 176,579 $ 268,681,445 $ 526,492 $ 269,384,516
Stock-based compensation (313 ) - 122,525 207 122,732
Dividends declared on common shares ($0.47 per share) - - - (8,343,576 ) (8,343,576 )
Net income - - - 7,463,839 7,463,839
Balance at June 30, 2022 17,752,290 $ 176,579 $ 268,803,970 $ (353,038 ) $ 268,627,511
Stock-based compensation (9,375 ) - 84,891 10,593 95,484
Dividends declared on common shares ($0.47 per share) - - - (8,339,170 ) (8,339,170 )
Net income - - - 9,768,969 9,768,969
Balance at September 30, 2022 17,742,915 $ 176,579 $ 268,888,861 $ 1,087,354 $ 270,152,794

	Common Stock					Additional Paid-In-		Accumulated			Total Stockholders’
	Shares			Amount		Capital		Earnings			Equity

Balance at April 1, 2023		18,162,298			180,887		274,925,072		(2,982,631	)		272,123,328
Issuance of common stock, net of offering costs		79,862			799		1,221,553		-			1,222,352
Stock-based compensation		(66,767	)		68		259,129		4,647			263,844
Dividends declared on common shares ($0.47 per share)		-			-		-		(8,563,028	)		(8,563,028	)
Net income		-			-		-		8,643,378			8,643,378
Balance at June 30, 2023		18,175,393		$	181,754	$	276,405,754	$	(2,897,634	)	$	273,689,874

Six months ended June 30, 2023

	Common Stock					Additional Paid-In-		Accumulated			Total Stockholders’
	Shares			Amount		Capital		Earnings			Equity

Balance at January 1, 2023		17,766,936			176,859		268,995,848		(5,139,684	)		264,033,023
Issuance of common stock, net of offering costs		79,862			799		1,221,553		-		$	1,222,352
Issuance of common stock in connection with private placement, net of offering costs, underwriting discounts and commissions		395,779			3,958		5,790,889		-		$	5,794,847
Stock-based compensation		(67,184	)		138		397,464		4,577		$	402,179
Dividends declared on common shares ($0.94 per share)		-			-		-		(17,098,254	)	$	(17,098,254	)
Net income		-			-		-		19,335,727		$	19,335,727
Balance at June 30, 2023		18,175,393		$	181,754	$	276,405,754	$	(2,897,634	)	$	273,689,874

Three months ended June 30, 2022

	Common Stock					Additional Paid-In-		Accumulated			Total Stockholders’
	Shares			Amount		Capital		Earnings			Equity

Balance at April 1, 2022		17,752,603			176,579		268,681,445		526,492			269,384,516
Stock-based compensation		(313	)		-		122,525		207			122,732
Dividends declared on common shares ($0.47 per share)		-			-		-		(8,343,576	)		(8,343,576	)
Net income		-			-		-		7,463,839			7,463,839
Balance at June 30, 2022		17,752,290		$	176,579	$	268,803,970	$	(353,038	)	$	268,627,511

Six months ended June 30, 2022

	Common Stock					Additional Paid-In-		Accumulated			Total Stockholders’
	Shares			Amount		Capital		Earnings			Equity

Balance at January 1, 2022		17,453,553			173,551		264,081,977		(177,560	)		264,077,968
Issuance of common stock, net of offering costs		302,800			3,028		4,478,528		-		$	4,481,556
Stock-based compensation		(4,063	)		-		243,465		1,182			244,647
Dividends declared on common shares ($0.87 per share)		-			-		-		(15,444,451	)		(15,444,451	)
Net income		-			-		-		15,267,791			15,267,791
Balance at June 30, 2022		17,752,290		$	176,579	$	268,803,970	$	(353,038	)	$	268,627,511

The accompanying notes are an integral part of these consolidated financial statements.

CHICAGO ATLANTIC REAL ESTATE FINANCE, INC.

CONSOLIDATED STATEMENTS OF CASH FLOWS

(UNAUDITED)

	For the nine months ended September 30, 2022			Period from March 30, 2021 (inception) to September 30, 2021
	(unaudited)			(unaudited)			For the six months ended June 30, 2023			For the six months ended June 30, 2022

Operating activities
Net income	$	25,036,760		$	5,136,072		$	19,335,727		$	15,267,791

Adjustments to reconcile net income to net cash provided by operating activities:
Accretion of deferred loan origination fees and other discounts		(2,139,972	)		(276,838	)		(1,433,293	)		(1,362,776	)
Payment-in-kind interest		(4,096,721	)		(278,079	)
Paid-in-kind interest								(4,345,434	)		(2,400,627	)
Provision for current expected credit losses		1,403,892			-			1,235,231			1,097,008
Amortization of deferred debt issuance costs		379,644			41,918			259,102			241,095
Stock based compensation		328,356			-			402,179			243,465

Changes in operating assets and liabilities:
Interest receivable		(529,544	)		(517,026	)		209,600			(777,837	)
Other assets		-			(84,384	)
Other receivables		(172,699	)		(13,868	)
Other receivables and assets, net								(119,819	)		(146,102	)
Interest reserve		(9,940,290	)		6,590,885			(1,526,242	)		(6,162,392	)
Escrow payable		-			800,000
Related party payable		1,100,201			683,842
Management fee payable		545,127			-
Related party payables								204,258			739,950
Related party receivables								(237,885	)		-
Purchase of debt securities, at fair value								(877,610	)		-
Management and incentive fees payable								(1,495,933	)		342,438
Accounts payable and accrued expenses		463,075			159,047			302,891			292,669
Net cash provided by operating activities		12,377,829			12,241,569			11,912,772			7,374,682

Cash flows from investing activities
Issuance of and fundings of loans held for investment		(134,314,003	)		(104,174,344	)
Proceeds from sale of loan held for investment		6,696,777			-
Principal repayment of loans held for investment		6,892,654			9,582,613
Net cash used in investing activities		(120,724,572	)		(94,591,731	)
Issuance of and fundings of loans								(34,791,660	)		(125,383,782	)
Proceeds from sales of loans								13,399,712			-
Principal repayment of loans								51,907,313			6,654,703
Net cash provided by/(used) in investing activities								30,515,365			(118,729,079	)

Cash flows from financing activities
Proceeds from sale of common stock		4,505,664			92,546,597			7,222,363			4,505,664
Proceeds from borrowings on revolving loan		53,000,000			-			34,000,000			45,000,000
Dividends paid		(19,874,715	)		(1,068,551	)
Repayment of borrowings on revolving loan								(49,000,000	)		-
Dividends paid to common shareholders								(22,004,274	)		(11,575,495	)
Payment of debt issuance costs		(177,261	)		-			(56,791	)		(177,261	)
Payment of deferred offering costs		(23,941	)		(485,978	)
Net cash provided by financing activities		37,429,747			90,992,068
Payment of offering costs								(284,574	)		(23,941	)
Net cash (used in)/provided by financing activities								(30,123,276	)		37,728,967

Change in cash		(70,916,996	)		8,641,906
Cash, beginning of period		80,248,526			100,000
Cash, end of period	$	9,331,530		$	8,741,906
Net increase (decrease) in cash and cash equivalents								12,304,861			(73,625,430	)
Cash and cash equivalents, beginning of period								5,715,827			80,248,526
Cash and cash equivalents, end of period							$	18,020,688		$	6,623,096

Supplemental disclosure of non-cash financing and investing activity
Loans acquired for issuance of shares of common stock	$	-		$	31,976,516
Interest reserve withheld from funding of loan		8,929,716			7,501,842			-			5,895,863
OID withheld from funding of loans		2,180,593			-
OID withheld from funding of loans held for investment								1,118,340			1,835,592
Dividends declared and not yet paid		8,409,628			-			8,708,161			8,380,271
Transfer of loan held for investment to loan held for sale								13,399,712			-

Supplemental information:
Interest paid during the period	$	646,278		$	-		$	2,442,866		$	102,500
Income taxes paid during the period		-			-

The accompanying notes are an integral part of these consolidated financial statements.

CHICAGO ATLANTIC REAL ESTATE FINANCE, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

1. ORGANIZATION AND DESCRIPTION OF BUSINESS

Chicago Atlantic Real Estate Finance, Inc., and its wholly owned consolidated subsidiary, Chicago Atlantic Lincoln LLC (“CAL”) (collectively the “Company”, “we”, or “our”), is a commercial mortgage real estate investment trust (“REIT”) incorporated in the state of Maryland on March 30, 2021. The Company has elected to be taxed as a REIT for United States federal income tax purposes under the Internal Revenue Code of 1986, as amended (the “Code”), commencing with its taxable year ended December 31, 2021. The Company generally will not be subject to United States federal income taxes on its REIT taxable income if it annually distributes to stockholders ~~all~~at least 90% of its REIT taxable income prior to the deduction for dividends paid and complies with various other requirements as a REIT.

The Company operates as one operating segment and its primary investment objective is to provide attractive, risk-adjusted returns for stockholders over time, primarily through consistent current income (dividends and distributions) and secondarily, through capital appreciation. The Company intends to achieve this objective by originating, structuring, and investing in first mortgage loans and alternative structured financings secured by commercial real estate properties. The Company’s loan portfolio is primarily comprised of senior loans to state-licensed operators in the cannabis industry, secured by real estate, equipment, receivables, licenses, and/or other assets of the borrowers to the extent permitted by applicable laws and regulations governing such borrowers.

The Company is externally managed by Chicago Atlantic REIT Manager, LLC (the “Manager”), a Delaware limited liability company, pursuant to the terms of the management agreement dated May 1, 2021, as amended in October 2021, which has a three-year initial term set to expire on April 30, 2024 (the “Management Agreement”), by and among the Company and the Manager. After the initial term, the management agreement is automatically renewed for one-year periods unless the Company or the Manager elects not to renew in accordance with the terms of the Management Agreement. The Manager conducts substantially all of the Company’s operations and provides asset management services for its real estate investments. For its services, the Manager is entitled to management fees and incentive compensation, both defined in and in accordance with the terms of the Management Agreement (Note 7). All of the Company’s investment decisions are made by the investment committee of the Manager, subject to oversight by the Company’s board of directors (the “Board”). The Manager is wholly-owned by Chicago Atlantic Group, ~~LLC~~LP. (the “Sponsor”).

2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Basis of Presentation

The accompanying unaudited condensed consolidated financial statements and related notes of the Company have been prepared on the accrual basis of accounting and in conformity with generally accepted accounting principles in the United States of America (“GAAP”) for interim financial information, the instructions to Form 10-Q and Article 10 of Regulation S-X. Our consolidated financial statements present the financial position, results of operations, and cash flows of Chicago Atlantic Real Estate Finance, Inc., and its wholly owned consolidated subsidiary, Chicago Atlantic Lincoln, LLC. All intercompany accounts and transactions have been eliminated in consolidation. Accordingly, these financial statements may not contain all disclosures required by generally accepted accounting principles. Reference should be made to Note 2 of the Company’s Consolidated Financial Statements included in the Company’s Annual Report on Form 10-K for the period ended December 31, ~~2021.~~2022. In the opinion of the Company, all normal recurring adjustments have been made that are necessary to the fair statement of the results of operations and financial position as of and for the periods presented. Operating results for the three and ~~nine-month~~six-month periods ended ~~September~~June 30, ~~2022~~2023 are not necessarily indicative of the results that may be expected for the year ending December 31, ~~2022.~~2023.

Cash and Cash Equivalents

The Company’s cash held with financial institutions may at times exceed the Federal Deposit Insurance Corporation (“FDIC”) insured limits. The Company and the Manager seek to manage this credit risk relating to cash by monitoring the financial stability of the financial institutions and their ability to continue in business for the foreseeable future.

Cash and cash equivalents include funds on deposit with financial institutions, including demand deposits with financial institutions. Cash and short-term investments with an original maturity of three months or less when acquired are considered cash and cash equivalents for the purpose of the consolidated balance sheets and consolidated statements of cash flows.

Use of Estimates in the Preparation of Consolidated Financial Statements

The preparation of the consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect certain reported amounts and disclosures. Actual results could differ from those estimates. Significant estimates include the provision for current expected credit losses.

~~Reclassifications~~Investments in Marketable Securities

~~Certain prior period amounts have been reclassified to conform to~~Investments in marketable securities consist of debt securities that are classified as trading securities. Marketable trading securities are recorded at fair value on the ~~current period presentation. Interest expense was previously presented as an operating expense~~consolidated balance sheets and ~~has been reclassified as a reduction to net revenue~~unrealized gains and losses shall be included within unrealized gain(loss) on trading securities on the consolidated statements of income. ~~General~~

Loans Held-for-Sale

Once the Company decides to sell a loan(s), they may be transferred from held for investment to held-for-sale and ~~administrative expense reimbursements due~~carried at the lower of cost or fair value. On the date a loan is transferred into the held-for-sale category, any previously recorded allowance for credit losses is reversed in earnings and the loan is recorded at its amortized cost. If the amortized cost exceeds the loan’s fair value at the date of transfer, a valuation allowance is recorded equal to the ~~Manager, which~~difference between amortized cost basis and fair value. There were ~~previously included in~~no loans classified as held-for-sale as of June 30, 2023 and December 31, 2022.

Revenue Recognition

Interest income on debt securities designated as trading securities is recognized on an accrual basis and is reported as interest receivable until collected. Interest income is accrued based on the ~~line item management~~outstanding face amount and ~~incentive fees payable, have been reclassified into related party payable in~~ the ~~consolidated balance sheets. In addition, other receivables amounts have been reclassified~~contractual terms of the securities. Original issue discount (“OID”), market discounts or premiums, if any, are recorded as an adjustment to ~~other receivables~~the amortized cost and ~~assets, net in~~accreted or amortized as an adjustment to interest income using a method that approximates the ~~consolidated balance sheets.~~effective interest method.

~~These reclassifications do not result in any changes to previously reported total assets and net income.~~

~~Investment Payable~~Income Taxes

~~Investment transactions are reported~~

The Company is a Maryland corporation and has elected to be taxed as a REIT under the Code, commencing with the taxable year ended December 31, 2021. The Company believes that it qualifies as a REIT and that its method of operations will enable it to continue to qualify as a REIT. However, no assurances can be given that the Company’s beliefs or expectations will be fulfilled, since qualification as a REIT depends on the Company satisfying numerous asset, income and distribution tests which depends, in part, on the Company’s operating results.

To qualify as a ~~trade-date basis. Unsettled trades as~~REIT, the Company must meet a number of organizational and operational requirements, including a requirement that the Company distributes annually to its stockholders at least 90% of the ~~balance sheet date,~~Company’s REIT taxable income prior to the deduction for dividends paid. To the extent that the Company distributes less than 100% of its REIT taxable income in any tax year (taking into account any distributions made in a subsequent tax year under Sections 857(b)(9) or 858 of the Code), the Company will pay tax at regular corporate rates on that undistributed portion. Furthermore, if the Company distributes less than the sum of 1) 85% of its ordinary income for the calendar year, 2) 95% of its capital gain net income for the calendar year, and 3) any undistributed shortfall from its prior calendar year (the “Required Distribution”) to its stockholders during any calendar year (including any distributions declared by the last day of the calendar year but paid in the subsequent year), then it is required to pay a non-deductible excise tax equal to 4% of any shortfall between the Required Distribution and the amount that was actually distributed. The 90% distribution requirement does not require the distribution of net capital gains. However, if the Company elects to retain any of its net capital gain for any tax year, it must notify its stockholders and pay tax at regular corporate rates on the retained net capital gain. The stockholders must include their proportionate share of the retained net capital gain in their taxable income for the tax year, and they are deemed to have paid the REIT’s tax on their proportionate share of the retained capital gain and receive an income tax credit for such amount. Furthermore, such retained capital gain may be subject to the nondeductible 4% excise tax. If it is determined that the Company’s estimated current year taxable income will be in excess of estimated dividend distributions (including capital gain dividend) for the current year from such income, the Company accrues excise tax on estimated excess taxable income as such taxable income is earned. The annual expense is calculated in accordance with applicable tax regulations.

FASB ASC Topic 740, Income Taxes (“ASC 740”), prescribes a recognition threshold and measurement attribute for the consolidated financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. ASC 740 also provides guidance on derecognition, classification, interest and penalties, accounting in interim periods, disclosure and transition. The Company has analyzed its various federal and state filing positions and believes that its income tax filing positions and deductions are documented and supported for the taxable years ended December 31, 2022 and December 31, 2021. Based on the Company’s evaluation, there is no reserve for any uncertain income tax positions. Accrued interest and penalties, if any, are included within other liabilities in ~~payable for investments purchased.~~

~~Recent Accounting Pronouncements~~the balance sheets.

~~As of September 30, 2022, the Company is evaluating the potential impact of recently issued accounting pronouncements on its consolidated financial statements.~~

Recent Accounting Pronouncements

In March 2022, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2022-02, Financial Instruments – Credit Losses (Topic 326): Troubled Debt Restructurings (“TDR”) and Vintage Disclosures. The amendments in this ASU eliminate the accounting guidance for TDRs by creditors in Subtopic 310-40, Receivables—Troubled Debt Restructurings by Creditors, while enhancing disclosure requirements for certain loan refinancings and restructurings by creditors when a borrower is experiencing financial difficulty. Additionally, for public business entities, the amendments in this ASU require that an entity disclose current-period gross write-offs by year of origination for financing receivables and net investments in leases within the scope of Subtopic 326-20, Financial Instruments—Credit Losses—Measured at Amortized Cost. The ASU’s amendments are effective for fiscal years beginning after December 15, 2022, and interim periods within those fiscal years and early adoption is permitted. The Company’s adoption of ASU 2022-02 on January 1, 2023 did not have a material impact on the Company’s consolidated financial statements.

3. LOANS HELD FOR INVESTMENT, NET

As of ~~September~~June 30, ~~2022~~2023 and December 31, ~~2021,~~2022, the Company’s portfolio was comprised of loans to 25 and 22 ~~and 21 portfolio companies,~~borrowers, respectively, that the Company has the ability and ~~intends~~intent to hold for the ~~loans to~~foreseeable future or until maturity. The portfolio of loans are held on the consolidated balance ~~sheet~~sheets at amortized cost. The Company’s aggregate loan commitments and outstanding principal were approximately ~~$348.9~~$329.2 million and ~~$334.5~~$318.0 million, respectively, as of ~~September~~June 30, ~~2022,~~2023, and ~~$235.1~~$351.4 million and ~~$200.6~~$343.0 million as of December 31, ~~2021.~~2022. During the three and ~~nine~~six months ended ~~September~~June 30, ~~2022,~~2023, the Company funded approximately ~~$5.7~~$1.9 million and ~~$143.6~~$35.9 million ~~respectively,~~ in new loan principal.

As of ~~September~~June 30, ~~2022~~2023 and December 31, ~~2021,~~2022, approximately ~~59.7%~~87.9% and ~~53.2%~~83.1%, respectively, of the Company’s portfolio was comprised of floating rate loans that pay interest at the ~~prime rate~~Prime Rate plus an applicable margin, and were subject to ~~prime rate floors.~~Prime Rate ceilings and floors as discussed in the tables below. The ~~outstanding principal~~carrying value of these loans was approximately ~~$199.7~~$276.2 million and ~~$106.7~~$281.6 million as of ~~September~~June 30, ~~2022~~2023 and December 31, ~~2021,~~2022, respectively.

The remaining ~~40.3%~~12.1% and ~~46.8%~~16.9% of the portfolio ~~as of September 30, 2022 and December 31, 2021, respectively,~~ was comprised of fixed rate loans that had ~~outstanding principal~~a carrying value of approximately ~~$134.8~~$38.3 million and ~~$93.9 million.~~$57.7 million as of June 30, 2023 and December 31, 2022, respectively.

The following tables summarize the Company’s loans held for investment as of ~~September~~June 30, ~~2022~~2023 and December 31, ~~2021:~~2022:

As of September 30, 2022 Weighted
Average
Outstanding Principal (1) Original Issue Discount Carrying Value (1) Remaining Life (Years) (2)
Senior Term Loans $ 334,502,935 $ (3,427,388 ) $ 331,075,547 2.1
Current expected credit loss reserve - - (1,497,933 )
Total loans held at carrying value, net $ 334,502,935 $ (3,427,388 ) $ 329,577,614

			As of December 31, 2021						Weighted Average	As of June 30, 2023
	Outstanding Principal (1)		Original Issue Discount			Carrying Value (1)			Remaining Life (Years) (2)	Outstanding Principal (1)		Original Issue Discount			Carrying Value (1)			Weighted Average Remaining Life (Years) (2)
Senior Term Loans	$	200,632,056	$	(3,647,490	)	$	196,984,566		2.2	$	317,977,743	$	(3,440,843	)	$	314,536,900			1.8
Current expected credit loss reserve		-		-			(134,542	)			-		-			(5,121,577	)
Total loans held at carrying value, net	$	200,632,056	$	(3,647,490	)	$	196,850,024			$	317,977,743	$	(3,440,843	)	$	309,415,323

	As of December 31, 2022
	Outstanding Principal (1)		Original Issue Discount			Carrying Value (1)			Weighted Average Remaining Life (Years) (2)
Senior Term Loans	$	343,029,334	$	(3,755,796	)	$	339,273,538			2.2
Current expected credit loss reserve		-		-			(3,940,939	)
Total loans held at carrying value, net	$	343,029,334	$	(3,755,796	)	$	335,332,599

(1)	The difference between the Carrying Value and the Outstanding Principal amount of the loans consists of unaccreted original issue discount, deferred loan fees and other upfront fees. Outstanding principal balance includes capitalized PIK interest, if applicable.

(2)	Weighted average remaining life is calculated based on the carrying value of the loans as of ~~September~~June 30, ~~2022~~2023 and December 31, ~~2021,~~2022, respectively.

The following tables present changes in loans held at carrying value as of and for the ~~nine~~six months ended ~~September~~June 30, ~~2022~~2023 and ~~the period from March 30, 2021 (inception) to September 30, 2021.~~2022.

	Principal (1)			Original Issue Discount			Current Expected Credit Loss Reserve			Carrying Value (1)			Principal (1)			Original Issue Discount			Current Expected Credit Loss Reserve			Carrying Value (1)
Balance at December 31, 2021	$	200,632,056		$	(3,647,490	)	$	(134,542	)	$	196,850,024
Issuance of and funding of loans		143,624,312			(2,180,593	)		-			141,443,719
Balance at December 31, 2022													$	343,029,334		$	(3,755,796	)	$	(3,940,939	)	$	335,332,599
New fundings														35,910,000			(1,118,340	)		-			34,791,660
Principal repayment of loans		(6,892,654	)		-			-			(6,892,654	)		(51,907,313	)		-			-			(51,907,313	)
Accretion of original issue discount		-			2,139,972			-			2,139,972			-			1,433,293			-			1,433,293
Proceeds from sale of loans		(6,957,500	)		260,723			-			(6,696,777	)
Sale of loan (2)														(13,399,712	)		-			-			(13,399,712	)
PIK Interest		4,096,721			-			-			4,096,721			4,345,434			-			-			4,345,434
Current expected credit loss reserve		-			-			(1,363,391	)		(1,363,391	)		-			-			(1,180,638	)		(1,180,638	)
Balance at September 30, 2022	$	334,502,935		$	(3,427,388	)	$	(1,497,933	)	$	329,577,614
Balance at June 30, 2023													$	317,977,743		$	(3,440,843	)	$	(5,121,577	)	$	309,415,323

(1)

~~(1)~~

(2)

One loan was reclassified as held for sale from loans held for investment as the decision was made to sell the loan during the six months ended June 30, 2023 to a syndicate of co-lenders which includes a third party and two affiliates under common control with our Manager. The sale was executed on March 31, 2023 (Note 7).

	Principal (1)			Original Issue Discount			Current Expected Credit Loss Reserve			Carrying Value (1)
Balance at December 31, 2021	$	200,632,056		$	(3,647,490	)	$	(134,542	)	$	196,850,024
New fundings		137,944,312			(1,835,592	)		-			136,108,720
Principal repayment of loans		(6,654,703	)		-			-			(6,654,703	)
Accretion of original issue discount		-			1,362,776			-			1,362,776
PIK Interest		2,400,627			-			-			2,400,627
Provision for credit losses		-			-			(1,068,882	)		(1,068,882	)
Balance at June 30, 2022	$	334,322,292		$	(4,120,306	)	$	(1,203,424	)	$	328,998,562

Principal (1) Original Issue Discount Current Expected Credit Loss Reserve Carrying Value (1)
Balance at March 30, 2021 (inception) $ - $ - $ - $ -
Loans contributed 32,589,907 (613,391 ) - 31,976,516
New fundings 105,952,844 (1,778,500 ) - 104,174,344
Principal repayment of loans (9,582,613 ) - - (9,582,613 )
Accretion of original issue discount - 276,838 - 276,838
Sale of loans - - - -
PIK Interest 278,079 - - 278,079
Balance at September 30, 2021 $ 129,238,217 $ (2,115,053 ) $ - $ 127,123,164

(1)

~~(1)~~

A more detailed listing of the Company’s loans held at carrying value based on information available as of ~~September~~June 30, ~~2022,~~2023, is as follows:

		Initial								Original						Percent of Our
Loan	Location(s)	Funding Date (1)		Maturity Date (2)		Total Commitment (3)		Principal Balance		Issue Discount			Carrying Value			Loan Portfolio			Future Fundings		Interest Rate (4)	Periodic Payment (5)	YTM IRR (6)
1	Various		10/27/2022		10/30/2026	$	30,000,000	$	30,000,000	$	(748,770	)	$	29,251,230			9.3	%		-	P+6.50% Cash, 0% PIK (10)	I/O		17.0	%
2	Michigan		3/5/2021		12/31/2024		35,891,667		38,001,475		(121,831	)		37,879,644			12.0	%		-	P+6.65% Cash, 4.25% PIK (7)(15)	P&I		18.0	%
3(17)	Various		3/25/2021		11/29/2024		20,105,628		20,392,227		(438,589	)		19,953,638			6.3	%		-	P+10.375% Cash, 2.75% PIK (7)	P&I		23.2	%
4(16)	Arizona		4/19/2021		12/31/2023		14,120,000		13,970,276		-			13,970,276			4.4	%		-	P+11.75% Cash (9)	I/O		17.5	%
5	Massachusetts		4/19/2021		4/30/2025		3,500,000		3,296,000		-			3,296,000			1.0	%		204,000	P+12.25% Cash (7)	P&I		22.4	%
6	Michigan		8/20/2021		2/20/2024		6,000,000		4,264,421		(2,464	)		4,261,957			1.4	%		1,500,000	P+9.00% Cash (7)	P&I		20.7	%
7	Illinois, Arizona		8/24/2021		6/30/2025		25,000,000		20,807,799		(171,792	)		20,636,007			6.6	%		-	P+6.00% Cash, 2% PIK (11)	P&I		18.5	%
8	West Virginia		9/1/2021		9/1/2024		9,500,000		11,030,188		(74,371	)		10,955,817			3.5	%		-	P+9.25% Cash, 2% PIK (7)	P&I		26.0	%
9(19)	Pennsylvania		9/3/2021		6/30/2024		15,000,000		16,155,903		-			16,155,903			5.1	%		-	P+10.75% Cash, 3% PIK (7)	P&I		19.2	%
10	Michigan		9/20/2021		9/30/2024		470,411		196,005		-			196,005			0.1	%		-	11% Cash	P&I		21.4	%
11	Maryland		9/30/2021		9/30/2024		32,000,000		32,975,433		(447,955	)		32,527,478			10.3	%		-	P+8.75% Cash, 2% PIK (7)	I/O		21.8	%
12	Various		11/8/2021		10/31/2024		13,574,667		12,628,000		(90,634	)		12,537,366			4.0	%		-	P+9.25% Cash (12)	P&I		19.5	%
13	Michigan		11/22/2021		11/1/2024		13,100,000		13,111,841		(91,308	)		13,020,533			4.1	%		-	P+6.00% Cash, 1.5% PIK (11)	I/O		18.7	%
14	Various		12/27/2021		12/27/2026		5,000,000		5,125,000		-			5,125,000			1.6	%		-	P+12.25% Cash, 2.5% PIK (8)	P&I		23.5	%
15	Michigan		12/29/2021		12/29/2023		6,000,000		3,884,077		(22,438	)		3,861,639			1.2	%		2,400,000	P+17.5% Cash, 5% PIK (9)	I/O		27.0	%
16	Florida		12/30/2021		12/31/2024		13,000,000		6,825,000		(37,603	)		6,787,397			2.2	%		5,500,000	P+9.25% Cash (7)	I/O		22.7	%
17	Florida		1/18/2022		1/31/2025		15,000,000		15,000,000		(200,009	)		14,799,991			4.7	%		-	P+4.75% Cash (10)	P&I		14.2	%
18	Ohio		2/3/2022		2/28/2025		11,662,050		12,837,973		(132,125	)		12,705,848			4.0	%		-	P+1.75% Cash, 3% PIK (11)	P&I		19.8	%
19	Florida		3/11/2022		8/29/2025		20,000,000		20,794,861		(62,431	)		20,732,430			6.6	%		-	11% Cash, 3% PIK	P&I		15.5	%
20	Missouri		5/9/2022		5/30/2025		17,000,000		17,513,744		(106,535	)		17,407,209			5.5	%		-	11% Cash, 3% PIK	P&I		14.7	%
21	Illinois		7/1/2022		6/30/2026		9,000,000		5,153,793		(67,999	)		5,085,794			1.6	%		4,000,000	P+8.50% Cash, 3% PIK	P&I		26.6	%
22	Maryland		1/24/2023		1/24/2026		11,250,000		11,093,727		(578,307	)		10,515,420			3.3	%		-	P+5.75% Cash, 1.4% PIK (10)	P&I		20.1	%
23	Arizona		3/27/2023		3/31/2026		2,000,000		1,980,000		(45,682	)		1,934,318			0.6	%		-	P+7.50% Cash, 0% PIK (13)	P&I		18.6	%
24	Oregon		3/31/2023		9/27/2026		1,000,000		940,000		-			940,000			0.3	%		-	P+10.50% Cash, 0% PIK (9)	P&I		21.5	%
25(18)	New York		-		-		-		-		-			-			0.0	%		-	15% Cash	P&I		16.3	%

Current expected credit loss reserve							-		-		-			(5,121,577	)
Total loans held at carrying value							329,174,423		317,977,743		(3,440,843	)		309,415,323			100.0	%		13,604,000		Wtd Average		19.2	%

(1)	All loans originated prior to April 1, 2021 were purchased from affiliated entities at fair value plus accrued interest on or subsequent to April 1, 2021.

Loan Location Outstanding
Principal(1) Original Issue
Premium/
(Discount) Carrying
Value(1) Contractual
Interest
Rate(4) Maturity
Date(2) Payment
Terms(3) Initial
Funding
Date
1 Various⁽⁶⁾ 30,000,000 (287,746 ) 29,712,254 10.07%⁽⁷⁾ 5/30/2023 I/O 7/2/2020
2 Michigan 36,646,551 (182,125 ) 36,464,426 P + 6.65%^(5)(11)
Cash, 3.25% PIK 12/31/2024 P&I 3/5/2021
3 Various⁽⁶⁾ 20,673,831 (444,457 ) 20,229,374
13.91% Cash, 2.59% PIK⁽¹⁰⁾
11/29/2024 P&I 3/25/2021
4 Arizona 11,909,539 - 11,909,539 19.01%⁽⁸⁾ 12/31/2023 P&I 4/19/2021
5 Massachusetts 1,500,000 - 1,500,000 P + 12.25%⁽⁵⁾ 4/30/2023 P&I 4/19/2021
6 Pennsylvania 13,263,665 - 13,263,665 P + 10.75%⁽⁵⁾
Cash, 4% PIK⁽⁹⁾ 5/31/2025 P&I 5/28/2021
7 Michigan 4,443,750 (5,558 ) 4,438,192 P + 9.00%⁽⁵⁾ 2/20/2024 P&I 8/20/2021
8 Various⁽⁶⁾ 23,168,151 (242,929 ) 22,925,222 13% Cash, 2.5% PIK 6/30/2025 P&I 8/24/2021
9 West Virginia 9,554,960 (121,586 ) 9,433,374 P + 9.25%⁽⁵⁾
Cash, 2% PIK 9/1/2024 P&I 9/1/2021
10 Pennsylvania 15,536,102 - 15,536,102 P + 10.75%⁽⁵⁾
Cash, 3% PIK 6/30/2024 P&I 9/3/2021
11 Michigan 313,607 - 313,607 11.00% 9/30/2024 P&I 9/20/2021
12 Maryland 32,479,495 (714,967 ) 31,764,528 P + 8.75%⁽⁵⁾
Cash, 2% PIK 9/30/2024 I/O 9/30/2021
13 Various⁽⁶⁾ 20,000,000 (210,110 ) 19,789,890 13.00% 10/31/2024 P&I 11/8/2021
14 Michigan 10,600,000 (22,487 ) 10,577,513 P + 7.00%⁽⁵⁾ 11/22/2022 I/O 11/22/2021
15 Various⁽⁶⁾ 5,000,000 - 5,000,000 15% Cash, 2.5% PIK 12/27/2026 P&I 12/27/2021
16 Michigan 3,739,861 (56,096 ) 3,683,765 10.50% Cash,
5% PIK 12/29/2023 I/O 12/29/2021
17 Various⁽⁶⁾ 7,500,000 (56,267 ) 7,443,733 P + 9.25%⁽⁵⁾ 12/31/2024 I/O 12/30/2021
18 Florida 15,000,000 (293,989 ) 14,706,011 11.00% 1/31/2025 P&I 1/18/2022
19 Ohio 30,602,729 (472,079 ) 30,130,650 P + 8.25%⁽⁵⁾
Cash, 3% PIK 2/28/2025 P&I 2/3/2022
20 Florida 20,327,703 (84,518 ) 20,243,185 11.00% Cash, 3% PIK 8/29/2025 P&I 3/11/2022
21 Missouri 17,204,978 (148,084 ) 17,056,894 11.00% Cash, 3% PIK 5/30/2025 P&I 5/9/2022
22 Illinois 5,038,013 (84,390 ) 4,953,623 P + 8.50%
Cash, 3%⁽⁵⁾ PIK 6/30/2026 P&I 7/1/2022

Current expected credit loss reserve - - (1,497,933 )
Total loans held at carrying value $ 334,502,935 $ (3,427,388 ) $ 329,577,614

(2)

~~(1)~~

The difference between the Carrying Value and the Outstanding Principal amount of the loans consists of unaccreted original issue discounts, deferred loan fees and other upfront fees. Outstanding principal balance includes capitalized PIK interest, if applicable.

~~(2)~~

Certain loans are subject to contractual extension options and may be subject to performance based on other conditions as stipulated in the loan agreement. Actual maturities may differ from contractual maturities stated herein as certain borrowers may have the right to prepay with or without a contractual prepayment penalty. The Company may also extend contractual maturities and amend other terms of the loans in connection with loan modifications.

(3)	Total Commitment excludes future amounts to be advanced at sole discretion of the lender and reflects receipt of scheduled amortization payments as of June 30, 2023.
(4)	“P” = prime rate and depicts floating rate loans that pay interest at the prime rate plus a specific percentage; “PIK” = paid-in-kind interest; subtotal represents weighted average interest rate.
(5)	P&I = principal and interest. I/O = interest only. P&I loans may include interest only periods for a portion of the loan term.
~~(4)~~(6)	~~P = prime rate~~Estimated YTM includes a variety of fees and ~~depicts floating rate~~features that affect the total yield, which may include, but is not limited to, OID, exit fees, prepayment fees, unused fees and contingent features. OID is recognized as a discount to the funded loan principal and is accreted to income over the term of the loan. The estimated YTM calculations require management to make estimates and assumptions, including, but not limited to, the timing and amounts of loan draws on delayed draw loans, ~~that pay~~the timing and collectability of exit fees, the probability and timing of prepayments and the probability of contingent features occurring. For example, certain credit agreements contain provisions pursuant to which certain PIK interest atrates and fees earned by us under such credit agreements will decrease upon the ~~prime rate plus a specific percentage; “PIK” = paid~~satisfaction of certain specified criteria which we believe may improve the risk profile of the applicable borrower. To be conservative, we have not assumed any prepayment penalties or early payoffs in ~~kind interest.~~our estimated YTM calculation. Estimated YTM is based on current management estimates and assumptions, which may change. Actual results could differ from those estimates and assumptions.
~~(5)~~(7)	This Loan is subject to a prime rate ~~floor.~~ floor of 3.25%
~~(6)~~(8)	~~Loans with material collateral in multiple jurisdictions, namely multi-state operators, are disclosed as “various.”~~This Loan is subject to a prime rate floor of 4.75%
~~(7)~~(9)	~~The aggregate loan commitment~~This Loan is subject to ~~Loan #1 includes~~ a ~~$4.005 million initial advance, which has an interest~~prime rate floor of 15.25%, a second advance of $15.995 million, which has an interest rate of 9.75%, and a third advance of $10.0 million, which has an interest rate of 8.50%. The statistics presented reflect the weighted average of the terms under all three advances for the total aggregate loan commitment. 5.50%
~~(8)~~(10)	This Loan is subject to a prime rate floor of 6.25%
(11)	This Loan is subject to a prime rate floor of 7.00%
(12)	This Loan is subject to a prime rate floor of 7.50%
(13)	This Loan is subject to a prime rate floor of 8.00%
(14)	This Loan is subject to a prime rate floor of 8.25%
(15)	This Loan is subject to a prime rate cap of 5.85%
(16)	The aggregate loan commitment to the borrower of Loan #4 includes a ~~$10.0~~$10.9 million initial ~~advance, which has a base interest rate of 15.00%,~~commitment advanced in April 2021, and a second ~~advance~~loan commitment of $2.0 million which ~~has an interest rate of 39%. The statistics~~was advanced in December 2021.The weighted average yield presented ~~reflect~~reflects the weighted average of the terms under both advances for the total aggregate loan commitment.
~~(9)~~	~~Subject to adjustment not below 2% if borrower receives at least two consecutive quarters of positive cash flow after the closing date.~~
~~(10)~~(17)	The aggregate loan commitment to Loan #3 includes a $15.9 million initial ~~advance,~~commitment which has a base interest rate of 13.625%, 2.75% PIK and a second ~~advance~~commitment of $4.2 million which has an interest rate of 15.00%, 2.00% PIK. The statistics presented reflect the weighted average of the terms under ~~both~~all advances for the total aggregate loan commitment.
~~(11)~~(18)	~~This~~ The Company has an aggregate commitment of $50.0 million to the borrower of Loan #25. The funding of such commitment is subject to ~~an interest rate cap.~~certain conditions precedent being met for which the Company, as lender, may exercise its sole discretion in determining if and when such proceeds are advanced. Accordingly, this commitment is not included in total contractual commitments as of June 30, 2023. During the period from July 1, 2023 through August 9, 2023, the Company advanced $18.7 million of the Loan #25 commitment (Note 13).
(19)	As of May 1, 2023, Loan #9 has been placed on non-accrual status.

~~As of September 30, 2022, all~~

Our loans are ~~current and none have been placed on non-accrual status. These loans are generally~~ held for investment and are substantially secured by real estate, equipment, licenses and other assets of the borrowers to the extent permitted by the applicable laws and the regulations governing such borrowers. The aggregate fair value of the Company’s loan portfolio was ~~$328,984,374~~$309,852,814 and ~~$197,901,779,~~$329,237,824, with gross unrecognized holding ~~losses of $2,091,173 and unrecognized holding~~ (losses)/gains of ~~$917,213~~$(4,684,085) and $10,035,714 as of ~~September~~June 30, ~~2022~~2023 and December 31, ~~2021,~~2022, respectively. The fair values, which are classified as Level 3 in the fair value hierarchy, are estimated using discounted cash flow models based on current market inputs for similar types of arrangements. The primary sensitivity in these models is based on the selection of appropriate discount rates. Fluctuations in these assumptions could result in different estimates of fair value. As of ~~September~~June 30, ~~2022,~~2023, the Company calculated the estimated fair value of the loans held for investment using unobservable inputs such as discount rates ranging from 11.36% to 24.79% with a weighted average discount rate of ~~17.54%~~16.31%.

The following table summarizes the significant unobservable inputs the Company used to value the loans categorized within Level 3 as of June 30, 2023. The tables are not intended to be all-inclusive, but instead capture the significant unobservable inputs relevant to the Company’s determination of fair values.

As of June 30, 2023

Primary

Unobservable Input

Fair Value

Valuation Techniques

Input

Estimated Range

Weighted Average

Senior term loans

309,852,814

Yield analysis

Market yield

11.36% - 24.79%

16.31

Total Investments

309,852,814

As of June 30, 2023, there were zero loans with principal or interest greater than 90 days past due.

The following table presents aging analyses of past due loans by amortized cost, excluding the CECL reserve, as of June 30, 2023. There were no past due loans as of December 31, 2022.

	As of June 30, 2023
	Current Loans		31–60 Days Past Due		61–90 Days Past Due		90+ Days Past Due (and accruing)		Non- Accrual⁽²⁾		Total Past Due		Total Loans
Loans held for investment	$	298,380,997	$	16,155,903	$	-	$	-	$	-	$	16,155,903	$	314,536,900
Total	$	298,380,997	$	16,155,903	$	-	$	-	$	-	$	16,155,903	$	314,536,900

Credit Quality Indicators

The Company assesses the risk factors of each loan, and assigns a risk rating based on a variety of factors, including, without limitation, payment history, real estate collateral coverage, property type, geographic and local market dynamics, financial performance, loan to enterprise value and fixed charge coverage ratios, loan structure and exit strategy, and project sponsorship. This review is performed quarterly. Based on a 5-point scale, the Company’s loans are rated “1” through “5,” from less risk to greater risk, which ratings are defined as follows:

Rating		Definition
1		Very low risk
2		Low risk
3		Moderate/average risk
4		High risk/potential for loss: a loan that has a risk of realizing a principal loss
5		Impaired/loss likely: a loan that has a high risk of realizing principal loss, has incurred principal loss or an impairment has been recorded

The risk ratings are primarily based on historical data and current conditions specific to each portfolio company, as well as consideration of future economic conditions and each borrower’s estimated ability to meet debt service requirements. The declines in risk ratings shown in the following table from December 31, ~~2021~~2022 to ~~September~~June 30, ~~2022 are not due to any~~2023 considered borrower specific credit ~~issues relating to the borrowers, but rather, are primarily due to the Company’s~~history and performance and reflect a quarterly re-evaluation of overall current macroeconomic conditions affecting ~~its~~the Company’s borrowers. As interest rates have increased due to rising rates from the Federal Reserve Board, it has impacted borrowers’ ability to service their debt obligations on a global scale. This decline in risk ratings ~~did not have a significant~~had an effect on the level of the current expected credit loss reserve ~~because~~though, other than the one loan placed on non-accrual status, the loans continued to perform as ~~expected, and~~expected. For approximately 74% of the portfolio, the fair value of the underlying real estate collateral exceeded the amounts outstanding under the ~~loans.~~loans as of June 30, 2023. The remaining approximately 26% of the portfolio, while not fully collateralized by real estate, may be partially collateralized by real estate and was secured by other forms of collateral including equipment, receivables, licenses and/or other assets of the borrowers to the extent permitted by applicable laws and regulations governing such borrowers. The amounts above exclude any apportionment of real estate collateral permissible under the applicable income and asset tests for REIT eligibility.

As of ~~September~~June 30, ~~2022~~2023 and December 31, ~~2021,~~2022, the carrying value, excluding the current expected credit loss reserve (the “CECL Reserve”), of the Company’s loans within each risk rating category by year of origination is as follows:

As of September 30, 2022 As of December 31, 2021
Risk Rating 2022 2021 2020 2019 Total 2021 2020 2019 Total
1 $ - $ 20,542,981 $ 29,712,254 $ - $ 50,255,235 $ 135,076,307 $ 32,242,114 $ 590,384 $ 167,908,805
2 93,424,139 79,819,303 - - 173,243,442 29,075,761 - - 29,075,761
3 30,130,650 77,446,220 - - 107,576,870 - - - -
4 - - - - - - - - -
5 - - - - - - - - -
Total $ 123,554,789 $ 177,808,504 $ 29,712,254 $ - $ 331,075,547 $ 164,152,068 $ 32,242,114 $ 590,384 $ 196,984,566

		As of June 30, 2023(1)(2)												As of December 31, 2022(1)
Risk Rating		2023		2022		2021		2020		2019		Total		2022		2021		2020		2019		Total
	1	$	10,515,420	$	30,113,057	$	196,005	$	-	$	-	$	40,824,482	$	-	$	274,406	$	-	$	-	$	274,406
	2		2,874,319		102,663,294		66,147,544		-		-		171,385,157		94,467,449		88,444,868		29,140,546		-		212,052,863
	3		-		5,085,794		55,859,471		-		-		60,945,265		30,415,113		83,131,444		-		-		113,546,557
	4		-		-		41,081,996		-		-		41,081,996		-		13,399,712		-		-		13,399,712
	5		-		-		-		-		-		-		-		-		-		-		-
	Total	$	13,389,739	$	137,862,145	$	163,285,016	$	-	$	-	$	314,536,900	$	124,882,562	$	185,250,430	$	29,140,546	$	-	$	339,273,538

(1)	Amounts are presented by loan origination year with subsequent advances shown in the original year of origination.
(2)	Loan #9 placed on non-accrual status is included in risk rating category “4”.

Real estate collateral coverage is also a significant credit quality indicator, and real estate collateral coverage, excluding the CECL Reserve, was as follows as of ~~September~~June 30, ~~2022~~2023 and December 31, ~~2021:~~2022:

As of September 30, 2022 Real Estate Collateral Coverage
As of June 30, 2023 Real Estate Collateral Coverage (1)															As of June 30, 2023 Real Estate Collateral Coverage (1)
	< 1.0x		1.0x - 1.25x		1.25x - 1.5x		1.50x - 1.75x		1.75x - 2.0x		> 2.0x		Total			< 1.0x		1.0x–1.25x		1.25x–1.5x		1.50x–1.75x		1.75x–2.0x		> 2.0x		Total
Fixed-rate	$	5,000,000	$	-	$	20,243,185	$	17,056,894	$	-	$	91,130,749	$	133,430,828		$	-	$	-	$	20,732,430	$	17,407,209	$	-	$	196,005	$	38,335,644
Floating-rate		8,943,733		97,660,654		-		31,920,426		13,263,665		45,856,241		197,644,719			82,072,899		36,109,541		61,372,826		13,970,277		22,570,325		60,105,388		276,201,256
	$	13,943,733	$	97,660,654	$	20,243,185	$	48,977,320	$	13,263,665	$	136,986,990	$	331,075,547		$	82,072,899	$	36,109,541	$	82,105,256	$	31,377,486	$	22,570,325	$	60,301,393	$	314,536,900

As of December 31, 2021 Real Estate Collateral Coverage
As of December 31, 2022 Real Estate Collateral Coverage (1)															As of December 31, 2022 Real Estate Collateral Coverage (1)
	< 1.0		1.0 - 1.25		1.25 - 1.5		1.50 - 1.75		1.75 - 2.0		> 2.0		Total			< 1.0x		1.0x–1.25x		1.25x–1.5x		1.50x–1.75x		1.75x–2.0x		> 2.0x		Total
Fixed-rate	$	7,017,793	$	-	$	35,836,099	$	3,086,298	$	-	$	45,373,778	$	91,313,968		$	-	$	-	$	20,406,737	$	17,203,138	$	-	$	20,089,663	$	57,699,538
Floating-rate		8,925,068		18,022,518		-		30,029,953		32,377,087		16,315,972		105,670,598			63,963,105		78,211,454		13,399,712		9,980,730		12,849,490		103,169,509		281,574,000
	$	15,942,861	$	18,022,518	$	35,836,099	$	33,116,251	$	32,377,087	$	61,689,750	$	196,984,566		$	63,963,105	$	78,211,454	$	33,806,449	$	27,183,868	$	12,849,490	$	123,259,172	$	339,273,538

(1)	Real estate collateral coverage is calculated based upon most recent third-party appraised values. The Company generally obtains new appraisal of all material real estate collateral at least once annually.

CECL Reserve

The Company records an allowance for current expected credit losses for its loans held for investment. The allowances are deducted from the gross carrying amount of the assets to present the net carrying value of the amounts expected to be collected on such assets. The Company estimates its CECL Reserve using among other inputs, third-party valuations, and a third-party probability-weighted model that considers the likelihood of default and expected loss given default for each individual loan based on the risk profile for approximately three years after which we immediately revert to use of historical loss data. ~~In the future, we may use other acceptable methods, such as a discounted cash flow method, WARM method, or other methods permitted under the standard.~~

ASC 326 requires an entity to consider historical loss experience, current conditions, and a reasonable and supportable forecast of the macroeconomic environment. The Company considers multiple datapoints and methodologies that may include likelihood of default and expected loss given default for each individual loan, valuations derived from discount cash flows (“DCF”), and other inputs including the risk rating of the loan, how recently the loan was originated compared to the measurement date, and expected prepayment, if applicable. The measurement of expected credit losses under CECL is applicable to financial assets measured at amortized cost, and off-balance sheet credit exposures such as unfunded loan commitments.

The Company evaluates its loans on a collective (pool) basis by aggregating on the basis of similar risk characteristics as explained above. We make the judgment that loans to cannabis-related borrowers that are fully collateralized by real estate exhibit similar risk characteristics and are evaluated as a pool. Further, loans that have no real estate collateral, but are secured by other forms of collateral, including equity pledges of the borrower, and otherwise have similar characteristics as those collateralized by real estate are evaluated as a pool. All other loans are analyzed individually, either because they operate in a different industry, may have a different risk profile, or maturities that extend beyond the forecast horizon for which we are able to derive reasonable and supportable forecasts.

Estimating the CECL Reserve also requires significant judgment with respect to various factors, including (i) the appropriate historical loan loss reference data, (ii) the expected timing of loan repayments, (iii) calibration of the likelihood of default to reflect the risk characteristics of the Company’s loan portfolio, and (iv) the Company’s current and future view of the macroeconomic environment. From time to time, the Company may consider loan-specific qualitative factors on certain loans to estimate its CECL Reserve, which may include (i) whether cash from the borrower’s operations is sufficient to cover the debt service requirements currently and into the future, (ii) the ability of the borrower to refinance the loan, and (iii) the liquidation value of collateral. For loans where we have deemed the borrower/sponsor to be experiencing financial difficulty, we may elect to apply a practical expedient, in which the fair value of the underlying collateral is compared to the amortized cost of the loan in determining a CECL Reserve.

To estimate the historic loan losses relevant to the Company’s portfolio, the Company evaluates its historical loan performance, which includes zero realized loan losses since the inception of its operations. Additionally, the Company analyzed its repayment history, noting it has limited “true” operating history, since the incorporation date of March 30, 2021. However, the Company’s Sponsor and its affiliates have had operations for the past three fiscal years and have made investments in similar loans that have similar characteristics including interest rate, collateral coverage, guarantees, and prepayment/make whole provisions, which fall into the pools identified above. Given the similarity of the structuring of the credit agreements for the loans in the Company’s portfolio to the loans originated by its Sponsor, management considered it appropriate to consider the past repayment history of loans originated by the Sponsor and its affiliates in determining the extent to which a CECL Reserve shall be recorded.

In addition, the Company reviews each loan on a quarterly basis and evaluates the borrower’s ability to pay the monthly interest and principal, if required, as well as the loan-to-value (LTV) ratio. When evaluating qualitative factors that may indicate the need for a CECL Reserve, the Company forecasts losses considering a variety of factors. In considering the potential current expected credit loss, the Manager primarily considers significant inputs to the Company’s forecasting methods, which include (i) key loan-specific inputs such as the value of the real estate collateral, liens on equity (including the equity in the entity that holds the state-issued license to cultivate, process, distribute, or retail cannabis), presence of personal or corporate guarantees, among other credit enhancements, LTV ratio, rate type (fixed or floating) and IRR, loan-term, geographic location, and expected timing and amount of future loan fundings, (ii) performance against the underwritten business plan and the Company’s internal loan risk rating, and (iii) a macro-economic forecast. Estimating the enterprise value of our borrowers in order to calculate LTV ratios is often a significant estimate. The Manager utilizes a third-party valuation appraiser to assist with the Company’s valuation process primarily using comparable transactions to estimate enterprise value of its portfolio companies and supplement such analysis with a multiple-based approach to enterprise value to revenue multiples of publicly-traded comparable companies obtained from S&P ~~CapitalIQ~~Capital IQ as of ~~September~~June 30, ~~2022,~~2023, to which the Manager may apply a private company discount based on the Company’s current borrower profile. These estimates may change in future periods based on available future macro-economic data and might result in a material change in the Company’s future estimates of expected credit losses for its loan portfolio.

Regarding real estate collateral, the Company generally cannot take the position of mortgagee-in-possession as long as the property is used by a cannabis operator, but it can request that the court appoint a receiver to manage and operate the subject real property until the foreclosure proceedings are completed. Additionally, while the Company cannot foreclose under state Uniform Commercial Code (“UCC”) and take title or sell equity in a licensed cannabis business, a potential purchaser of a delinquent or defaulted loan could.

In order to estimate the future expected loan losses relevant to the Company’s portfolio, the Company utilizes historical market loan loss data obtained from a third-party database for commercial real estate loans, which the Company believes is a reasonably comparable and available data set to use as an input for its type of loans. The Company believes this dataset to be representative for future credit losses whilst considering that the cannabis industry is maturing, and consumer adoption, demand for production, and retail capacity are increasing akin to commercial real estate over time. For periods beyond the reasonable and supportable forecast period, the Company reverts back to historical loss data.

All of the above assumptions, although made with the most available information at the time of the estimate, are subjective and actual activity may not follow the estimated schedule. These assumptions impact the future balances that the loss rate will be applied to and as such impact the Company’s CECL Reserve. As the Company acquires new loans and the Manager monitors loan and borrower performance, these estimates will be revised each period.

Activity related to the CECL Reserve for outstanding balances and unfunded commitments on the Company’s loans held at carrying value and loans receivable at carrying value as of and for the ~~nine~~six months ended ~~September~~June 30, 2023 and 2022 is presented in the table below. ~~The Company had no CECL Reserve as of and for the period March 30, 2021 (inception) to September 30, 2021.~~

	Outstanding⁽¹⁾		Unfunded⁽²⁾		Total
Balance at December 31, 2022	$	3,940,939	$	94,415	$	4,035,354
Provision for current expected credit losses		1,180,638		54,593		1,235,231
Balance at June 30, 2023	$	5,121,577	$	149,008	$	5,270,585

Outstanding⁽¹⁾ Unfunded⁽²⁾ Total
Balance at December 31, 2021 $ 134,542 $ 13,407 $ 147,949
Provision for current expected credit losses 1,363,391 40,501 1,403,892
Write-off charged - - -
Recoveries - - -
Balance at September 30, 2022 $ 1,497,933 $ 53,908 $ 1,551,841

	Outstanding⁽¹⁾		Unfunded⁽²⁾		Total
Balance at December 31, 2021	$	134,542	$	13,407	$	147,949
Provision for current expected credit losses		1,068,882		28,126		1,097,008
Balance at June 30, 2022	$	1,203,424	$	41,533	$	1,244,957

(1)	As of ~~September~~June 30, 2023 and December 31, 2022, the CECL Reserve related to outstanding balances on loans at carrying value is recorded within current expected credit loss reserve in the Company’s consolidated balance sheets.

(2)	As of ~~September~~June 30, 2023 and December 31, 2022, the CECL Reserve related to unfunded commitments on loans at carrying value is recorded within accounts payable and other accrued liabilities in the Company’s consolidated balance sheets.

Outstanding Unfunded
Balance at December 31, 2021 $ 134,542 $ 13,407
Provision for current expected credit losses 48,296 3,047
Balance at March 31, 2022 182,838 16,454
Provision for current expected credit losses 1,020,586 25,079
Balance at June 30, 2022 1,203,424 41,533
Provision for current expected credit losses 294,509 12,375
Balance at September 30, 2022 $ 1,497,933 $ 53,908

The Company has made an accounting policy election to exclude accrued interest receivable, ($~~727,279~~994,812 and $1,204,412 as of ~~September~~June 30, ~~2022)~~2023 and December 31, 2022, respectively) included in Interest Receivable on its consolidated balance sheet, from the amortized cost basis of the related loans held for investment in determining the CECL Reserve, as any uncollectible accrued interest receivable is written off in a timely manner. To date, the Company has had zero write-offs related to uncollectible interest receivable, but will discontinue accrual of interest on loans if deemed to be uncollectible, with any previously accrued uncollected interest on the loan charged to interest income in the same period.

~~As of September 30, 2022, there were no loans with principal or interest greater than 30 days past due.~~

4. INTEREST RECEIVABLE

The following table summarizes the interest receivable by the Company as of ~~September~~June 30, ~~2022~~2023 and December 31, ~~2021:~~2022:

	As of June 30, 2023		As of December 31, 2022
Interest receivable	$	944,007	$	1,203,330
Unused fees receivable		50,805		1,082
Total interest receivable	$	994,812	$	1,204,412

The following table presents aging analyses of past due loans by class as of June 30, 2023 and December 31, 2022, respectively:

	As of June 30, 2023
	Current Loans⁽¹⁾		31–60 Days Past Due		61–90 Days Past Due		90+ Days Past Due (and accruing)		Non- Accrual⁽²⁾		Total Past Due		Total Loans
Interest receivable	$	863,267	$	131,545	$	-	$	-	$	-	$	131,545	$	994,812
Total	$	863,267	$	131,545	$	-	$	-	$	-	$	131,545	$	994,812

	As of December 31, 2022
	Current Loans⁽¹⁾		31–60 Days Past Due		61–90 Days Past Due		90+ Days Past Due (and accruing)		Non- Accrual		Total Past Due		Total Loans
Interest receivable	$	1,203,088	$	1,324	$	-	$	-	$	-	$	1,324	$	1,204,412
Total	$	1,203,088	$	1,324	$	-	$	-	$	-	$	1,324	$	1,204,412

(1)	Loans 1-30 days past due are included in the current loans. Amounts are presented on a gross and net basis, including the effects of any interest reserves for non-accrual loans.
(2)	On May 1, 2023, Loan #9 was placed on non-accrual status with an outstanding principal amount of approximately $16.2 million. For the period from May 1, 2023, through June 30, 2023, the Company ceased the accrual and recognition of all interest. As of June 30, 2023, the borrower of Loan #9 is 60 days past due, however there is $0 of accrued interest receivable relating to Loan #9.

As of
September 30,
2022 As of
December 31,
2021
Interest receivable $ 627,709 $ 193,790
PIK interest receivable 95,139 -
Unused fees receivable 4,431 3,945
Total interest receivable $ 727,279 $ 197,735

5. INTEREST RESERVE

~~At September~~As of June 30, 2023 and December 31, 2022, the Company had ~~six~~two loans and three loans, respectively, that included a prepaid interest reserve.

The following table presents changes in interest reserves as of ~~September~~June 30, ~~2022~~2023 and December 31, ~~2021,~~2022, respectively:

	As of September 30, 2022			As of December 31, 2021			As of June 30, 2023			As of December 31, 2022
Initial reserves	$	6,636,553		$	-
Beginning reserves							$	1,868,193		$	6,636,553
New reserves		8,929,716			9,223,802			446,212			9,049,834
Reserves disbursed		(9,940,290	)		(2,587,249	)		(1,972,454	)		(13,818,194	)
Total interest reserve	$	5,625,979		$	6,636,553
Ending reserve							$	341,951		$	1,868,193

6. DEBT

In May 2021, in connection with the Company’s acquisition of its wholly-owned financing subsidiary, CAL, the Company was assigned a secured revolving credit facility (the “Revolving Loan”). The Revolving Loan ~~has~~had an original aggregate borrowing base of up to $10,000,000 and bore interest, payable in cash in arrears, at a per annum rate equal to the greater of (x) Prime Rate plus 1.00% and (y) 4.75%. The Company incurred debt issuance costs of $100,000 related to the origination of the Revolving Loan, which were capitalized and are subsequently being amortized through maturity. The maturity date of the Revolving Loan was the earlier of (i) February 12, 2023 and (ii) the date on which the Revolving Loan is terminated pursuant to terms in the Revolving Loan Agreement.

On December 16, 2021, ~~the Company~~CAL entered into an amended ~~the~~and restated Revolving Loan ~~Agreement~~agreement (the “First ~~Amendment”~~Amendment and Restatement”). The First Amendment and Restatement increased the loan commitment from $10,000,000 to $45,000,000 and decreased the interest rate, from the greater of the (1) Prime Rate plus 1.00% and (2) 4.75% to the greater of (1) the Prime Rate plus the applicable margin and (2) 3.25%. The applicable margin is derived from a floating rate grid based upon the ratio of debt to equity of CAL and increases from 0% at a ratio of 0.25 to 1 to 1.25% at a ratio of 1.5 to 1. The First Amendment and Restatement also extended the maturity date from February 12, 2023 to the earlier of (i) December 16, 2023 and (ii) the date on which the Revolving Loan is terminated pursuant to the terms of the Revolving Loan agreement. The Company has the option to extend the initial term for an additional one-year term, provided no events of default exist and the Company provides the required notice of the extension pursuant to the First ~~Amendment.~~Amendment and Restatement. The Company incurred debt issuance costs of $859,500 related to the First Amendment and Restatement, which were capitalized and are subsequently being amortized through maturity.

On May 12, 2022, ~~the Company~~CAL entered into a second amended ~~the~~and restated Revolving Loan ~~Agreement~~agreement (the “Second ~~Amendment”~~Amendment and Restatement”). The Second Amendment and Restatement increased the loan commitment from $45,000,000 to $65,000,000. No other material terms of the Revolving Loan were modified as a result of the execution of the Second ~~Amendment.~~Amendment and Restatement. The Company incurred debt issuance costs of $177,261 related to the Second Amendment and Restatement, which were capitalized and are subsequently amortized through maturity. As of September 30, 2022 and December 31, 2021, unamortized debt issuance costs related to the Revolving Loan and the First and Second Amendments of $665,639 and $868,022, respectively, are recorded in other receivables and assets, net on the consolidated balance sheets.

The Revolving Loan incurs unused fees at a rate of 0.25% per annum which began on July 1, 2022 pursuant to the Second ~~Amendment. Additionally, during~~Amendment and Restatement.

On November 7, 2022, CAL entered into a third amended and restated Revolving Loan agreement (the “Third Amendment and Restatement”). The Third Amendment and Restatement increased the ~~period~~loan commitment from ~~January 1, 2022~~$65,000,000 to ~~September 30, 2022, the Company borrowed $53.0 million against~~$92,500,000. No other material terms of the Revolving Loan were modified as a result of the execution of the Third Amendment and Restatement. The Company incurred ~~$991,694 in interest expense for~~debt issuance costs of $323,779 related to the ~~period then ended.~~Third Amendment and Restatement, which were capitalized and are subsequently being amortized through maturity.

On February 27, 2023, CAL entered into an amendment to the Third Amendment and Restatement (the “Amendment”). The ~~Second~~ Amendment extended the contractual maturity date of the Revolving Loan until December 16, 2024 and the Company retained its option to extend the initial term for an additional one-year period, provided no events of default exist and the Company provides 365 days’ notice of the extension pursuant to the Amendment. No other material terms of the Revolving Loan were modified as a result of the execution of the Amendment. The Company incurred debt issuance costs of $2,988 related to the Amendment, which were capitalized and are subsequently amortized through maturity.

On June 30, 2023, CAL entered into a Fourth Amended and Restated Loan and Security Agreement (the “Fourth Amendment and Restatement”). The Fourth Amendment and Restatement increased the loan commitment from $92.5 million to $100.0 million. No other material terms of the Revolving Loan were modified as a result of the execution of the Fourth Amendment. The Company incurred debt issuance costs of $109,291 related to the Amendment, which were capitalized and are subsequently amortized through maturity.

The Revolving Loan provides for certain affirmative covenants, including requiring us to deliver financial information and any notices of default, and conducting business in the normal course. Additionally, the Company must comply with certain financial covenants including: (1) maximum capital expenditures of $150,000, (2) maintaining a debt service coverage ratio greater than 1.35 to 1, and (3) maintaining a leverage ratio less than 1.50 to 1. As of ~~September~~June 30, ~~2022, we were~~2023, the Company is in compliance with all financial covenants with respect to the Revolving Loan.

As of June 30, 2023 and December 31, 2022, unamortized debt issuance costs related to the Revolving Loan, including all amendments and amendments and restatements thereto, as applicable, of $662,938 and $805,596, respectively, are recorded in other receivables and assets, net on the consolidated balance sheets.

As of and for the six months ended June 30, 2023, the Company had net repayments of $15.0 million against the Revolving Loan. As of June 30, 2023, the Company had $57.0 million available under the Revolving Loan. Additionally, as of June 30, 2023, $279,229,247 of loans held for investment, at amortized cost, are pledged as collateral against the Revolving Loan.

The fair value of the Revolving Loan, which is classified as Level 2 in the fair value hierarchy, approximates the carrying value as it bears a market rate of interest that is reset frequently.

The following table reflects a summary of interest expense incurred during the three and ~~nine~~six months ended ~~September~~June 30, 2023 and 2022. ~~There was no interest expense incurred during the period March 30, 2021 (inception) to September 30, 2021.~~

					Three months ended		Three months ended		Six months ended		Six months ended
	Three months ended September 30, 2022		Nine months ended September 30, 2022		June 30, 2023		June 30, 2022		June 30, 2023		June 30, 2022
Interest expense	$	715,132	$	991,694	$	871,428	$	276,562	$	2,312,420	$	276,562
Unused fee expense		7,667		11,834		31,701		4,167		41,701		4,167
Amortization of deferred financing costs		138,549		379,644		91,797		168,827		259,101		241,095
Total interest expense	$	861,348	$	1,383,172	$	994,926	$	449,556	$	2,613,222	$	521,824

7. RELATED PARTY TRANSACTIONS

Management Agreement

Pursuant to the Management Agreement, the Manager ~~is responsible for managing~~will manage the ~~loan portfolio~~loans and ~~the~~ day-to-day operations of the Company, subject at all times to the further terms and conditions set forth in the Management Agreement and such further limitations or parameters as may be imposed from time to time by the Company’s Board.

The Manager is entitled to receive base management fees (the “Base Management Fee”) that are calculated and payable quarterly in arrears, in an amount equal to 0.375% of the Company’s Equity, determined as of the last day of each such quarter; reduced by an amount equal to 50% of the pro rata amount of origination fees earned and paid to the Manager during the applicable quarter for loans that were originated on the Company’s behalf by the Manager or affiliates of the Manager (“Outside Fees”). For the three and ~~nine~~six months ended ~~September~~June 30, 2023, the Base Management Fee payable was reduced by Outside Fees in the amount of $125,000 and $130,000, respectively. For the three and six months ended June 30, 2022, the Base Management Fee payable was reduced by Outside Fees in the amount of ~~$192,751~~$364,500 and ~~$1,275,001,~~$1,082,251, respectively.

In addition to the Base Management Fee, the Manager is entitled to receive incentive compensation (the “Incentive Compensation” or “Incentive Fees”) under the Management Agreement. Under the Management Agreement, the Company will pay Incentive Fees to the Manager based upon the Company’s achievement of targeted levels of Core Earnings. “Core Earnings” is defined in the Management Agreement as, for a given period, the net income (loss) for such period, computed in accordance with GAAP, excluding (i) non-cash equity compensation expense, (ii) the Incentive Compensation, (iii) depreciation and amortization, (iv) any unrealized gains or losses or other non-cash items that are included in net income for the applicable reporting period, regardless of whether such items are included in other comprehensive income or loss, or in net income, and (v) one-time events pursuant to changes in GAAP and certain non-cash charges, in each case after discussions between the Manager and the members of the Compensation Committee of the Board, each of whom are Independent Directors, and approved by a majority of the members of the Compensation Committee. Incentive compensation for the three and ~~nine~~six months ended ~~September~~June 30, 2023 was $874,854 and $1,986,060, respectively. Incentive compensation for the three and six months ended June 30, 2022 was ~~$519,223~~$598,763 and ~~$1,500,129,~~$980,906, respectively.

The Company shall pay all of its costs and expenses and shall reimburse the Manager or its affiliates for expenses of the Manager and its affiliates paid or incurred on behalf of the Company, excepting only those expenses that are specifically the responsibility of the Manager pursuant to the Management Agreement. We reimburse our Manager or its affiliates, as applicable, for the Company’s fair and equitable allocable share of the compensation, including annual base salary, bonus, any related withholding taxes and employee benefits, paid to (i) subject to review by the Compensation Committee of the Board, the Manager’s personnel serving as an officer of the Company, based on the percentage of his or her time spent devoted to the Company’s affairs and (ii) other corporate finance, tax, accounting, internal audit, legal, risk management, operations, compliance, and other non-investment personnel of the Manager and its affiliates who spend all or a portion of their time managing the Company’s affairs, with the allocable share of the compensation of such personnel described in this clause (ii) being as reasonably determined by the Manager to appropriately reflect the amount of time spent devoted by such personnel to our affairs.

The following table summarizes the related party fees and expenses incurred by the Company and amounts payable to the Manager for the three and ~~nine~~six months ended ~~September~~June 30, ~~2022, the three months ended September 30, 2021~~2023 and ~~for the period from March 30, 2021 (inception) to September 30, 2021. The Manager waived all amounts owed to it for the period ended September 30, 2021.~~2022.

For the
three months
ended
September 30,
2022 For the
three months
ended
September 30,
2021 For the
nine months
ended
September 30,
2022 Period from
March 30,
2021
(inception) to
September 30,
2021
Affiliate Payments
Management fees earned $ 1,020,949 $ - $ 3,041,359 $ -
Less: Outside fees earned (192,751 ) - (1,275,001 ) -
Base management fee, net 828,198 - 1,766,358 -
Incentive fees 519,223 - 1,500,129 -
Total management and incentive fees earned 1,347,421 - 3,266,487 -
General and administrative expenses reimbursable to Manager 980,949 - 2,132,419 -
Total $ 2,328,370 $ - $ 5,398,906 $ -

	For the three months ended June 30,						For the six months ended June 30,
	2023			2022			2023			2022
Affiliate Payments
Management fees earned	$	1,049,813		$	1,013,298		$	2,081,612		$	2,020,411
Less: Outside Fees earned		(125,000	)		(364,500	)		(130,000	)		(1,082,251	)
Base management fees, net		924,813			648,798			1,951,612			938,160
Incentive fees		874,854			598,763			1,986,060			980,906
Total management and incentive fees earned		1,799,667			1,247,561			3,937,672			1,919,066
General and administrative expenses reimbursable to Manager		1,212,210			686,981			2,388,586			1,151,471
Total	$	3,011,877		$	1,934,542		$	6,326,258		$	3,070,537

General administrative expenses reimbursable to the Manager are included in the related party payable line item of the consolidated balance sheets as of ~~September~~June 30, ~~2022~~2023 and December 31, ~~2021. Amounts~~2022. Total amounts payable to the Manager as of ~~September~~June 30, ~~2022~~2023 and December 31, ~~2021~~2022 were approximately ~~$2.6~~$3.4 million and ~~$2.7~~$4.7 million, respectively, which included bonuses accrued ~~for fiscal year 2022~~of $0.5 million which are not reimbursed to the Manager until paid.

Co-Investment in Loans

From time to time, the Company may co-invest with other investment vehicles managed by its affiliates, in accordance with the Manager’s co-investment allocation policies. The Company is not obligated to provide, nor has it provided, any financial support to the other managed investment vehicles. As such, the Company’s risk is limited to the carrying value of its investment in any such loan. As of ~~September~~June 30, 2023 and December 31, 2022, 18 and 15 of the Company’s loans were co-invested by affiliates of the ~~Company.~~Company, respectively.

~~On July 8, 2022,~~In connection with investments in loans, the Company may receive the option to assign the right (the “Assigned Right”) to acquire warrants and/or equity of the borrower. The Company may sell the Assigned Right, and the sale may be to an affiliate of the Company. The proceeds from the sale of Assigned Rights are accounted for as additional original issue discount and accreted over the life of the related loans. During the six months ended June 30, 2023, the Company sold an Assigned Right amounting to $237,885. There were no sales of Assigned Rights for the six months ended June 30, 2022.

During the six months ended June 30, 2023, the Company sold a senior secured loan to ~~an affiliate~~a syndicate of co-lenders, including a third party and two affiliates under common ~~control.~~control with our Manager. The total selling price of approximately ~~$6.7~~$14.2 million was approved by the audit committee of the Board. The fair value approximated the carrying value of the loan of $13.4 million plus accrued unpaid interest of $0.8 million through the sale date, March 31, 2023.

In addition, the Company purchased a senior secured loan from an affiliate under common control with our Manager. The purchase price of approximately $19.3 million was approved by the audit committee of the Board. The fair value approximated the carrying value of the loan of $19.0 million, plus accrued and unpaid ~~interest. On August 4, 2022,~~interest through the ~~Company assigned $10.0 million~~purchase date, January 24, 2023, of ~~unfunded commitment of a senior secured loan to an affiliate.~~$0.3 million.

8. COMMITMENTS AND CONTINGENCIES

Off-Balance Sheet Arrangements

Off-balance sheet commitments may consist of unfunded commitments on delayed draw term loans. The Company does not have any relationships with unconsolidated entities or financial partnerships, such as entities often referred to as structured investment vehicles, special purpose entities, or variable interest entities, established to facilitate off-balance sheet arrangements or other contractually narrow or limited purposes. Further, the Company has not guaranteed any obligations of unconsolidated entities or entered into any commitment to provide additional funding to any such entities. As of ~~September~~June 30, ~~2022~~2023 and December 31, ~~2021,~~2022, the Company had the following unfunded commitments on existing loans.

	As of September 30, 2022			As of December 31, 2021			As of June 30, 2023			As of December 31, 2022

Total original loan commitments	$	348,867,706		$	235,063,593		$	329,174,423		$	351,367,706
Less: drawn commitments		(330,384,897	)		(200,359,026	)		(315,570,423	)		(336,323,706	)
Total undrawn commitments	$	18,482,809		$	34,704,567		$	13,604,000		$	15,044,000

Refer to “Note 3 – Loans Held for Investment, Net” for further information regarding the CECL Reserve attributed to unfunded commitments. Total original loan commitments excludes the impact of principal payments received since origination of the loan.

As disclosed in Note 3, the Company has an aggregate commitment of $50.0 million to the borrower of Loan #25. The funding of such commitment is subject to certain conditions precedent being met for which the Company, as lender, may exercise its sole discretion in determining if and when such proceeds are advanced. Accordingly, this commitment is not included in total contractual commitments as of June 30, 2023.

The following table summarizes our material commitments as of June 30, 2023:

Commitments due by period
	2023		2024		2025		2026		2027		Thereafter		Total
Undrawn commitment	$	2,400,000	$	7,000,000	$	204,000	$	4,000,000	$	-	$	-	$	13,604,000
Revolving loan		-		43,000,000		-		-		-		-		43,000,000
Total	$	2,400,000	$	50,000,000	$	204,000	$	4,000,000	$	-	$	-	$	56,604,000

Other Contingencies

The Company from time to time may be a party to litigation in the normal course of business. As of ~~September~~June 30, ~~2022,~~2023, the Company is not aware of any legal claims that could materially impact its business, financial condition, or results of operations.

The Company’s ability to grow or maintain its business depends, in part, on state laws pertaining to the cannabis industry. New laws that are adverse to the Company’s portfolio companies may be enacted, and current favorable state or national laws or enforcement guidelines relating to cultivation, production, and distribution of cannabis may be modified or eliminated in the future, which would impede the Company’s ability to grow and could materially and adversely affect its business.

Management’s plan to mitigate risks include monitoring the legal landscape as deemed appropriate. Also, should a loan default or otherwise be seized, the Company may be prohibited from owning cannabis assets and thus could not take possession of collateral, in which case the Company would look to sell the loan, provide consent to allow the borrower to sell the real estate to a third party, institute a foreclosure proceeding to have the real estate sold or evict the tenant, have the cannabis operations removed from the property and take title to the underlying real estate, each of which may result in the Company realizing a loss on the transaction.

9. STOCKHOLDERS’ EQUITY

Common Stock

On January 5, 2022, the underwriters of the Company’s initial public offering (the “IPO”) partially exercised their over-allotment option to purchase 302,800 shares of the Company’s common stock at a price of $16.00 per share, raising $4,844,800 in additional gross proceeds or $4,505,664 in net proceeds after underwriting commissions of $339,136, which is reflected as a reduction of additional paid-in capital on the consolidated statements of stockholders’ equity.

During the period from March 30, 2021 (inception) to December 31, 2021, the Company issued 10,636,363 shares of its common stock pursuant to transactions that were exempt from registration pursuant to Section 4(a)(2) of the Securities Act of 1933, as amended.

On ~~December 10, 2021,~~February 15, 2023, the Company completed ~~its IPO~~a registered direct offering of ~~6,250,000~~395,779 shares of ~~its~~ common stock at a price of ~~$16.00~~$15.16 per share, raising ~~$100,000,000 in gross proceeds. The underwriting commission~~net proceeds of ~~$7,000,000 is reflected as a reduction of additional paid-in capital on the consolidated statements of stockholders’ equity.~~approximately $6.0 million. The Company incurred approximately $1,265,877 of expenses in connection with the IPO, which is reflected as a reduction in additional paid-in capital. The net proceeds to the Company totaled approximately $91,734,123. Concurrent with the closing of the IPO, the Company sold ~~468,750~~ shares of its common stock at the public offering price of $16.00 per share in a private placement to John Mazarakis, the Company’s Executive Chairman, Anthony Cappell, the Company’s Chief Executive Officer, and Dr. Andreas Bodmeier, the Company’s Co-President. Gross proceeds received were $7,500,000, and no underwriting discounts or commissions were paid in respect of these shares.

On October 21, 2021, the Board approved a 6,427-for-one stock split of the Company’s common stock. All common shares and per share information presented in the consolidated financial statements have been adjusted to reflect the stock split on a retroactive basis for all periods presented, including reclassifying an amount equal to the increase in par value of common stock ~~from additional paid-in capital. There was no change in~~directly, without the ~~par value~~use of ~~the Company’s common stock.~~underwriters or placement agents, to institutional investors registered pursuant to its effective shelf registration statement.

Equity Incentive Plan

The Company has established an equity incentive compensation plan (the “2021 Plan”). The Board authorized the adoption of the 2021 Plan and the Compensation Committee of the Board approved restricted stock award grants of 98,440 shares of common stock during the quarter ended December 31, 2021. The Compensation Committee appointed by the Board administers the 2021 Plan. The 2021 Plan authorizes stock options, stock appreciation rights, restricted stock, stock bonuses, stock units, and other forms of awards granted or denominated in the Company’s common stock. The 2021 Plan retains flexibility to offer competitive incentives and to tailor benefits to specific needs and circumstances. Any award may be structured to be paid or settled in cash. The Company has and currently intends to continue to grant restricted stock awards to participants in the 2021 Plan, but it may also grant any other type of award available under the 2021 Plan in the future. Persons eligible to receive awards under the 2021 Plan include the Company’s officers and employees of the Manager and its affiliates or officers and employees of the Company’s subsidiaries, if any, the members of the Board, and certain consultants and other service providers.

As of ~~September~~June 30, ~~2022~~2023 and December 31, ~~2021,~~2022, the maximum number of shares of the Company’s common stock that may be delivered pursuant to awards under the 2021 Plan (the “Share Limit”) equals 8.50% of the issued and outstanding shares of the Company’s common stock on a fully-diluted basis following the completion of the IPO. Shares that are subject to or underlie awards that expire or for any reason are cancelled or terminated, are forfeited, fail to vest, or for any other reason are not paid or delivered under the 2021 Plan will not be counted against the Share Limit and will again be available for subsequent awards under the 2021 Plan.

On December 31, 2022, restricted stock award grants of 24,880 shares of common stock were granted to members of the Board. Pursuant to each respective award agreement, the restricted stock awards (“RSA’s”) vest annually in equal installments over a three-year period beginning on the first anniversary of the date of the grant. Upon vesting, the vested restricted stock awards are exchanged for an equal number of the Company’s common stock.

On June 1, 2023, restricted stock award grants of 321,500 shares of common stock were granted to employees of our Manager. Pursuant to the respective award agreements, the RSA’s vest annually in equal installments over a three-year period beginning on the first anniversary of the date of the grant. Upon vesting, the vested restricted stock awards are exchanged for an equal number of the Company’s common stock.

There were ~~13,438~~1,147 and 4,063 shares forfeited during the ~~nine~~six months ended ~~September~~June 30, ~~2022. There is no forfeiture rate applied to awards or options granted to non-employee directors or executive employees because their pre-vesting forfeitures are anticipated to be highly unlikely.~~2023 and 2022, respectively. As individual awards and options become fully vested, stock-based compensation expense is adjusted to recognize actual forfeitures.

Shares that are exchanged by a participant or withheld by the Company as full or partial payment in connection with any award granted under the 2021 Plan, as well as any shares exchanged by a participant or withheld by the Company to satisfy tax withholding obligations related to any award granted under the 2021 Plan, will not be counted against the Share Limit and will again be available for subsequent awards under the 2021 Plan. To the extent that an award is settled in cash or a form other than shares, the shares that would have been delivered had there been no such cash or other settlement will not be counted against the Share Limit and will again be available for subsequent awards under the 2021 Plan.

Based on the closing market price of our common stock on June 30, 2023, the aggregate intrinsic value of our restricted stock awards was as follows:

	As of June 30, 2023
	Outstanding		Vested
Aggregate intrinsic value	$	5,871,186	$	633,861

The following table summarizes the restricted stock activity for the Company’s directors and officers and employees of the Manager ~~as of September~~during the six months ended June 30, ~~2022~~2023 and ~~December 31, 2021.~~2022.

As of
September 30,
2022 As of
December 31,
2021
Non-vested 98,440 98,440
Forfeited (13,438 ) -
Balance 85,002 98,440

	Six months ended June 30, 2023			Grant Date Fair Value per Share
Balance at December 31, 2022		80,984		$	15.71
Granted		321,500		$	14.75
Vested		(13,800	)	$	16.00
Forfeited		(1,147	)	$	16.00
Balance at June 30, 2023		387,537		$	14.90

	Six months ended June 30, 2022			Grant Date Fair Value per Share
Balance at December 31, 2021		98,440		$	16.00
Vested		-		$	16.00
Forfeited		(4,063	)	$	16.00
Unvested Balance at June 30, 2022		94,377		$	16.00

Restricted stock compensation expense is based on the Company’s stock price at the date of the grant and is amortized over the vesting period. Forfeitures are recognized as they occur. The share-based compensation expense for the Company was ~~$328,356~~$402,179 and $0$243,465 for the ~~nine~~six months ended ~~September~~June 30, ~~2022~~2023 and ~~for the period from March 30, 2021 (inception) to September 30, 2021,~~2022, respectively. The unamortized share-based compensation expense for the Company was approximately ~~$1.0 million as~~$5,577,827 and $1,078,216 for the six months ended June 30, 2023 and 2022, respectively, which the Company expects to recognize over the remaining weighted-average term of ~~September 30, 2022.~~2.7 years.

At-the-Market Offering Program (“ATM” Program”)

On June 20, 2023, the Company entered into an At-the-Market Sales Agreement (the “Sales Agreement”) with BTIG, LLC, Compass Point Research & Trading, LLC and Oppenheimer & Co. Inc. (each a “Sales Agent” and together the “Sales Agents”) under which the Company may, from time to time, offer and sell shares of common stock, having an aggregate offering price of up to $75.0 million. Under the terms of the Sales Agreement, the Company has agreed to pay the Sales Agents a commission of up to 3.0% of the gross proceeds from each sale of common stock sold through the Sales Agents. Sales of common stock, if any, may be made in transactions that are deemed to be “at-the-market” offerings, as defined in Rule 415(a)(4) promulgated under the Securities Act of 1933, as amended (the “Securities Act”).

During the quarter ended June 30, 2023, the Company sold an aggregate of 79,862 shares of the Company’s common stock under the Sales Agreement at an average price of $15.78 per share, generating net proceeds of approximately $1.2 million.

As of June 30, 2023, the shares of common stock sold pursuant to the registered direct offering in February 2023 and under the ATM Program are the only offerings that have been initiated under the Shelf Registration Statement.

10. EARNINGS PER SHARE

The following information sets forth the computations of basic earnings per common share for the three and ~~nine~~six months ended ~~September~~June 30, 2023 and 2022, ~~the three months ended September 30, 2021 and for the period from March 30, 2021 (inception) to September 30, 2021:~~respectively:

	For the three months ended June 30,				For the six months ended June 30,
	2023		2022		2023		2022
Net income attributable to common stockholders	$	8,643,378	$	7,463,839	$	19,335,727	$	15,267,791
Divided by:
Basic weighted average shares of common stock outstanding		18,094,288		17,657,913		17,989,684		17,649,548
Diluted weighted average shares of common stock outstanding		18,273,512		17,752,413		18,117,919		17,745,234
Basic earnings per common share	$	0.48	$	0.42	$	1.07	$	0.87
Diluted earnings per common share	$	0.47	$	0.42	$	1.07	$	0.86

For the
three months
ended
September 30,
2022 For the
three months
ended
September 30,
2021 For the
nine months
ended
September 30,
2022 Period from
March 30,
2021
(inception) to
September 30,
2021
Net income attributable to common stockholders $ 9,768,969 $ 4,067,521 $ 25,036,760 $ 5,136,072
Divided by:
Basic weighted average shares of common stock outstanding 17,657,913 $ 4,895,694 17,652,367 3,658,310
Diluted weighted average shares of common stock outstanding 17,752,290 $ 4,895,694 17,747,612 3,658,310
Basic earnings per common share $ 0.55 $ 0.83 $ 1.42 $ 1.40
Diluted earnings per common share $ 0.55 $ 0.83 $ 1.41 $ 1.40

~~11. INCOME TAX~~

~~The income tax provision for~~There were no anti-dilutive shares excluded from the ~~Company was $0~~computations of earnings per common share for ~~the nine months ended September 30, 2022.~~

~~For~~ the three and ~~nine~~six months ended ~~September~~June 30, ~~2022,~~2023 and 2022.

11. INCOME TAX

To qualify as a REIT, we must meet a number of organizational and operational requirements, including a requirement that we distribute annually to our stockholders at least 90% of our REIT taxable income prior to the ~~Company incurred no expense~~deduction for ~~United States federal~~dividends paid. To the extent that we distribute less than 100% of our REIT taxable income in any tax year (taking into account any distributions made in a subsequent tax year under Sections 857(b)(9) or 858 of the Code), we will pay tax at regular corporate rates on that undistributed portion. Furthermore, if we distribute less than the sum of 1) 85% of our ordinary income for the calendar year, 2) 95% of our capital gain net income for the calendar year, and 3) any undistributed shortfall from our prior calendar year (the “Required Distribution”) to our stockholders during any calendar year (including any distributions declared by the last day of the calendar year but paid in the subsequent year), then we are required to pay a non-deductible excise tax equal to 4% of any shortfall between the Required Distribution and the amount that was actually distributed. The 90% distribution requirement does not require the distribution of net capital gains. However, if we elect to retain any of our net capital gain for any tax year, we must notify our stockholders and pay tax at regular corporate rates on the retained net capital gain. Our stockholders must include their proportionate share of the retained net capital gain in their taxable income for the tax year, and they are deemed to have paid the REIT’s tax on their proportionate share of the retained capital gain. Furthermore, such retained capital gain may be subject to the nondeductible 4% excise tax. If it is determined that ~~the Company’s~~our estimated current year taxable income will be in excess of estimated dividend distributions (including capital gain dividend) for the current year from such income, ~~the Company~~we will accrue excise tax on estimated excess taxable income as such taxable income is earned. The annual expense is calculated in accordance with applicable tax regulations. Excise tax expense, if any, is included in the line item, income tax expense. For the six months ended June 30, 2023 and the year ended December 31, 2022, we did not incur excise tax expense. The income tax provision for the Company was $0 for the six months ended June 30, 2023 and the year ended December 31, 2022, respectively.

As of ~~September~~June 30, ~~2022~~2023 and December 31, ~~2021,~~2022, the Company does not have any unrecognized tax ~~benefits and does not expect that to change in the next 12 months.~~ benefits.

12. DIVIDENDS AND DISTRIBUTIONS

The following table summarizes the Company’s dividends declared during the ~~nine~~six months ended ~~September~~June 30, 2023 and 2022.

	Record Date	Payment Date	Common Share Distribution Amount		Taxable Ordinary Income		Return of Capital		Section 199A Dividends		Record Date	Payment Date	Common Share Distribution Amount		Taxable Ordinary Income		Return of Capital		Section 199A Dividends
Regular cash dividend	3/31/2022	4/14/2022	$	0.40	$	0.40	$	-	$	0.40	3/31/2023	4/14/2023	$	0.47	$	0.47	$	-	$	0.47
Regular cash dividend	6/30/2022	7/15/2022	$	0.47	$	0.47	$	-	$	0.47	6/30/2023	7/14/2023	$	0.47		0.47		-		0.47
Regular cash dividend	9/30/2022	10/14/2022	$	0.47	$	0.47	$	-	$	0.47
Total cash dividend			$	1.34	$	1.34	$	-	$	1.34			$	0.94	$	0.94	$	-	$	0.94

	Record Date	Payment Date	Common Share Distribution Amount		Taxable Ordinary Income		Return of Capital		Section 199A Dividends
Regular cash dividend	3/31/2022	4/14/2022	$	0.40	$	0.40	$	-	$	0.40
Regular cash dividend	6/30/2022	7/15/2022	$	0.47	$	0.47		-	$	0.47
Total cash dividend			$	0.87	$	0.87	$	-	$	0.87

13. SUBSEQUENT EVENTS

Investment Activity

~~On October 27, 2022, one borrower with $30.0~~

Through August 9, 2023, the Company funded approximately $18.7 million of ~~outstanding principal in multiple tranches maturing in April and May~~the $50.0 million commitment to the borrower of Loan #25.

Revolving Loan

During the period from July 1, 2023, ~~refinanced and consolidated~~through August 9, 2023, the ~~multiple tranches of debt into one loan maturing in October 2026.~~

On November 7, 2022, the Company’s wholly-owned financing subsidiary, CAL, entered into a Third Amended and Restated Loan and Security Agreement (the “Third Amendment”), whereby CAL exercised the existing accordion feature ofCompany borrowed $15.0 million on the Revolving ~~Loan to increase the aggregate commitment by $27.5 million, from $65 million to $92.5 million. No other material terms~~Loan. As of August 9, 2023, outstanding borrowings and remaining availability on the Revolving Loan were ~~modified~~$58.0 million and $42.0 million, respectively.

Payment of Dividend

On July 14, 2023, the Company paid its regular quarterly dividend of $0.47 per common share relating to the second quarter of 2023 to stockholders of record as ~~a result~~ of the ~~execution~~close of business on June 30, 2023. The total amount of the ~~Third Amendment. As of November 9, 2022, the Company has~~cash dividend payment was approximately ~~$34.5 million of availability under the Revolving Loan.~~ $8.5 million.

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

FORWARD-LOOKING STATEMENTS

Some of the statements contained in this quarterly report constitute forward-looking statements, within the meaning of the Private Securities Litigation Reform Act of 1995 and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), and we intend such statements to be covered by the safe harbor provisions contained therein. Forward-looking statements relate to future events or the future performance or financial condition of Chicago Atlantic Real Estate Finance, Inc. (the “Company,” “we,” “us,” and “our”). The information contained in this section should be read in conjunction with our consolidated financial statements and notes thereto appearing elsewhere in this quarterly report on Form 10-Q. This description contains forward-looking statements that involve risks and uncertainties. Actual results could differ significantly from the results discussed in the forward-looking statements due to the factors set forth in this quarterly report and in “Risk Factors” in our annual report on Form 10-K filed with the Securities and Exchange Commission (the “SEC”) and in Part II, Item 1A of this quarterly report on Form 10-Q, as such risks may by updated, amended, or superseded from time to time by subsequent reports we file with the SEC. The forward-looking statements contained in this report involve a number of risks and uncertainties, including statements concerning:

●

our future operating results and projected operating results;

●

~~the impact of COVID-19 on our business and the global economy, including disruptions to the supply chain;~~

●

the ability of our Manager to locate suitable loan opportunities for us, monitor and actively manage our loan portfolio, and implement our investment strategy;

●

the allocation of loan opportunities to us by our Manager;

●

the impact of inflation on our operating results;

●

actions and initiatives of the federal or state governments and changes to government policies related to cannabis and the execution and impact of these actions, initiatives, and policies, including the fact that cannabis remains illegal under federal law;

●

the estimated growth in and evolving market dynamics of the cannabis market;

●

the demand for cannabis cultivation and processing facilities;

●

shifts in public opinion regarding cannabis;

●

the state of the U.S. economy generally or in specific geographic regions;

●

economic trends and economic recoveries;

●

the amount and timing of our cash flows, if any, from our loans;

●

our ability to obtain and maintain financing arrangements;

●

our expected leverage;

●

changes in the value of our loans;

●

our expected investment and underwriting process;

●

rates of default or decreased recovery rates on our loans;

●

the degree to which any interest rate or other hedging strategies may or may not protect us from interest rate volatility;

●

changes in interest rates and impacts of such changes on our results of operations, cash flows, and the market value of our loans;

●

interest rate mismatches between our loans and our borrowings used to fund such loans;

●

the departure of any of the executive officers or key personnel supporting and assisting us from our Manager or its affiliates;

●

impact of and changes in governmental regulations, tax law and rates, accounting guidance, and similar matters;

●

our ability to maintain our exclusion or exemption from registration under the Investment Company Act;

●

our ability to qualify and maintain our qualification as a real estate investment trust (“REIT”) for U.S. federal income tax purposes;

●

estimates relating to our ability to make distributions to our stockholders in the future;

●

our understanding of our competition;

●

market trends in our industry, interest rates, real estate values, the securities markets or the general economy; and

●

any of the other risks, uncertainties and other factors we identify in our annual report on Form 10-K or this quarterly report on Form 10-Q.

Available Information

We routinely post important information for investors on our website, www.chicagoatlantic.com. We intend to use this webpage as a means of disclosing material information, for complying with our disclosure obligations under Regulation FD and to post and update investor presentations and similar materials on a regular basis. We encourage investors, analysts, the media, and others interested in us to monitor the Investments section of our website, in addition to following our press releases, SEC filings, public conference calls, presentations, webcasts and other information we post from time to time on our website. To sign-up for email-notifications, please visit “Contact” section of our website under “Join Our Mailing List” and enter the required information to enable notifications.

Overview

We are a commercial mortgage real estate ~~finance company.~~investment trust. Our primary investment objective is to provide attractive, risk-adjusted returns for stockholders over time primarily through consistent current income dividends and other distributions and secondarily through capital appreciation. We intend to achieve this objective by originating, structuring and investing in first mortgage loans and alternative structured financings secured by commercial real estate properties. Our current portfolio is comprised primarily of senior loans to state-licensed operators in the cannabis industry, secured by real estate, equipment, receivables, licenses or other assets of the borrowers to the extent permitted by applicable laws and regulations governing such borrowers. We intend to grow the size of our portfolio by continuing the track record of our business and the business conducted by our Manager and its affiliates by making loans to leading operators and property owners in the cannabis industry. There is no assurance that we will achieve our investment objective.

Our Manager and its affiliates seek to originate real estate loans between $5 million and $200 million, generally with one- to five-year terms and amortization when terms exceed three years. We generally act as co-lenders in such transactions and intend to hold up to ~~$30~~$50 million of the aggregate loan amount, with the remainder to be held by affiliates or third party co-investors. We may revise such concentration limits from time to time as our loan portfolio grows. Other investment vehicles managed by our Manager or affiliates of our Manager may co-invest with us or hold positions in a loan where we have also invested, including by means of splitting commitments, participating in loans or other means of syndicating loans. We will not engage in a co-investment transaction with an affiliate where the affiliate has a senior position to the loan held by us. To the extent that an affiliate provides financing to one of our borrowers, such loans will be working capital loans or loans that are subordinate to our loans. We may also serve as co-lenders in loans originated by third parties and, in the future, we may also acquire loans or loan participations. Loans that have a one to two year maturities are generally interest only loans.

Our loans are secured by real estate and, in addition, when lending to owner-operators in the cannabis industry, other collateral, such as equipment, receivables, licenses or other assets of the borrowers to the extent permitted by applicable laws and regulations. In addition, we seek to impose strict loan covenants and seek personal or corporate guarantees for additional protection. As of ~~September~~June 30, 2023 and December 31, 2022, 21.1% and 13.6%, respectively, of the principal of loans held in our portfolio are backed by personal or corporate guarantees. We aim to maintain a portfolio diversified across jurisdictions and across verticals, including cultivators, processors, dispensaries, as well as ancillary businesses. In addition, we may invest in borrowers that have equity securities that are publicly traded on the Canadian Stock Exchange (“CSE”) in Canada and/or over-the-counter in the United States.

As of June 30, 2023, our portfolio is comprised primarily of first mortgages to established multi-state or single-state cannabis operators or property owners. In addition, we own approximately $0.9 million, at fair value, of publicly-traded corporate bonds issued by a cannabis operator. We consider cannabis operators to be established if they are state-licensed and are deemed to be operational and in good standing by the applicable state regulator. We do not own any stock, warrants to purchase stock or other forms of equity in any of our portfolio companies that are involved in the cannabis industry, and we will not take stock, warrants or equity in such issuers until permitted by applicable laws and regulations, including U.S. federal laws and regulations.

We are an externally managed Maryland corporation that elected to be taxed as a REIT under Section 856 of the Code, commencing with our taxable year ended December 31, 2021. We believe that our method of operation will enable us to continue to qualify as a REIT. However, no assurances can be given that our beliefs or expectations will be fulfilled, since qualification as a REIT depends on us continuing to satisfy numerous asset, income, and distribution tests, which in turn depend, in part, on our operating results. We also intend to operate our business in a manner that will permit us and our subsidiaries to maintain one or more exclusions or exemptions from registration under the Investment Company Act.

Revenues

We operate as one operating segment and are primarily focused on financing senior secured loans and other types of loans for established state-licensed operators in the cannabis industry. These loans are generally held for investment and are substantially secured by real estate, equipment, licenses and other assets of the borrowers to the extent permitted by the applicable laws and the regulations governing such borrowers.

We generate revenue primarily in the form of interest income on loans. As of ~~September~~June 30, ~~2022~~2023 and December 31, ~~2021,~~2022, approximately ~~59.7%~~87.9% and ~~53.2%~~83.1%, respectively, of our portfolio was comprised of floating rate loans, and ~~40.3%~~12.1% and ~~46.8%~~16.9% of our portfolio was comprised of fixed rate loans, respectively. The floating rate loans described above are variable based upon the ~~prime rate~~Prime Rate plus an applicable margin, and in many cases, a ~~prime rate~~Prime Rate floor.

The ~~prime rate~~Prime Rate during the six months ended June 30, 2023 and the year ended December 31, 2022 was 3.25% for the period from January 1, 2022 through March 16, 2022, and increased to 3.50% effective March 17, 2022. It was increased to 4.00% effective May 5, 2022, increased to 4.75% effective June 16, 2022, increased to 5.50% effective July 28, 2022, and increased again to 6.25% effective September 22, 2022.as follows:

Effective Date	Rate⁽¹⁾
May 4, 2023		8.25	%
March 23, 2023		8.00	%
February 2, 2023		7.75	%
December 15, 2022		7.50	%
November 3, 2022		7.00	%
September 22, 2022		6.25	%
July 28, 2022		5.50	%
June 16, 2022		4.75	%
May 5, 2022		4.00	%
March 17, 2022		3.50	%
March 15, 2020		3.25	%

(1)	Rate obtained from the Wall Street Journal’s “Bonds, Rates & Yields” table.

Interest on our loans is generally payable monthly. The principal amount of our loans and any accrued but unpaid interest thereon generally become due at the applicable maturity date. In some cases, our interest income includes a paid-in-kind (“PIK”) component for a portion of the total interest. The PIK interest, computed at the contractual rate specified in each applicable loan agreement, is accrued in accordance with the terms of such loan agreement and capitalized to the principal balance of the loan and recorded as interest income. The PIK interest added to the principal balance is typically amortized and paid in accordance with the applicable loan agreement. In cases where the loans do not amortize, the PIK interest is collected ~~and recognized~~ upon repayment of the outstanding principal. We also generate revenue from original issue discounts (“OID”), which is also recognized as interest income ~~through amortization~~from loans over the initial term of the applicable loans. Delayed draw loans may earn interest or unused fees on the undrawn portion of the loan, which is recognized as interest income in the period earned. Other fees, including prepayment fees and exit fees, are also recognized as interest income when received. Any such fees will be generated in connection with our loans and recognized as earned in accordance with generally accepted accounting principles (“GAAP”).

Expenses

Our primary operating ~~expenses are~~expense is the payment of Base Management Fees and Incentive Compensation under our Management Agreement with our Manager and the allocable portion of overhead and other expenses paid or incurred on our behalf, including reimbursing our Manager for a certain portion of the compensation of certain personnel of our Manager who assist in the management of our affairs, excepting only those expenses that are specifically the responsibility of our Manager pursuant to our Management Agreement. We bear all other costs and expenses of our operations and transactions, including (without limitation) fees and expenses relating to:

●

organizational and offering expenses;

●

quarterly valuation expenses;

●

fees payable to third parties relating to, or associated with, making loans and valuing loans (including third-party valuation firms);

●

fees and expenses associated with investor relations and marketing efforts (including attendance at investment conferences and similar events);

●

accounting and audit fees and expenses from our independent registered public accounting firm;

●

federal and state registration fees;

●

any exchange listing fees;

●

federal, state and local taxes;

●

independent directors’ fees and expenses;

●

brokerage commissions;

●

costs of proxy statements, stockholders’ reports and notices; and

●

costs of preparing government filings, including periodic and current reports with the SEC.

Income Taxes

We are a Maryland corporation that elected to be taxed as a REIT under the Code, commencing with ~~our~~the taxable ~~year~~period ended December 31, 2021. We believe that we qualify as a REIT and that our method of operation will enable us to continue to qualify as a REIT. However, no assurances can be given that our beliefs or expectations will be fulfilled, since qualification as a REIT depends on us satisfying numerous asset, income and distribution tests which ~~depend,~~depends, in part, on our operating results.

To qualify as a REIT, we must meet a number of organizational and operational requirements, including a requirement that we distribute annually to our stockholders at least 90% of our REIT taxable income prior to the deduction for dividends ~~paid and our net capital gain.~~paid. To the extent that we distribute less than 100% of our REIT taxable income in any tax year (taking into account any distributions made in a subsequent tax year under Sections 857(b)(9) or 858 of the Code), we will pay tax at regular corporate rates on that undistributed portion. Furthermore, if we distribute less than the sum of 1) 85% of our ordinary income for the calendar year, 2) 95% of our capital gain net income for the calendar year, and 3) any ~~Required Distributions~~undistributed shortfall from our prior calendar year (the “Required Distribution”) to our stockholders during any calendar year (including any distributions declared by the last day of the calendar year but paid in the subsequent year), then we are required to pay a non-deductible excise tax equal to 4% of any shortfall between the Required Distribution and the amount that was actually distributed. The 90% distribution requirement does not require the distribution of net capital gains. However, if we elect to retain any of our net capital gain for any tax year, we must notify our stockholders and pay tax at regular corporate rates on the retained net capital gain. ~~The~~Our stockholders must include their proportionate share of the retained net capital gain in their taxable income for the tax year, and they are deemed to have paid the REIT’s tax on their proportionate share of the retained capital gain. Furthermore, such retained capital gain may be subject to the nondeductible 4% excise tax. If it is determined that our estimated current year taxable income will be in excess of estimated dividend distributions (including capital gain dividend) for the current year from such income, we will accrue excise tax on estimated excess taxable income as such taxable income is earned. The annual expense is calculated in accordance with applicable tax regulations. Excise tax expense, if any, is included in the line item, income tax expense. For the six months ended June 30, 2023 and the year ended December 31, 2022, we did not incur excise tax expense.

Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Topic 740 - Income Taxes (“ASC 740”), prescribes a recognition threshold and measurement attribute for the consolidated financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. ASC 740 also provides guidance on derecognition, classification, interest and penalties, accounting in interim periods, disclosure, and transition. We have analyzed our various federal and state filing positions and believe that our income tax filing positions and deductions are ~~well~~ documented and supported as of ~~September~~June 30, ~~2022.~~2023. Based on our evaluation, there is no reserve for any uncertain income tax positions. Accrued interest and penalties, if any, are included within other liabilities in the consolidated balance sheets.

Factors Impacting our Operating Results

The results of our operations are affected by a number of factors and primarily depend on, among other things, the level of our net interest income, the market value of our assets and the supply of, and demand for, commercial real estate debt and other financial assets in the marketplace. Our net interest income, which includes the accretion and amortization of OID, is recognized based on the contractual rate and the outstanding principal balance of the loans we originate. Interest rates will vary according to the type of loan, conditions in the financial markets, creditworthiness of our borrowers, competition and other factors, some of which cannot be predicted with any certainty. Our operating results may also be impacted by credit losses in excess of initial anticipations or unanticipated credit events experienced by borrowers.

Changes in Market Interest Rates and Effect on Net Interest Income

Interest rates are highly sensitive to many factors, including fiscal and monetary policies and domestic and international economic and political considerations, as well as other factors beyond our control. We will be subject to interest rate risk in connection with our assets and our related financing obligations.

Our operating results will depend in large part on differences between the income earned on our assets and our cost of borrowing. The cost of our borrowings generally will be based on prevailing market interest rates. During a period of rising interest rates, our borrowing costs generally will increase (a) while the yields earned on our leveraged fixed-rate loan assets will remain static, and (b) at a faster pace than the yields earned on our leveraged floating-rate loan assets, which could result in a decline in our net interest spread and net interest margin. The severity of any such decline would depend on our asset/liability composition at the time as well as the magnitude and duration of the interest rate increase. Further, an increase in short-term interest rates could also have a negative impact on the market value of our target investments. If any of these events happen, we could experience a decrease in net income or incur a net loss during these periods, which could adversely affect our liquidity and results of operations.

Interest Rate Cap Risk

We currently own and intend to acquire in the future floating-rate assets. These are assets in which the loans may be subject to periodic and lifetime interest rate caps and floors, which limit the amount by which the asset’s interest yield may change during any given period. However, our borrowing costs pursuant to our financing agreements may not be subject to similar restrictions. Therefore, in a period of increasing interest rates, interest rate costs on our borrowings could increase without limitation by caps, while the interest-rate yields on our floating-rate assets would effectively be limited. In addition, floating-rate assets may be subject to periodic payment caps that result in some portion of the interest being deferred and added to the principal outstanding. This could result in our receipt of cash income from such assets in an amount that is less than the amount that we would need to pay the interest cost on our related borrowings.

These factors could lower our net interest income or cause a net loss during periods of rising interest rates, which would harm our financial condition, cash flows and results of operations. As of June 30, 2023, all of our floating rate loans have interest rate floors, and one loan is subject to an interest rate cap (Note 3).

Interest Rate Mismatch Risk

We may fund a portion of our origination of loans, or of loans that we may in the future acquire, with borrowings that are based on the Prime Rate or a similar measure, while the interest rates on these assets may be fixed or indexed to the Prime Rate or another index rate. Accordingly, any increase in the Prime Rate will generally result in an increase in our borrowing costs that would not be matched by fixed-rate interest earnings and may not be matched by a corresponding increase in floating-rate interest earnings. Any such interest rate mismatch could adversely affect our profitability, which may negatively impact distributions to our stockholders.

Our analysis of risks is based on our Manager’s experience, estimates, models and assumptions. These analyses rely on models which utilize estimates of fair value and interest rate sensitivity. Actual economic conditions or implementation of decisions by our Manager and our management may produce results that differ significantly from the estimates and assumptions used in our models and the projected results.

Market Conditions

We believe that favorable market conditions, including an imbalance in supply and demand of credit to cannabis operating companies, have provided attractive opportunities for non-bank lenders, such as us, to finance commercial real estate loans and other loans that exhibit strong fundamentals but also require more customized financing structures and loan products than regulated financial institutions can presently provide. Additionally, to the extent that additional states legalize cannabis, our addressable market will increase. We intend to continue to capitalize on these opportunities and growing the size of our portfolio.

Developments During the ~~Third~~Second Quarter of ~~2022~~2023

Updates to Our Loan Portfolio during the ~~Third~~Second Quarter of ~~2022~~2023

In May 2023, the Company entered into an amendment to Loan #4, which extended the make-whole period through maturity and re-priced the second tranche to the prime rate plus a spread of 11.75%. In connection with the amendment, the Company received a $0.01 million amendment fee and also agreed to, subject to certain terms and conditions, waive compliance with certain covenants for one fiscal quarter.

In June 2023, the Company entered into an amendment to Loan #7, which resulted in a pay down of $5.0 million, along with applicable make-whole fees under the credit facility. Among other things, the amendment decreased the PIK rate from 2.5% to 2.0% and deferred an upcoming principal payment until September 30, 2023.

In June 2023, the Company entered into an amendment to Loan #18, to cure certain non-monetary covenant breaches which resulted in a re-pricing of the cash interest rate to the Prime Rate plus 1.75%.

~~On July 1, 2022, we closed one~~During May and June 2023, the Administrative Agent party to the Loan #9 credit facility with a new borrower, which has an aggregate commitment of $9.0 million, $5.0 million of which was advanced at closing. On July 8, 2022, we sold a senior secured loan to an affiliate under common control. The selling price of approximately $6.7 million was approved by the audit committeeagreement provided written notice, on behalf of the ~~Board. The fair value approximated~~Lenders, that one or more Events of Default occurred relating to failure to make principal and interest payments due for the ~~carrying value~~respective months, and for non-compliance with certain financial covenants and obligations pursuant to the agreement. On June 20, 2023, the Administrative Agent issued an acceleration notice resulting from these uncured Events of Default, requesting immediate payment of all amounts outstanding thereunder and notification that Administrative Agent intends to exercise rights and remedies with respect to the ~~loan plus accrued~~specified defaults in the event of further non-payment. As described in Note 3, Loan #9 has been placed on non-accrual status and ~~unpaid interest through July 8, 2022. On August 4, 2022, we assigned $10.0 million~~the Company will cease further recognition of ~~unfunded commitment~~income until such Events of ~~a senior secured loan to an affiliate. On September 2, 2022, we advanced approximately $680 thousand in aggregate principal on an existing credit facility to one borrower.~~Default are cured or obligations are repaid.

Subsequent Updates to Our Loan Portfolio

During the period from July 1, 2023 to August 9, 2023, we received unscheduled principal repayments of $1.6 million.

During the period from July 1, 2023 to August 9, 2023, we funded approximately $18.7 million of the $50.0 million commitment to the borrower of Loan #25.

At-the-Market Offering Program (“ATM” Program”)

On ~~October 27, 2022, one borrower~~June 20, 2023, the Company entered into an At-the-Market Sales Agreement (the “Sales Agreement”) with ~~$30.0 million~~BTIG, LLC, Compass Point Research & Trading, LLC and Oppenheimer & Co. Inc. (each a “Sales Agent” and together the “Sales Agents”) under which the Company may, from time to time, offer and sell shares of ~~outstanding principal~~common stock, having an aggregate offering price of up to $75.0 million. Under the terms of the Sales Agreement, the Company has agreed to pay the Sales Agents a commission of up to 3.0% of the gross proceeds from each sale of common stock sold through the Sales Agents. Sales of common stock, if any, may be made in ~~multiple tranches maturing~~transactions that are deemed to be “at-the-market” offerings, as defined in ~~April and May~~Rule 415(a)(4) promulgated under the Securities Act of ~~2023 refinanced and consolidated the multiple tranches of debt into one loan maturing in October 2026.~~1933, as amended (the “Securities Act”).

Dividends Declared Per Share

~~For~~During the ~~period from July 1, 2022 through September~~three months ended June 30, ~~2022,~~2023, we declared an ordinary cash dividend of $0.47 per share of our common stock, relating to the ~~third~~second quarter of ~~2022,~~2023, which was paid on ~~October~~July 14, ~~2022~~2023 to stockholders of record as of the close of business on ~~September~~June 30, ~~2022.~~2023. The total amount of the cash dividend payment was approximately ~~$8.3~~$8.5 million.

The payment of ~~these dividends~~this dividend is not indicative of our ability to pay such dividends in the future.

Results of Operations

~~For~~Comparison of the three months ended ~~September 30, 2022 and~~ June 30, 2023 and 2022

For the
three months
ended For the
three months
ended
September 30,
2022 June 30,
2022
Revenue
Interest income $ 13,795,097 $ 11,850,028
Interest expense (861,348 ) (449,556 )
Net interest income 12,933,749 11,400,472

Expenses
Management and incentive fees, net 1,347,421 1,247,561
General and administrative expense 1,076,798 777,212
Provision for current expected credit losses 306,885 1,045,665
Professional fees 348,785 743,670
Stock based compensation 84,891 122,525
Total expenses 3,164,780 3,936,633

Net Income before income taxes 9,768,969 7,463,839
Income tax expense - -
Net Income $ 9,768,969 $ 7,463,839

	For the three months ended June 30,						Variance
	2023			2022			Amount			%
Revenues
Interest income	$	14,659,222		$	11,850,028		$	2,809,194			24	%
Interest expense		(994,926	)		(449,556	)		(545,370	)		121	%
Net interest income		13,664,296			11,400,472			2,263,824			20	%

Expenses
Management and incentive fees, net		1,799,667			1,247,561			552,106			44	%
General and administrative expense		1,280,401			777,212			503,189			65	%
Professional fees		537,894			743,670			(205,776	)		(28	)%
Stock based compensation		263,844			122,525			141,319			115	%
Provision for current expected credit losses		1,139,112			1,045,665			93,447			9	%
Total expenses	$	5,020,918		$	3,936,633		$	1,084,285			28	%

Net Income before income taxes		8,643,378			7,463,839			1,179,539			16	%
Income tax expense					-
Net Income	$	8,643,378		$	7,463,839		$	1,179,539			16	%

●

Interest income increased by approximately ~~$1.9~~$2.8 million, or ~~16%~~24%, during the quarter ended ~~September~~June 30, ~~2022~~2023, compared to the quarter ended June 30, 2022. The increase was driven primarily by an increase in the ~~prime rate~~Prime Rate from 4.75% as of June 30, 2022, to ~~6.25%~~8.25% as of ~~September~~June 30, ~~2022,~~2023, impacting approximately ~~60%~~87.9% of the Company’s loans, as of June 30, 2023, which bear a floating ~~rate~~rate. Additionally, we recognized approximately $0.6 million of interest from prepayment fees on unscheduled principal repayments during the quarter ended June 30, 2023 as ~~well as new fundings of approximately $5.7 million~~compared to $0 for the same period in ~~loan principal.~~2022.

●

Net interest income increased approximately ~~$1.5~~$2.3 million or ~~13% during~~20% over the comparative period. The increase was ~~primarily~~ attributable to the increase in interest income described above, and was offset by a corresponding increase in interest ~~expense. During~~expense driven by the ~~third quarter~~timing of ~~2022, we borrowed an additional $8.0 million on~~borrowings and increase in the ~~revolving credit facility, which also~~Prime Rate as noted above given the Revolving Loan bears interest at the ~~prime rate~~Prime Rate plus an ~~applicable margin~~Applicable Margin. The outstanding balance on the Revolving Loan was $43,000,000 and ~~was subject to the prime rate increases during the quarter.~~$45,000,000, as of June 30, 2023 and 2022, respectively.

●

We incurred base management and incentive fees payable to our Manager of approximately ~~$1.3~~$1.8 million for the three months ended ~~September~~June 30, ~~2022,~~2023, as compared to approximately ~~$1.2~~$1.3 million for the three months ended June 30, 2022. The increase was primarily attributable to greater assets under management, which was offset by fewer origination fee offsets in the three months ended ~~September~~June 30, ~~2022 of~~2023 of approximately ~~$193,000,~~$0.1 million, compared to approximately ~~$365,000~~$0.4 million for the three months ended June 30, 2022, as well as an increase in weighted average equity as defined by the Management Agreement for the comparable period.

●

General and administrative expenses and professional fees ~~decreased~~increased by approximately ~~$95,000, or 6%,~~$0.3 million for the three months ended ~~September~~June 30, ~~2022~~2023, as compared to the three months ended June 30, 2022. The ~~decrease~~increase was primarily due to ~~a decrease in audit, legal, investor relations and third-party consulting fees, offset in part by~~ an increase in overhead reimbursements for costs incurred by the Manager on behalf of the ~~Company.~~Company which were $1.2 million for the three months ended June 30, 2023 compared to $0.7 million for the three months ended June 30, 2022. These increases were partially offset by a decrease in professional fees of $0.2 million during the comparative period.

●

Provision for current expected credit losses ~~decreased~~increased $0.1 million in the three months ended ~~September~~June 30, ~~2022~~2023 as compared to the three months ended June 30, 2022, primarily due to ~~the decrease in origination activities and fewer advances to our existing borrowers. The~~ declines in risk ratings ~~shown in the following table~~(discussed below) from ~~December 31, 2021 to September~~June 30, 2022 to June 30, 2023, which are ~~not~~ due to ~~any~~both borrower specific credit ~~issues relating to the borrowers, but rather, are primarily due to our~~changes, and quarterly ~~re-evaluation~~re-evaluations of overall current macroeconomic conditions affecting our ~~borrowers.~~borrowers and the industry. As interest rates have risen over the year ended December 31, 2022 and the six months ended June 30, 2023, the ability of our borrowers to service their debt and fund operations has been reduced. The current expected credit loss ~~reserve~~reserve represents 44approximately 160 basis ~~points~~points of our aggregate loan commitments held at carrying value of approximately ~~$348.9~~$329.2 million, as compared to approximately 35 basis points as of June 30, 2022, and was bifurcated between (i) the current expected credit loss reserve (contra-asset) related to outstanding balances on loans held at carrying value of approximately ~~$1.5~~$5.1 million and (ii) a liability for unfunded commitments of ~~$53,908.~~$0.2 million. The liability is based on the unfunded portion of loan commitments over the full contractual period over which we are exposed to credit risk through a current obligation to extend credit. Management considered the likelihood that funding will occur, and if funded, the expected credit loss on the funded portion. We continuously evaluate the credit quality of each loan by assessing the risk factors of each loan.

~~For the nine months ended September 30, 2022 and period from March 30, 2021 (inception) to September 30, 2021~~

For the
nine months
ended
September 30,
2022
Period
from
March 30,
2021
(inception)
to
September 30,
2021
Revenue
Interest income $ 35,478,178 $ 5,295,812
Interest expense (1,383,172 ) (41,918 )
Net interest income 34,095,006 5,253,894

Expenses
Management and incentive fees, net 3,266,487 -
General and administrative expense 2,410,151 13,531
Organizational expense - 104,291
Provision for current expected credit losses 1,403,892 -
Professional fees 1,649,360 -
Stock based compensation 328,356 -
Total expenses $ 9,058,246 $ 117,822

Net Income before income taxes 25,036,760 5,136,072
Income tax expense - -
Net Income $ 25,036,760 $ 5,136,072

~~We commenced operations on March 30, 2021 and, therefore,~~Comparison of the ~~comparative period for the three and nine~~six months ended ~~September~~June 30, 2023 and 2022 ~~is from March 30, 2021 (inception) to September 30, 2021 (the “Prior Period” or “period ended September 30, 2021”).~~

●

Interest income increased as we deployed a significant amount of capital subsequent to September 30, 2021 as a result of our initial public offering and higher interest rates on our floating rate loans held for investment, reflecting an increasing trend in interest income.

	For the six months ended June 30,						Variance
	2023			2022			Amount			%
Revenues
Interest income	$	31,186,526		$	21,683,081		$	9,503,445			44	%
Interest expense		(2,613,222	)		(521,824	)		(2,091,398	)		401	%
Net interest income		28,573,304			21,161,257			7,412,047			35	%

Expenses
Management and incentive fees, net		3,937,672			1,919,066			2,018,606			105	%
General and administrative expense		2,555,226			1,333,353			1,221,873			92	%
Professional fees		1,107,269			1,300,574			(193,305	)		(15	)%
Stock based compensation		402,179			243,465			158,714			65	%
Provision for current expected credit losses		1,235,231			1,097,008			138,223			13	%
Total expenses	$	9,237,577		$	5,893,466		$	3,344,111			57	%

Net Income before income taxes		19,335,727			15,267,791			4,067,936			27	%
Income tax expense					-
Net Income	$	19,335,727		$	15,267,791		$	4,067,936			27	%

●

~~We drew $53~~

Interest income increased by approximately $9.5 million, ~~on the revolving credit facility~~or 44%, during the ~~nine~~six months ended ~~September~~June 30, ~~2022 contributing~~2023, compared to the six months ended June 30, 2022. The increase was driven primarily by an increase in the Prime Rate discussed above, impacting approximately 87.9% of the Company’s loans, which bear a floating rate as of June 30, 2023, compared to 59.8% as of June 30, 2022.

Additionally, we recognized approximately $1.7 million of interest from prepayment fees on unscheduled principal repayments during the six months ended June 30, 2023 as compared to $0 for the same period in 2022.

●

Interest expense increased approximately $2.1 million over the comparative period resulting from timing of borrowings and amounts outstanding under the Revolving Loan, but primarily due to the series of Prime Rate increases from 4.75% to 8.25% as of June 30, 2023. Additionally, the Company increased the availability under the Revolving Loan from $65.0 million as of June 30, 2022 to $100.0 million as of June 30, 2023, resulting in an increase to unused fee interest expense ~~that previously included only amortization~~(25 basis points of ~~deferred financing costs for~~amounts outstanding) during the comparative ~~prior year~~ period.

●

We incurred base management and incentive fees payable to our Manager ~~for the nine months ended September 30, 2022~~ of approximately $3.3 million and $0 for the period ended September 30, 2021. Pursuant to a Fee Waiver Letter Agreements executed by our Manager, dated September 30, 2021, all base management fees that would have been payable to our Manager for the period from May 1, 2021 to September 30, 2021 were voluntarily waived and are not subject to recoupment at a later date. Our Manager has incurred general administrative expenses on our behalf and was reimbursed approximately $2.1$3.9 million for the ~~nine~~six months ended ~~September~~June 30, ~~2022. For~~2023, as compared to approximately $1.9 million for the ~~period~~six months ended ~~September~~June 30, ~~2021, all reimbursements~~2022, an increase of approximately $2.0 million. The increase was primarily attributable to ~~our Manager~~greater assets under management, which was offset by fewer origination fee offsets in the six months ended June 30, 2023 of approximately $0.1 million, compared to approximately $1.1 million for ~~general~~the six months ended June 30, 2022 as well as an increase in weighted average equity as defined by the Management Agreement for the comparable period.

●

General and administrative expenses ~~were waived.~~and professional fees increased by approximately $1.0 million for the six months ended June 30, 2023, as compared to the six months ended June 30, 2022. The increase was primarily due to an increase in overhead reimbursements for costs incurred by the Manager of $2.4 million for the six months ended June 30, 2023 compared to $1.2 million for the same period in 2022, offset by a decrease in professional fees of $0.2 million.

●

Provision for current expected credit losses increased by $0.1 million in the ~~nine~~six months ended ~~September~~June 30, ~~2022~~2023 as compared to the ~~period~~six months ended ~~September~~June 30, ~~2021. The declines~~2022, primarily due to changes in risk ratings ~~shown in~~from June 30, 2022 to June 30, 2023 and benchmark loss rates for commercial real estate loans resulting from macroenvironmental conditions. As interest rates have risen over the ~~following table from~~year ended December 31, ~~2021~~2022 and the six months ended June 30, 2023, the ability of borrowers to September 30, 2022, are not due to any borrower specific credit issues relating to the borrowers, but rather, are primarily due to our re-evaluation of overall current macroeconomic conditions affecting our borrowers.service their debt and fund operations becomes more constrained. The current expected credit loss ~~reserve~~reserve represents 44approximately 160 basis points of our aggregate loan commitments held at ~~held at~~ carrying value of approximately ~~$348.9~~$329.2 million and was bifurcated between (i) the current expected credit loss reserve (contra-asset) related to outstanding balances on loans held at carrying value of approximately ~~$1.5~~$5.1 million and (ii) a liability for ~~unfunded~~unfunded commitments of ~~$53,908.~~$0.2 million. The liability is based on the unfunded portion of loan commitments over the full contractual period over which we are exposed to credit risk through a current obligation to extend credit. Management considered the likelihood that funding will occur, and if funded, the expected credit loss on the funded portion. We continuously evaluate the credit quality of each loan by assessing the risk factors of each loan.

●

~~Professional fees increased in the nine months ended September 30, 2022 as compared to the period ended September 30, 2021 primarily as a result of higher audit and consulting fees.~~

●

Stock based compensation was issued in December 2021 following the completion of our initial public offering resulting in $328,356 in stock compensation expense for the nine months ended September 30, 2022.

Loan Portfolio

As of ~~September~~June 30, ~~2022~~2023 and December 31, ~~2021,~~2022, our portfolio included 2225 and 2122 loans held for investment, of approximately ~~$331.1~~$314.5 million and ~~$197.0~~$339.3 million, ~~of loans receivable, respectively.~~respectively, prior to the reserve for current expected credit losses. The aggregate originated commitment under these loans was approximately ~~$348.9~~$329.2 million and ~~$235.1~~$351.4 million and outstanding principal was approximately ~~$334.5~~$318.0 million and ~~$200.6~~$343.0 million as of ~~September~~June 30, ~~2022~~2023 and December 31, ~~2021,~~2022, respectively. As of ~~September~~June 30, ~~2022~~2023 and December 31, ~~2021,~~2022, our loan portfolio had a weighted-average yield-to-maturity internal rate of return (“YTM IRR”) of ~~18.3%~~19.2% and ~~18.6%~~19.7%, respectively, and was substantially secured by real estate and, with respect to certain of our loans, substantially all assets of the borrowers and certain of their subsidiaries, including equipment, receivables, and licenses. YTM IRR is calculated using various inputs, including (i) cash and ~~payment-in-kind~~paid-in-kind (“PIK”) interest, which is capitalized and added to the outstanding principal balance of the applicable loan, (ii) original issue discount (“OID”), (iii) amortization, (iv) unused fees, and (v) exit fees. Certain of our loans have extension fees, which are not included in our YTM IRR calculations, but may increase YTM IRR if such extension options are exercised by borrowers.

As of ~~September~~June 30, ~~2022~~2023 and December 31, ~~2021,~~2022, approximately ~~59.7%~~87.9% and ~~53.2%~~83.1%, respectively, of ~~its~~our portfolio was comprised of floating rate loans that pay interest at the ~~prime rate~~Prime Rate plus an applicable margin and were subject to a ~~prime rate~~Prime Rate floor. The ~~prime rate~~Prime Rate was 3.25% for the period from January 1, 2022 through March 16, 2022, increased to ~~3.5%~~3.50% effective March 17, 2022, increased to ~~4.0%~~4.00% effective May 5, 2022, increased ~~again~~ to 4.75% effective June 16, 2022, increased to 5.50% effective July 28, 2022, ~~and~~ increased ~~again~~ to 6.25% effective September 22, ~~2022.~~ 2022, increased to 7.00% effective November 3, 2022, increased to 7.50% effective December 15, 2022, increased to 7.75% effective February 2, 2023, increased to 8.00% effective March 23, 2023 and increased again to 8.25% effective May 4, 2023. The below summarizes our portfolio as of ~~September~~June 30, ~~2022:~~2023:

	Funding	Maturity	Total		Principal		Carrying		Our Loan			Future		Interest	Periodic	YTM					Initial								Original Issue						Percent of Our
Loan	Date (1)	Date (2)	Commitment (3)		Balance		Value		Portfolio			Fundings		Rate (4)	Payment (5)	IRR (6)				Location(s)	Funding Date (1)		Maturity Date (2)		Total Commitment (3)		Principal Balance		Discount			Carrying Value			Loan Portfolio			Future Fundings		Interest Rate (4)	Periodic Payment (5)	YTM IRR (6)
1⁽⁸⁾	7/2/2020	5/30/2023		30,000,000		30,000,000		29,712,254		9.0	%		-	10.07%	I/O		12.8	%		Various		10/27/2022		10/30/2026	$	30,000,000	$	30,000,000	$	(748,770	)	$	29,251,230			9.3	%		-	P+6.50% Cash, 0% PIK (10)	I/O		17.0	%
2	3/5/2021	12/31/2024		35,891,667		36,646,551		36,464,426		11.0	%		-	P + 6.65%(7)(13) Cash, 3.25% PIK	P&I		16.9	%		Michigan		3/5/2021		12/31/2024		35,891,667		38,001,475		(121,831	)		37,879,644			12.0	%		-	P+6.65% Cash, 4.25% PIK (7)(15)	P&I		18.0	%
3	3/25/2021	11/29/2024		20,105,628		20,673,831		20,229,374		6.1	%		-	13.91 Cash, 2.59% PIK(12)	P&I		20.8	%
4⁽⁹⁾	4/19/2021	12/31/2023		12,900,000		11,909,539		11,909,539		3.6	%		939,952	19.01%	P&I		23.4	%
3(17)																				Various		3/25/2021		11/29/2024		20,105,628		20,392,227		(438,589	)		19,953,638			6.3	%		-	P+10.375% Cash, 2.75% PIK (7)	P&I		23.2	%
4(16)																				Arizona		4/19/2021		12/31/2023		14,120,000		13,970,276		-			13,970,276			4.4	%		-	P+11.75% Cash (9)	I/O		17.5	%
5	4/19/2021	4/30/2023		3,500,000		1,500,000		1,500,000		0.5	%		2,000,000	P + 12.25%(7)	P&I		24.3	%		Massachusetts		4/19/2021		4/30/2025		3,500,000		3,296,000		-			3,296,000			1.0	%		204,000	P+12.25% Cash (7)	P&I		22.4	%
6	5/28/2021	5/31/2025		12,900,000		13,263,665		13,263,665		4.0	%		-	P + 10.75%(7) Cash, 4% PIK(10)	P&I		22.3	%		Michigan		8/20/2021		2/20/2024		6,000,000		4,264,421		(2,464	)		4,261,957			1.4	%		1,500,000	P+9.00% Cash (7)	P&I		20.7	%
7	8/20/2021	2/20/2024		6,000,000		4,443,750		4,438,192		1.3	%		1,500,000	P + 9.00%(7)	P&I		16.5	%		Illinois, Arizona		8/24/2021		6/30/2025		25,000,000		20,807,799		(171,792	)		20,636,007			6.6	%		-	P+6.00% Cash, 2% PIK (11)	P&I		18.5	%
8	8/24/2021	6/30/2025		25,000,000		23,168,151		22,925,222		6.9	%		2,142,857	13% Cash, 2.5% PIK	P&I		17.4	%		West Virginia		9/1/2021		9/1/2024		9,500,000		11,030,188		(74,371	)		10,955,817			3.5	%		-	P+9.25% Cash, 2% PIK (7)	P&I		26.0	%
9	9/1/2021	9/1/2024		9,500,000		9,554,960		9,433,374		2.8	%		-	P + 9.25%(7) Cash, 2% PIK	P&I		19.9	%
9(19)																				Pennsylvania		9/3/2021		6/30/2024		15,000,000		16,155,903		-			16,155,903			5.1	%		-	P+10.75% Cash, 3% PIK (7)	P&I		19.2	%
10	9/3/2021	6/30/2024		15,000,000		15,536,102		15,536,102		4.7	%		-	P + 10.75%(7) Cash, 3% PIK	P&I		22.8	%		Michigan		9/20/2021		9/30/2024		470,411		196,005		-			196,005			0.1	%		-	11% Cash	P&I		21.4	%
11	9/20/2021	9/30/2024		470,411		313,607		313,607		0.1	%		-	11.00%	P&I		21.4	%		Maryland		9/30/2021		9/30/2024		32,000,000		32,975,433		(447,955	)		32,527,478			10.3	%		-	P+8.75% Cash, 2% PIK (7)	I/O		21.8	%
12	9/30/2021	9/30/2024		32,000,000		32,479,495		31,764,528		9.6	%		-	P + 8.75%(7) Cash, 2% PIK	I/O		19.4	%		Various		11/8/2021		10/31/2024		13,574,667		12,628,000		(90,634	)		12,537,366			4.0	%		-	P+9.25% Cash (12)	P&I		19.5	%
13	11/8/2021	10/31/2024		20,000,000		20,000,000		19,789,890		6.0	%		-	13.00%	P&I		15.9	%		Michigan		11/22/2021		11/1/2024		13,100,000		13,111,841		(91,308	)		13,020,533			4.1	%		-	P+6.00% Cash, 1.5% PIK (11)	I/O		18.7	%
14	11/22/2021	11/22/2022		10,600,000		10,600,000		10,577,513		3.2	%		-	P + 7.00%(7)	I/O		17.9	%		Various		12/27/2021		12/27/2026		5,000,000		5,125,000		-			5,125,000			1.6	%		-	P+12.25% Cash, 2.5% PIK (8)	P&I		23.5	%
15	12/27/2021	12/27/2026		5,000,000		5,000,000		5,000,000		1.5	%		-	15% Cash, 2.5% PIK	P&I		18.5	%		Michigan		12/29/2021		12/29/2023		6,000,000		3,884,077		(22,438	)		3,861,639			1.2	%		2,400,000	P+17.5% Cash, 5% PIK (9)	I/O		27.0	%
16	12/29/2021	12/29/2023		6,000,000		3,739,861		3,683,765		1.1	%		2,400,000	10.50% Cash, 1% to 5% PIK(11)	I/O		20.6	%		Florida		12/30/2021		12/31/2024		13,000,000		6,825,000		(37,603	)		6,787,397			2.2	%		5,500,000	P+9.25% Cash (7)	I/O		22.7	%
17	12/30/2021	12/31/2024		13,000,000		7,500,000		7,443,733		2.2	%		5,500,000	P + 9.25%(7)	I/O		20.6	%		Florida		1/18/2022		1/31/2025		15,000,000		15,000,000		(200,009	)		14,799,991			4.7	%		-	P+4.75% Cash (10)	P&I		14.2	%
18	1/18/2022	1/31/2025		15,000,000		15,000,000		14,706,011		4.4	%		-	11.00%	P&I		13.1	%		Ohio		2/3/2022		2/28/2025		11,662,050		12,837,973		(132,125	)		12,705,848			4.0	%		-	P+1.75% Cash, 3% PIK (11)	P&I		19.8	%
19	2/3/2022	2/28/2025		30,000,000		30,602,729		30,130,650		9.1	%		-	P + 8.25%(7) Cash, 3% PIK	P&I		23.4	%		Florida		3/11/2022		8/29/2025		20,000,000		20,794,861		(62,431	)		20,732,430			6.6	%		-	11% Cash, 3% PIK	P&I		15.5	%
20	3/11/2022	8/29/2025		20,000,000		20,327,703		20,243,185		6.1	%		-	11% Cash, 3% PIK	P&I		15.4	%		Missouri		5/9/2022		5/30/2025		17,000,000		17,513,744		(106,535	)		17,407,209			5.5	%		-	11% Cash, 3% PIK	P&I		14.7	%
21	5/9/2022	5/30/2025		17,000,000		17,204,978		17,056,894		5.2	%		-	11% Cash, 3% PIK	P&I		15.5	%		Illinois		7/1/2022		6/30/2026		9,000,000		5,153,793		(67,999	)		5,085,794			1.6	%		4,000,000	P+8.50% Cash, 3% PIK	P&I		26.6	%
22	7/1/2022	6/30/2026		9,000,000		5,038,013		4,953,623		1.5	%		4,000,000	P + 8.50%(7) Cash, 3% PIK	P&I		25.1	%		Maryland		1/24/2023		1/24/2026		11,250,000		11,093,727		(578,307	)		10,515,420			3.3	%		-	P+5.75% Cash, 1.4% PIK (10)	P&I		20.1	%
23																				Arizona		3/27/2023		3/31/2026		2,000,000		1,980,000		(45,682	)		1,934,318			0.6	%		-	P+7.50% Cash, 0% PIK (13)	P&I		18.6	%
24																				Oregon		3/31/2023		9/27/2026		1,000,000		940,000		-			940,000			0.3	%		-	P+10.50% Cash, 0% PIK (9)	P&I		21.5	%
25(18)																				New York		-		-		-		-		-			-			0.0	%		-	15% Cash	P&I		16.3	%
		Subtotal		348,867,706		334,502,935		331,075,547		100.0	%		18,482,809	15.8%	Wtd Average		18.3	%
Current expected credit loss reserve																			Current expected credit loss reserve							-		-		-			(5,121,577	)
Total loans held at carrying value																			Total loans held at carrying value							329,174,423		317,977,743		(3,440,843	)		309,415,323			100.0	%		13,604,000		Wtd Average		19.2	%

(1)	All loans originated prior to April 1, 2021 were purchased from affiliated entities at fair value plus accrued interest on or subsequent to April 1, 2021.

~~(2)~~

~~Certain loans have extension options from original maturity date.~~

(2)	Certain loans are subject to contractual extension options and may be subject to performance based on other conditions as stipulated in the loan agreement. Actual maturities may differ from contractual maturities stated herein as certain borrowers may have the right to prepay with or without a contractual prepayment penalty. The Company may also extend contractual maturities and amend other terms of the loans in connection with loan modifications.
(3)	Total Commitment excludes future amounts to be advanced at sole discretion of the ~~lender.~~lender and reflects receipt of scheduled amortization payments as of June 30, 2023.
(4)	“P” = prime rate and depicts floating rate loans that pay interest at the prime rate plus a specific percentage; “PIK” = ~~paid in kind interest.~~paid-in-kind interest; subtotal represents weighted average interest rate.
(5)	P&I = principal and interest. I/O = interest only. P&I loans may include interest only periods for a portion of the loan term.
(6)	Estimated YTM includes a variety of fees and features that affect the total yield, which may include, but is not limited to, OID, exit fees, prepayment fees, unused fees and contingent features. OID is recognized as a discount to the funded loan principal and is accreted to income over the term of the loan. The estimated YTM calculations require management to make estimates and assumptions, including, but not limited to, the timing and amounts of loan draws on delayed draw loans, the timing and collectability of exit fees, the probability and timing of prepayments and the probability of contingent features occurring. For example, certain credit agreements contain provisions pursuant to which certain PIK interest rates and fees earned by us under such credit agreements will decrease upon the satisfaction of certain specified criteria which we believe may improve the risk profile of the applicable borrower. To be conservative, we have not assumed any prepayment penalties or early payoffs in our estimated YTM calculation. Estimated YTM is based on current management estimates and assumptions, which may change. Actual results could differ from those estimates and assumptions.
(7)	This Loan is subject to a prime rate ~~floor.~~floor of 3.25%
(8)	This Loan is subject to a prime rate floor of 4.75%
(9)	This Loan is subject to a prime rate floor of 5.50%
(10)	This Loan is subject to a prime rate floor of 6.25%
(11)	This Loan is subject to a prime rate floor of 7.00%
(12)	This Loan is subject to a prime rate floor of 7.50%
(13)	This Loan is subject to a prime rate floor of 8.00%
(14)	This Loan is subject to a prime rate floor of 8.25%
(15)	This Loan is subject to a prime rate cap of 5.85%
(16)	The aggregate loan commitment to ~~Loan #1 includes a $4.005 million initial advance which has an interest rate~~the borrower of 15.25%, a second advance of $15.995 million, which has an interest rate of 9.75%, and a third advance of $10.0 million, which has an interest rate of 8.5%. The statistics presented reflect the weighted average of the terms under all three advances for the total aggregate loan commitment.
~~(9)~~	~~The aggregate loan commitment to~~ Loan #4 includes a ~~$10.0~~$10.9 million ~~advance, which has a base interest rate of 15.00%,~~initial commitment advanced in April 2021, and a second ~~advance~~loan commitment of $2.0 million which ~~has an interest rate of 39.00%. The statistics~~was advanced in December 2021.The weighted average yield presented ~~reflect~~reflects the weighted average of the terms under both advances for the total aggregate loan commitment.
~~(10)~~	~~Subject to adjustment not below 2% if borrower receives at least two consecutive quarters of positive cash flow after the closing date.~~
~~(11)~~	PIK is variable with an initial rate of five percent (5.00%) per annum, until borrower’s delivery of audited financial statements for the fiscal year ended December 31, 2021, at which time the PIK interest rate shall be adjusted to a rate of 1% to 5% contingent on the financial results of the borrower.

~~(12)~~(17)

The aggregate loan commitment to Loan #3 includes a $15.9 million initial ~~advance,~~commitment which has a base interest rate of 13.625%, 2.75% PIK and a second ~~advance~~commitment of $4.2 million which has an interest rate of 15.00%, 2.00% PIK. The statistics presented reflect the weighted average of the terms under ~~both~~all advances for the total aggregate loan commitment.

~~(13)~~(18)

~~This~~The Company has an aggregate commitment of $50.0 million to the borrower of Loan #25. The funding of such commitment is subject to ~~an interest rate cap.~~certain conditions precedent being met for which the Company, as lender, may exercise its sole discretion in determining if and when such proceeds are advanced. Accordingly, this commitment is not included in total contractual commitments as of June 30, 2023. During the period from July 1, 2023 through August 9, 2023, the Company advanced $18.7 million of the Loan #25 commitment.

(19)

As of May 1, 2023, Loan #9 has been placed on non-accrual status.

The following tables summarize our loans held for investment as of ~~September~~June 30, ~~2022~~2023 and December 31, ~~2021:~~2022:

	As of September 30, 2022										As of June 30, 2023
	Outstanding Principal (1)		Original Issue Discount			Carrying Value (1)			Weighted Average Remaining Life (Years) (2)		Outstanding Principal (1)		Original Issue Discount			Carrying Value (1)			Weighted Average Remaining Life (Years) (2)
Senior Term Loans	$	334,502,935	$	(3,427,388	)	$	331,075,547			2.1	$	317,977,743	$	(3,440,843	)	$	314,536,900			1.8
Current expected credit loss reserve		-		-			(1,497,933	)				-		-			(5,121,577	)
Total loans held at carrying value, net	$	334,502,935	$	(3,427,388	)	$	329,577,614				$	317,977,743	$	(3,440,843	)	$	309,415,323

	As of December 31, 2022
	Outstanding Principal (1)		Original Issue Discount			Carrying Value (1)			Weighted Average Remaining Life (Years) (2)
Senior Term Loans	$	343,029,334	$	(3,755,796	)	$	339,273,538			2.2
Current expected credit loss reserve		-		-			(3,940,939	)
Total loans held at carrying value, net	$	343,029,334	$	(3,755,796	)	$	335,332,599

(1)	The difference between the Carrying Value and the Outstanding Principal amount of the loans consists of unaccreted original issue discount, deferred loan fees and other upfront fees. Outstanding principal balance includes capitalized PIK interest, if applicable.

(2)	Weighted average remaining life is calculated based on the carrying value of the loans as of June 30, 2023 and December 31, 2022, respectively.

The following tables present changes in loans held for investment at carrying value as of and for the six months ended June 30, 2023 and 2022:

	Principal (1)			Original Issue Discount			Current Expected Credit Loss Reserve			Carrying Value (1)
Balance at December 31, 2022	$	343,029,334		$	(3,755,796	)	$	(3,940,939	)	$	335,332,599
New fundings		35,910,000			(1,118,340	)		-			34,791,660
Principal repayment of loans		(51,907,313	)		-			-			(51,907,313	)
Accretion of original issue discount		-			1,433,293			-			1,433,293
Sale of loan (2)		(13,399,712	)		-			-			(13,399,712	)
PIK Interest		4,345,434			-			-			4,345,434
Current expected credit loss reserve		-			-			(1,180,638	)		(1,180,638	)
Balance at June 30, 2023	$	317,977,743		$	(3,440,843	)	$	(5,121,577	)	$	309,415,323

(1)

The difference between the Carrying Value and the Outstanding Principal amount of the loans consists of unaccreted original issue discount, deferred loan fees and ~~loan origination costs.~~

~~(2)~~

~~Weighted average remaining life is calculated based on the carrying value of the loans as of September 30, 2022.~~other upfront fees. Outstanding principal balance includes capitalized PIK interest, if applicable.

As of December 31, 2021
Outstanding
Principal (1) Original
Issue
Discount Carrying
Value (1) Weighted
Average
Remaining
Life
(Years) (2)
Senior Term Loans $ 200,632,056 $ (3,647,490 ) $ 196,984,566 2.2
Current expected credit loss reserve - - (134,542 )
Total loans held at carrying value, net $ 200,632,056 $ (3,647,490 ) $ 196,850,024

~~(1)~~

~~The difference between the Carrying Value and the Outstanding Principal amount of the loans consists of unaccreted original issue discount and loan origination costs~~

(2)

~~Weighted average remaining life is calculated based~~One loan was reclassified as held for sale from loans held for investment as the decision was made to sell the loan during the six months ended June 30, 2023 to a syndicate of co-lenders which includes a third party and two affiliates under common control with our Manager. The sale was executed on ~~the carrying value of the loans as of December~~March 31, ~~2021~~2023.

	Principal (1)			Original Issue Discount			Current Expected Credit Loss Reserve			Carrying Value
Balance at December 31, 2021	$	200,632,056		$	(3,647,490	)	$	(134,542	)	$	196,850,024
New fundings		137,944,312			(1,835,592	)		-			136,108,720
Principal repayment of loans		(6,654,703	)		-			-			(6,654,703	)
Accretion of original issue discount		-			1,362,776			-			1,362,776
PIK Interest		2,400,627			-			-			2,400,627
Current expected credit loss reserve		-			-			(1,068,882	)		(1,068,882	)
Balance at June 30, 2022	$	334,322,292		$	(4,120,306	)	$	(1,203,424	)	$	328,998,562

The following table presents changes in loans held for investment at carrying value as of and for the nine months ended September 30, 2022 as well as the period from March 30, 2021 (inception) to September 30, 2021:

Principal (1) Original
Issue
Discount Current
Expected
Credit Loss
Reserve Carrying
Value (1)
Balance at December 31, 2021 $ 200,632,056 $ (3,647,490 ) $ (134,542 ) $ 196,850,024
Loans contributed - - - -
New fundings 143,624,312 (2,180,593 ) - 141,443,719
Principal repayment of loans (6,892,654 ) - - (6,892,654 )
Accretion of original issue discount - 2,139,972 - 2,139,972
Sale of loans (6,957,500 ) 260,723 - (6,696,777 )
PIK Interest 4,096,721 - - 4,096,721
Current expected credit loss reserve - - (1,363,391 ) (1,363,391 )
Balance at September 30, 2022 $ 334,502,935 $ (3,427,388 ) $ (1,497,933 ) $ 329,577,614

(1)	The difference between the Carrying Value and the Outstanding Principal amount of the loans consists of unaccreted original issue discount, deferred loan fees and loan origination costs. Outstanding principal balance includes capitalized PIK interest, if applicable.

Principal (1) Original
Issue
Discount Current
Expected
Credit Loss
Reserve Carrying
Value (1)
Balance at March 30, 2021 (inception) $ - $ - $ - $ -
Loans contributed 32,589,907 (613,391 ) - 31,976,516
New fundings 105,952,844 (1,778,500 ) - 104,174,344
Principal repayment of loans (9,582,613 ) - - (9,582,613 )
Accretion of original issue discount - 276,838 - 276,838
Sale of loans - - - -
PIK Interest 278,079 - - 278,079
Balance at September 30, 2021 $ 129,238,217 $ (2,115,053 ) $ - $ 127,123,164

~~(1)~~

The difference between the Carrying Value and the Outstanding Principal amount of the loans consists of unaccreted original issue discount, deferred loan fees and loan origination costs. Outstanding principal balance includes capitalized PIK interest, if applicable.

We may make modifications to loans, including loans that are in default. Loan terms that may be modified include interest rates, required prepayments, maturity dates, covenants, principal amounts and other loan terms. The terms and conditions of each modification vary based on individual circumstances and will be determined on a case by case basis. Our Manager monitors and evaluates each of our loans held for investment and has maintained regular communications with borrowers regarding ~~the~~ potential impacts ~~of the COVID-19 pandemic~~ on our loans.

~~CECL Reserve~~

In accordance with ASC 326, we record allowances for our loans held for investment. The allowances are deducted from the gross carrying amount of the assets to present the net carrying value of the amounts expected to be collected on such assets. The Company estimates its CECL Reserve using among other inputs, third-party valuations, and a third-party probability-weighted model that considers the likelihood of default and expected loss given default for each individual loan based on the risk profile for approximately three years after which we immediately revert to use of historical loss data.

ASC 326 requires an entity to consider historical loss experience, current conditions, and a reasonable and supportable forecast of the macroeconomic environment. We consider multiple datapoints and methodologies that may include likelihood of default and expected loss given default for each individual loans, valuations derived from discount cash flows (“DCF”), and other inputs including the risk rating of the loan, how recently the loan was originated compared to the measurement date, and expected prepayment, if applicable. The measurement of expected credit losses under CECL is applicable to financial assets measured at amortized cost, and off-balance sheet credit exposures such as unfunded loan commitments.

We evaluate our loans on a collective (pool) basis by aggregating on the basis of similar risk characteristics as explained above. We make the judgment that loans to cannabis-related borrowers that are fully collateralized by real estate exhibit similar risk characteristics and are evaluated as a pool. Further, loans that have no real estate collateral, but are secured by other forms of collateral, including equity pledges of the borrower, and otherwise have similar characteristics as those collateralized by real estate are evaluated as a pool. All other loans are analyzed individually, either because they operate in a different industry, may have a different risk profile, or have maturities that extend beyond the forecast horizon for which we are able to derive reasonable and supportable forecasts.

Estimating the CECL Reserve also requires significant judgment with respect to various factors, including (i) the appropriate historical loan loss reference data, (ii) the expected timing of loan repayments, (iii) calibration of the likelihood of default to reflect the risk characteristics of our loan portfolio, and (iv) our current and future view of the macroeconomic environment. From time to time, we may consider loan-specific qualitative factors on certain loans to estimate our CECL Reserve, which may include (i) whether cash from the borrower’s operations is sufficient to cover the debt service requirements currently and into the future, (ii) the ability of the borrower to refinance the loan and (iii) the liquidation value of collateral. For loans where we have deemed the borrower/sponsor to be experiencing financial difficulty, we may elect to apply a practical expedient, in which the fair value of the underlying collateral is compared to the amortized cost of the loan in determining a CECL Reserve.

To estimate the historic loan losses relevant to our portfolio, we evaluate our historical loan performance, which includes zero realized loan losses since our inception of operations. Additionally, we analyzed our repayment history, noting we have limited “true” operating history, since the incorporation date of March 30, 2021. However, our Sponsor has had operations for the past two fiscal years and has made investments in similar loans that have similar characteristics, including interest rate, collateral coverage, guarantees, and prepayment/make whole provisions, which fall into the pools identified above. Given the similarity of the structuring of the credit agreements for the loans in our portfolio, management considered it appropriate to consider the past repayment history of loans originated by the Sponsor in determining the extent to which we should record a CECL Reserve.

In addition, we review each loan on a quarterly basis and evaluate the borrower’s ability to pay the monthly interest and principal, if required, as well as the loan-to-value (LTV) ratio. In considering the potential current expected credit loss, the Manager primarily considers significant inputs to our forecasting methods, which include (i) key loan-specific inputs such as the value of the real estate collateral, liens on equity (including the equity in the entity that holds the state-issued license to cultivate, process, distribute, or retail cannabis), presence of personal or corporate guarantees, among other credit enhancements, LTV ratio, ratio type (fixed or floating) and IRR, loan-term, geographic location, and expected timing and amount of future loan fundings, (ii) performance against the underwritten business plan and our internal loan risk rating and (iii) a macro-economic forecast. Estimating the enterprise value of our borrowers in order to calculate LTV ratios is often a significant estimate. We rely primarily on comparable transactions to estimate enterprise value of our portfolio companies and supplement such analysis with a multiple-based approach to enterprise value to revenue multiples of publicly-traded comparable companies obtained from S&P CapitalIQ as of the quarter end, to which we apply a private company discount based on our current borrower profile. These estimates may change in future periods based on available future macro-economic data and might result in a material change in our future estimates of expected credit losses for our loan portfolio.

Regarding real estate collateral, we generally cannot take the position of mortgagee-in-possession as long as the property is used by a cannabis operator, but we can request that the court appoint a receiver to manage and operate the subject real property until the foreclosure proceedings are completed. Additionally, while we cannot foreclose under state Uniform Commercial Code (“UCC”) and take title or sell equity in a licensed cannabis business, a potential purchaser of a delinquent or defaulted loan could.

In order to estimate the future expected loan losses relevant to our portfolio, we utilize historical market loan loss data obtained from a third-party database for commercial real estate loans, which we believe is a reasonably comparable and available data set to use as an input for our type of loans. We expect this dataset to be representative for future credit losses whilst considering that the cannabis industry is maturing, and consumer adoption, demand for production, and retail capacity are increasing akin to commercial real estate over time. For periods beyond the reasonable and supportable forecast period, we revert back to historical loss data.

All of the above assumptions, although made with the most available information at the time of the estimate, are subjective and actual activity may not follow the estimated schedule. These assumptions impact the future balances that the loss rate will be applied to and as such impact our CECL Reserve. As we acquire new loans and our Manager monitors loan and borrower performance, these estimates will be revised each period.

~~Risk Ratings~~

We assess the risk factors of each loan, and assign a risk rating based on a variety of factors, including, without limitation, payment history, real estate collateral coverage, property type, geographic and local market dynamics, financial performance, enterprise value of the portfolio company, loan structure and exit strategy, and project sponsorship. This review is performed quarterly. Based on a 5-point scale, our loans are rated “1” through “5,” from less risk to greater risk, which ratings are defined as follows:

~~Rating~~		~~Definition~~
1		~~Very low risk~~
2		~~Low risk~~
3		~~Moderate/average risk~~
4		~~High risk/potential for loss: a loan that has a risk of realizing a principal loss~~
5		~~Impaired/loss likely: a loan that has a high risk of realizing principal loss, has incurred principal loss or an impairment has been recorded~~

~~As of September 30, 2022 and December 31, 2021, the carrying value, excluding the CECL Reserve, of the Company’s loans within each risk rating by year of origination is as follows:~~

As of September 30, 2022 (1)
Risk Rating 2022 2021 2020 2019 Total
1 $ - $ 20,542,981 $ 29,712,254 $ - $ 50,255,235
2 93,424,139 79,819,303 - - 173,243,442
3 30,130,650 77,446,220 - - 107,576,870
4 - - - - -
5 - - - - -
Total $ 123,554,789 $ 177,808,504 $ 29,712,254 $ - $ 331,075,547

~~(1)~~

~~Amounts are presented by loan origination year with subsequent advances shown in the original year of origination.~~

As of December 31, 2021 (1)
Risk Rating 2021 2020 2019 Total
1 $ 135,076,307 $ 32,242,114 $ 590,384 $ 167,908,805
2 29,075,761 - - 29,075,761
3 - - - -
4 - - - -
5 - - - -
Total $ 164,152,068 $ 32,242,114 $ 590,384 $ 196,984,566

~~(1)~~

~~Amounts are presented by loan origination year with subsequent advances shown in the original year of origination.~~

Non-GAAP Measures and Key Financial Measures and Indicators

As a commercial mortgage real estate ~~finance company,~~investment trust, we believe the key financial measures and indicators for our business are Distributable Earnings, Adjusted Distributable Earnings, book value per share, and dividends declared per share.

Distributable Earnings and Adjusted Distributable Earnings

In addition to using certain financial metrics prepared in accordance with GAAP to evaluate our performance, we also use Distributable Earnings and Adjusted Distributable Earnings to evaluate our performance. Each of Distributable Earnings and Adjusted Distributable Earnings is a measure that is not prepared in accordance with GAAP. We define Distributable Earnings as, for a specified period, the net income (loss) computed in accordance with GAAP, excluding (i) non-cash equity compensation expense, (ii) depreciation and amortization, (iii) any unrealized gains, losses or other non-cash items recorded in net income (loss) for the period; provided that Distributable Earnings does not exclude, in the case of investments with a deferred interest feature (such as OID, debt instruments with PIK interest and zero coupon securities), accrued income that we have not yet received in cash, (iv) provision for current expected credit losses and (v) one-time events pursuant to changes in GAAP and certain non-cash charges, in each case after discussions between our Manager and our independent directors and after approval by a majority of such independent directors. We define Adjusted Distributable Earnings, for a specified period, as Distributable Earnings excluding certain non-recurring organizational expenses (such as one-time expenses related to our formation and start-up).

We believe providing Distributable Earnings and Adjusted Distributable Earnings on a supplemental basis to our net income as determined in accordance with GAAP is helpful to stockholders in assessing the overall performance of our business. As a REIT, we are required to distribute at least 90% of our annual REIT taxable income and to pay tax at regular corporate rates to the extent that we annually distribute less than 100% of such taxable income. Given these requirements and our belief that dividends are generally one of the principal reasons that stockholders invest in our common stock, we generally intend to attempt to pay dividends to our stockholders in an amount equal to our net taxable income, if and to the extent authorized by our Board. Distributable Earnings is one of many factors considered by our Board in authorizing dividends and, while not a direct measure of net taxable income, over time, the measure can be considered a useful indicator of our dividends.

Distributable Earnings and Adjusted Distributable Earnings should not be considered as substitutes for GAAP net income. We caution readers that our methodology for calculating Distributable Earnings and Adjusted Distributable Earnings may differ from the methodologies employed by other REITs to calculate the same or similar supplemental performance measures, and as a result, our reported Distributable Earnings and Adjusted Distributable Earnings may not be comparable to similar measures presented by other REITs.

The following table provides a reconciliation of GAAP net income to Distributable Earnings and Adjusted Distributable Earnings (in thousands, except per share data):

For the
three months
ended
September 30,
2022 For the
three months
ended
September 30,
2021 For the
nine months
ended
September 30,
2022 Period from
March 30,
2021
(inception) to
September 30,
2021
Net Income $ 9,768,969 $ 4,067,521 $ 25,036,760 $ 5,136,072
Adjustments to net income
Non-cash equity compensation expense 84,891 - 328,356 -
Depreciation and amortization 138,549 25,206 379,644 41,918
Provision for current expected credit losses 306,885 - 1,403,892 -
Distributable Earnings $ 10,299,294 $ 4,092,727 $ 27,148,652 $ 5,177,990
Adjustments to Distributable Earnings - - - -
Adjusted Distributable Earnings 10,299,294 4,092,727 27,148,652 5,177,990
Basic weighted average shares of common stock outstanding (in shares) 17,657,913 4,895,694 17,652,367 3,658,310
Adjusted Distributable Earnings per Weighted Average Share $ 0.58 $ 0.84 $ 1.54 $ 1.42
Diluted weighted average shares of common stock outstanding (in shares) 17,752,290 4,895,694 17,747,612 3,658,310
Adjusted Distributable Earnings per Weighted Average Share $ 0.58 $ 0.84 $ 1.53 $ 1.42

	For the three months ended		For the three months ended		For the six months ended		For the six months ended
	June 30, 2023		June 30, 2022		June 30, 2023		June 30, 2022
Net Income	$	8,643,378	$	7,463,839	$	19,335,727	$	15,267,791
Adjustments to net income
Non-cash equity compensation expense		263,844		122,525		402,179		243,465
Depreciation and amortization		91,798		168,826		259,102		241,095
Provision for current expected credit losses		1,139,112		1,045,665		1,235,231		1,097,008
Distributable Earnings		10,138,132		8,800,855		21,232,239		16,849,359
Adjustments to Distributable Earnings		-		-		-		-
Adjusted Distributable Earnings		10,138,132		8,880,855		21,232,239		16,849,359
Basic weighted average shares of common stock outstanding (in shares)		18,094,288		17,657,913		17,989,684		17,649,548
Adjusted Distributable Basic Earnings per Weighted Average Share	$	0.56	$	0.50	$	1.18	$	0.95
Diluted weighted average shares of common stock outstanding (in shares)	$	18,273,512		17,752,413		18,117,919		17,745,234
Adjusted Distributable Diluted Earnings per Weighted Average Share	$	0.55	$	0.50	$	1.17	$	0.95

Book Value Per Share

The book value per share of our common stock as of ~~September~~June 30, ~~2022~~2023 and December 31, ~~2021~~2022 was approximately ~~$15.23~~$15.06 and ~~$15.13,~~$14.86, respectively.

Liquidity and Capital Resources

Liquidity is a measure of our ability to meet potential cash requirements, including ongoing commitments to repay borrowings, fund and maintain our assets and operations, make distributions to our stockholders, and meet other general business needs. We use significant cash to invest in loans, repay principal and interest on our borrowings, make distributions to our stockholders, and fund our operations.

Our primary sources of cash generally consist of unused borrowing capacity under our financing sources, the net proceeds of future offerings of equity or debt securities, payments of principal and interest we receive on our portfolio of assets and cash generated from our operating results. WeOn a long-term basis, we expect that our primary sources of financing will be, to the extent available to us, through (a) credit facilities and (b) public and private offerings of our equity and debt securities. ~~In the future, we~~We may utilize other sources of financing to the extent available to us. As the cannabis industry continues to evolve and to the extent that additional states legalize cannabis, the demand for capital continues to increase as operators seek to enter and build out new markets. WeIn the short-term, we expect the principal amount of the loans we originate to increase and that we will need to raise additional equity and/or debt financing to increase our ~~liquidity in the near future.~~liquidity. We expect to achieve this through recycling capital from loan paydowns, repayments, and sales of common stock related to our shelf registration statement.

As of ~~September~~June 30, ~~2022~~2023 and December 31, ~~2021,~~2022, all of our cash was unrestricted and totaled approximately ~~$9.3~~$18.0 million and ~~$80.2~~$5.7 million, respectively. We believe that our cash on hand, capacity available under our Revolving Loan, and cash flows from operations for the next twelve months will be sufficient to satisfy the operating requirements of our business through at least the next twelve months. The sources of financing for our target investments are described below.

Credit ~~Facilities~~Facility

In May 2021, in connection with our acquisition of our financing subsidiary, CAL, we were assigned a secured revolving credit facility (the “Revolving Loan”). The Revolving Loan had an aggregate borrowing base of up to $10,000,000 and bore interest, payable in cash in arrears, at a per annum rate equal to the greater of (x) Prime Rate plus 1.00% and (y) 4.75%. We incurred debt issuance costs of $100,000 related to the origination of the Revolving Loan, which were capitalized and are subsequently being amortized through maturity. The maturity date of the Revolving Loan was the earlier of (i) February 12, 2023 and (ii) the date on which the Revolving Loan is terminated pursuant to terms in the Revolving Loan agreement.

On December 16, 2021, we amended the Revolving Loan (the “First Amendment”). The First Amendment increased the loan commitment from $10,000,000 to $45,000,000, decreased the interest rate, from the greater of the (1) Prime Rate plus 1.00% and (2) 4.75% to the greater of (1) the Prime Rate plus the applicable margin and (2) 3.25%. The applicable margin depends on the ratio of debt to equity of CAL and increases from 0% at a ratio of 0.25 to 1 to 1.25% at a ratio of 1.5 to 1. The First Amendment also extended the maturity date from February 12, 2023 to the earlier of (i) December 16, 2023 and (ii) the date on which the Revolving Loan is terminated pursuant to terms in the Revolving Loan agreement. We incurred debt issuance costs of $859,500 related to the First Amendment, which were capitalized and are subsequently being amortized through maturity.

On May 12, 2022, we amended the Revolving Loan (the “Second Amendment”) which provides for an increase in the aggregate commitment from $45 million to $65 million. No other material terms of the Revolving Loan were modified as a result of the execution of the Second Amendment. As of ~~September~~June 30, ~~2022~~2023 and December 31, ~~2021,~~2022, unamortized debt issuance costs related to the Revolving Loan, including all amendments and ~~First~~amendments and ~~Second Amendments~~restatements thereto, as applicable, of ~~$665,639~~$662,938 and ~~$868,022,~~$805,596, respectively, are recorded in other receivables and assets, net on the consolidated balance sheets.

~~On November 7, 2022, we amended~~As of and for the ~~Revolving Loan (the “Third Amendment”), whereby we exercised~~six months ended June 30, 2023, the ~~existing accordion feature~~Company had net repayments of the Revolving Loan to increase the aggregate commitment by $27.5 million, from $65 million to $92.5 million. No other material terms of the Revolving Loan were modified as a result of the execution of the Third Amendment.

The Revolving Loan incurs unused fees at a rate of 0.25% per annum. During the nine month period ended September 30, 2022, we incurred $11,833 in unused fees in connection with the Second Amendment. For the period from January 1, 2022 to September 30, 2022, we borrowed $53.0$15.0 million against the Revolving ~~Loan and incurred approximately $1.0 million in interest expense for the period then ended. In the future, we may use certain sources~~Loan. As of financing to fund the origination or acquisition of our target investments, including credit facilities and other secured and unsecured forms of borrowing. These financings may be collateralized or non-collateralized and may involve one or more lenders. We expect that these facilities will typically have maturities ranging from two to five years and may accrue interest at either fixed or floating rates.

The First Amendment and the Second Amendment provide for certain affirmative covenants, including requiring us to deliver financial information and any notices of default, and conducting business in the normal course. Additionally,June 30, 2023, the Company ~~must comply with certain financial covenants including: (1) maximum capital expenditures of $150,000, (2) maintaining a debt service coverage ratio greater than 1.35 to 1,~~had $57.0 million available and (3) maintaining a leverage ratio less than 1.50 to 1. To the best of our knowledge, as of September 30, 2022, we were in compliance in all material respects with the covenants with respect to the Revolving Loan.

~~During the period ended September 30, 2022, we borrowed $53.0~~$43.0 million ~~against the Revolving Loan and had $53.0 million outstanding at September 30, 2022. For the period ended December 31, 2021 we did not borrow against the Revolving Loan and therefore had $0~~ outstanding under the Revolving Loan ~~as of such date.~~(Note 6).

Capital Markets

We may seek to raise further equity capital and issue debt securities in order to fund our future investments in loans. Our Shelf Registration Statement became effective on January 19, 2023, allowing us to sell, from time to time in one or more offerings, up to $500 million of our securities, including common stock, preferred stock, debt securities, warrants and rights (including as part of a unit) to purchase shares of our common stock, preferred stock, or debt securities. The specifics of any future offerings, along with the use of proceeds of any securities offered, will be described in detail in a prospectus supplement, or other offering materials, at the time of any offering. We may also access liquidity through our ATM Program, which was established in June 2023, pursuant to which we may sell, from time to time, up to $75.0 million of our common stock.

Cash Flows

The following table sets forth changes in cash and cash equivalents for the ~~nine~~six months ended ~~September~~June 30, ~~2022~~2023 and ~~the period March 30, 2021 (inception) to September 30, 2021,~~2022, respectively:

For the
nine months
ended
September 30,
2022 Period from
March 30,
2021
(inception) to
September 30,
2021
(unaudited) (unaudited)
Net income $ 25,036,760 $ 5,136,072
Adjustments to reconcile net income to net cash (used in) provided by operating activities and changes in operating assets and liabilities (12,658,931 ) 7,105,497
Net cash provided by operating activities 12,377,829 12,241,569
Net cash used in investing activities (120,724,572 ) (94,591,731 )
Net cash provided by financing activities 37,429,747 90,992,068
Change in cash and cash equivalents $ (70,916,996 ) $ 8,641,906

	For the six months ended June 30, 2023			For the six months ended June 30, 2022

Net income	$	19,335,727		$	15,267,791
Adjustments to reconcile net income to net cash provided by operating activities and changes in operating assets and liabilities		(7,422,955	)		(7,893,109	)
Net cash provided by operating activities		11,912,772			7,374,682
Net cash provided by/(used in) investing activities		30,515,365			(118,729,079	)
Net cash (used in)/provided by financing activities		(30,123,276	)		37,728,967
Net increase (decrease) in cash and cash equivalents	$	12,304,861		$	(73,625,430	)

Net Cash Provided by Operating Activities

For the ~~nine~~six months ended ~~September~~June 30, 2023 and 2022, ~~net~~we reported “Net cash provided by operating activities” of approximately $11.9 million and $7.4 million, respectively. Net cash flows provided by operating activities ~~totaled approximately $12.4 million. For the nine months ended September 30, 2022, adjustments~~increased $4.5 million, primarily attributable to an increase in net income ~~related to operating activities primarily included accretion~~over the comparable period of ~~deferred loan original issue discount~~$4.1 million, and ~~other discounts~~a change in the interest reserve for applied interest payments of ~~approximately $2.1 million, PIK interest of approximately $4.1 million,~~$4.6 million. These changes were offset by an increase in provision for current expected credit losses of approximately ~~$1.4~~$0.1 million, ~~amortization~~an increase in PIK interest of ~~deferred financing costs relating to the revolving credit facility of $379,644, and stock-based compensation expense of $328,356. Additionally, other changes in operating assets and liabilities were~~ approximately ~~$8.5~~$1.9 million, ~~of which approximately $9.9 million is attributable to interest reserves disbursed, a $529,544~~an increase in interest receivable ~~and a $172,699~~of approximately $1.0 million, an increase in ~~other receivables offset by a $545,127~~related party receivable of approximately $0.2 million, an increase in related party payables of approximately $0.2 million, a decrease in management ~~fee~~and incentive fees payable ~~and~~of approximately $1.5 million, an ~~approximately $1.6 million~~ increase in accounts payable and other accrued ~~expenses.~~

During the period March 30, 2021 (inception) through September 30, 2021, net cash provided by operating activities total approximately $12.2 million. For the period March 30, 2021 (inception) through September 30, 2021, adjustments to net income related to operating activities primarily included accretion of deferred loan original issue discount and other discountsexpenses of approximately ~~$277,000, PIK interest~~$0.4 million, and an increase in stock based compensation of approximately ~~$278,000,~~$0.2 million, and ~~amortization of deferred financing costs~~$0.9 million relating to the ~~revolving credit facility~~purchase of approximately $42,000. Additionally, other changes in operating assets and liabilities were approximately $7.6 million, of which approximately $6.6 million is attributable to new interest reserves, a $517,026 increase in interest receivable, a $84,384 increase in other assets, a $13,868 increase in other receivables, a $800,000 decrease in escrow payable, and an approximately $843,000 increase in accounts payable and other accrued expenses.debt securities, at fair value.

Net Cash Provided by/(Used inin) Investing Activities

For the six months ended June 30, 2023 and 2022, we reported “Net cash provided by/(used in) investing activities” of approximately $30.5 million and ($118.7) million, respectively.

For the ~~nine~~six months ended ~~September~~June 30, ~~2022, net~~2023, cash ~~used in investing activities totaled approximately $120.7 million. The net cash used in investing activities was~~outflows primarily ~~a result of the cash~~related to $34.8 million used for the origination and funding of loans held for investment, partially offset by $13.4 million received from the sales of ~~approximately $134.3~~loans and $51.9 million ~~exceeding the~~of cash received from the principal repayment of loans held for ~~investment of approximately $6.9 million and approximately $6.7 million received from the sales of loans for the nine months ended September 30, 2022.~~investment.

~~During~~For the ~~period March~~six months ended June 30, ~~2021 (inception) through September 30, 2021, net~~2022, cash ~~used in investing activities totaled approximately $94.6 million. The cash used in investing activities was~~outflows primarily ~~a result of the cash~~related to $125.4 million used for the origination and funding of loans held for investment, ~~of approximately $104.2~~partially offset by $6.7 million ~~exceeding the~~of cash received from the principal repayment of loans held for ~~investment of approximately $9.6 million for the period March 30, 2021 (inception) through September 30, 2021.~~investment.

Net Cash (Used in)/Provided by Financing Activities

For the ~~nine~~six months ended ~~September~~June 30, 2023 and 2022, ~~net~~we reported “Net cash (used in)/provided by financing ~~activities totaled~~activities” of approximately ~~$37.4~~$(30.1) million and $37.7 million, respectively.

For the six months ended June 30, 2023, cash inflows of approximately $7.2 million related to ~~drawdowns~~proceeds received from sales of our common stock through the registered direct offering and ATM offering of $6.0 million and $1.2 million, respectively. Additionally, we had cash inflows related to draw downs on our Revolving Loan of $34.0 million, which were offset by approximately $49.0 million in repayments on our Revolving Loan, $22.0 million in dividends paid, approximately $0.1 million in debt issuance costs paid, and approximately $0.3 million in offering costs paid associated with the ~~revolving credit facility of $53.0 million,~~registered direct offering and ATM offering.

For the six months ended June 30, 2022, cash inflows primarily related to approximately $4.5 million ~~in proceeds~~ received from the underwriters’ partial exercise of their over-allotment option ~~less~~and $45.0 million related to draw downs on our Revolving Loan, offset by approximately ~~$19.9~~$11.6 million in dividends paid, and approximately $0.2 million in debt issuance costs and offering costs ~~relating to~~paid in connection with our Revolving Loan and initial public ~~offering of approximately $24,000 and $177,261 in debt issuances costs paid,~~offering.

During the period from March 30, 2021 (inception) through September 30, 2021, we received approximately $91.0 million in cash from financing activities related to proceeds received from the issuance of shares of our common stock of approximately $92.5 million offset by dividends paid of approximately $1.1 million and payment of deferred offering costs of approximately $485,000.Leverage Policies

~~Leverage Policies~~

Although we are not required to maintain any particular leverage ratio, we expect to employ prudent amounts of leverage and, when appropriate, to use debt as a means of providing additional funds for the acquisition of loans, to refinance existing debt or for general corporate purposes. Leverage is primarily used to provide capital for forward commitments until additional equity is raised or additional medium- to long-term financing is arranged. This policy is subject to change by management and our Board.

Dividends

~~Dividends~~

We have elected to be taxed as a REIT for United States federal income tax purposes and, as such, anticipate annually distributing to our stockholders at least 90% of our REIT taxable income, prior to the deduction for dividends paid and our net capital gain. If we distribute less than 100% of our REIT taxable income in any tax year (taking into account any distributions made in a subsequent tax year under Sections 857(b)(9) or 858 of the Code), we will pay tax at regular corporate rates on that undistributed portion. Furthermore, if we distribute less than the sum of (i) 85% of our ordinary income for the calendar year, (ii) 95% of our capital gain net income for the calendar year and (iii) any Required Distribution to our stockholders during any calendar year (including any distributions declared by the last day of the calendar year but paid in the subsequent year), then we are required to pay non-deductible excise tax equal to 4% of any shortfall between the Required Distribution and the amount that was actually distributed. Any of these taxes would decrease cash available for distribution to our stockholders. The 90% distribution requirement does not require the distribution of net capital gains. However, if we elect to retain any of our net capital gain for any tax year, we must notify our stockholders and pay tax at regular corporate rates on the retained net capital gain. The stockholders must include their proportionate share of the retained net capital gain in their taxable income for the tax year, and they are deemed to have paid the REIT’s tax on their proportionate share of the retained capital gain. Furthermore, such retained capital gain may be subject to the nondeductible 4% excise tax. If we determine that our estimated current year taxable income (including net capital gain) will be in excess of estimated dividend distributions (including capital gains dividends) for the current year from such income, we accrue excise tax on a portion of the estimated excess taxable income as such taxable income is earned.

To the extent that our cash available for distribution is less than the amount required to be distributed under the REIT provisions of the Code, we may be required to fund distributions from working capital or through equity, equity-related or debt financings or, in certain circumstances, asset sales, as to which our ability to consummate transactions in a timely manner on favorable terms, or at all, cannot be assured, or we may make a portion of the Required Distribution in the form of a taxable stock distribution or distribution of debt securities.

The following table summarizes the Company’s dividends declared during the ~~nine~~six months ended ~~September~~June 30, ~~2022.~~2023 and 2022, respectively.

	Record Date	Payment Date	Common Share Distribution Amount		Taxable Ordinary Income		Return of Capital		Section 199A Dividends
Regular cash dividend	3/31/2023	4/14/2023	$	0.47	$	0.47	$	-	$	0.47
Regular cash dividend	6/30/2023	7/14/2023	$	0.47	$	0.47	$		$	0.47
Total cash dividend			$	0.94	$	0.94	$	-	$	0.94

	Record Date	Payment Date	Common Share Distribution Amount		Taxable Ordinary Income		Return of Capital		Section 199A Dividends
Regular cash dividend	3/31/2022	4/14/2022	$	0.40	$	0.40	$	-	$	0.40
Regular cash dividend	6/30/2022	7/15/2022	$	0.47	$	0.47	$	-	$	0.47
Total cash dividend			$	0.87	$	0.87	$	-	$	0.87

CECL Reserve

ASC 326 requires an entity to consider historical loss experience, current conditions, and a reasonable and supportable forecast of the macroeconomic environment. We consider multiple datapoints and methodologies that may include likelihood of default and expected loss given default for each individual loans, valuations derived from discounted cash flows (“DCF”), and other inputs including the risk rating of the loan, how recently the loan was originated compared to the measurement date, and expected prepayment, if applicable. The measurement of expected credit losses under CECL is applicable to financial assets measured at amortized cost, and off-balance sheet credit exposures such as unfunded loan commitments.

Estimating the CECL Reserve also requires significant judgment with respect to various factors, including (i) the appropriate historical loan loss reference data, (ii) the expected timing of loan repayments, (iii) calibration of the likelihood of default to reflect the risk characteristics of our loan portfolio, and (iv) our current and future view of the macroeconomic environment. From time to time, we may consider loan-specific qualitative factors on certain loans to estimate our CECL Reserve, which may include (i) whether cash from the borrower’s operations is sufficient to cover the debt service requirements currently and into the future, (ii) the ability of the borrower to refinance the loan and (iii) the liquidation value of collateral. For loans where we have deemed the borrower/sponsor to be experiencing financial difficulty, we may elect to apply a practical expedient, in which the fair value of the underlying collateral is compared to the amortized cost of the loan in determining a CECL Reserve.

In addition, we review each loan on a quarterly basis and evaluate the borrower’s ability to pay the monthly interest and principal, if required, as well as the loan-to-value (LTV) ratio. In considering the potential current expected credit loss, the Manager primarily considers significant inputs to our forecasting methods, which include (i) key loan-specific inputs such as the value of the real estate collateral, liens on equity (including the equity in the entity that holds the state-issued license to cultivate, process, distribute, or retail cannabis), presence of personal or corporate guarantees, among other credit enhancements, LTV ratio, ratio type (fixed or floating) and IRR, loan-term, geographic location, and expected timing and amount of future loan fundings, (ii) performance against the underwritten business plan and our internal loan risk rating and (iii) a macro-economic forecast. Estimating the enterprise value of our borrowers in order to calculate LTV ratios is often a significant estimate. We rely primarily on comparable transactions to estimate enterprise value of our portfolio companies and supplement such analysis with a multiple-based approach to enterprise value to revenue multiples of publicly-traded comparable companies obtained from S&P Capital IQ as of the quarter end, to which we apply a private company discount based on our current borrower profile. These estimates may change in future periods based on available future macro-economic data and might result in a material change in our future estimates of expected credit losses for our loan portfolio.

All of the above assumptions, although made with the most available information at the time of the estimate, are subjective and actual activity may not follow the estimated schedule. These assumptions impact the future balances that the loss rate will be applied to and as such impact our CECL Reserve. As we acquire new loans and our Manager monitors loan and borrower performance, these estimates will be revised each period.

Risk Ratings

We assess the risk factors of each loan, and assigns a risk rating based on a variety of factors, including, without limitation, payment history, real estate collateral coverage, property type, geographic and local market dynamics, financial performance, enterprise value of the portfolio company, loan structure and exit strategy, and project sponsorship. This review is performed quarterly. Based on a 5-point scale, our loans are rated “1” through “5,” from less risk to greater risk, which ratings are defined as follows:

Rating		Definition
1		Very low risk
2		Low risk
3		Moderate/average risk
4		High risk/potential for loss: a loan that has a risk of realizing a principal loss
5		Impaired/loss likely: a loan that has a high risk of realizing principal loss, has incurred principal loss or an impairment has been recorded

The risk ratings are primarily based on historical data and current conditions specific to each portfolio company, as well as consideration of future economic conditions and each borrower’s estimated ability to meet debt service requirements. The risk ratings shown in the following table as of June 30, 2023 and December 31, 2022 consider borrower specific credit history and performance and quarterly re-evaluation of overall current macroeconomic conditions affecting the borrowers. As interest rates have increased due to rising rates from the Federal Reserve Board, it has impacted borrowers’ ability to service their debt obligations on a global scale. This decline in risk ratings had an effect on the level of the current expected credit loss reserve though, other than the one loan placed on non-accrual status, the loans continued to perform as expected. For approximately 74% of the portfolio, the fair value of the underlying real estate collateral exceeded the amounts outstanding under the loans as of June 30, 2023. The remaining approximately 26% of the portfolio, while not fully collateralized by real estate, may be partially collateralized by real estate and was secured by other forms of collateral including equipment, receivables, licenses and/or other assets of the borrowers to the extent permitted by applicable laws and regulations governing such borrowers.

As of June 30, 2023 and December 31, 2022, the carrying value, excluding the CECL Reserve, of the Company’s loans within each risk rating by year of origination is as follows:

	As of June 30, 2023												As of December 31, 2022
Risk Rating	2023		2022		2021		2020		2019		Total		2022		2021		2020		2019		Total
1	$	10,515,420	$	30,113,057	$	196,005	$	-	$	-	$	40,824,482	$	-	$	274,406	$	-	$	-	$	274,406
2		2,874,319		102,663,294		66,147,544		-		-		171,385,157		94,467,449		88,444,868		29,140,546		-		212,052,863
3		-		5,085,794		55,859,471		-		-		60,945,265		30,415,113		83,131,444		-		-		113,546,557
4		-		-		41,081,996		-		-		41,081,996		-		13,399,712		-		-		13,399,712
5		-		-		-		-		-		-		-		-		-		-		-
Total	$	13,389,739	$	137,862,145	$	163,285,016	$	-	$	-	$	314,536,900	$	124,882,562	$	185,250,430	$	29,140,546	$	-	$	339,273,538

Record Date Payment Date Common Share Distribution Amount Taxable Ordinary Income Return of Capital Section 199A Dividends
Regular cash dividend 3/31/2022 4/14/2022 $ 0.40 $ 0.40 $ - $ 0.40
Regular cash dividend 6/30/2022 7/15/2022 $ 0.47 $ 0.47 $ - $ 0.47
Regular cash dividend 9/30/2022 10/14/2022 $ 0.47 $ 0.47 $ - $ 0.47
Total cash dividend $ 1.34 $ 1.34 $ - $ 1.34

(1)	Amounts are presented by loan origination year with subsequent advances shown in the original year of origination.

Accounting Policies and Estimates

As of ~~September~~June 30, ~~2022,~~2023, there were no significant changes in the application of our accounting policies or estimates from those presented in our annual report on Form 10-K. Refer to Note 2 to our consolidated financial statements for the ~~nine~~six months ended ~~September~~June 30, ~~2022,~~2023, titled “Significant Accounting Policies” for information on recent accounting pronouncements.

Item 3. Quantitative and Qualitative Disclosures About Market Risk

We are exposed to market risks in the ordinary course of our business. These risks primarily relate to fluctuations in interest rates. Our loans are typically valued using a yield analysis, which is typically performed for ~~non-credit impaired~~performing loans to borrowers. Changes in market yields may change the fair value of certain of our loans. Generally, an increase in market yields may result in a decrease in the fair value of certain of our loans, however this is mitigated to the extent our loans bear interest at a floating rate. As of ~~September~~June 30, ~~2022,~~2023, we had 1321 floating-rate loans, representing approximately ~~59.7%~~87.9% of our loan portfolio based on aggregate outstanding principal balances, ~~most of which are~~ subject to a ~~prime rate~~Prime Rate floor. We estimate that a hypothetical 100 basis points increase in the ~~prime rate~~Prime Rate would result in an increase in annual cash interest income, excluding the effects of PIK interest, of approximately ~~$1.8~~$2.8 million and a 100 basis points decrease in ~~prime rate~~the Prime Rate would result in a decrease in annual interest income of approximately ~~$1.9~~$(2.8) million. Our loans generally have a ~~prime rate~~Prime Rate floor established at the prevailing Prime Rate at the time of ~~3.25%.~~origination. Refer to Note 3 for Prime Rate floor by loan.

In addition, our Revolving Loan is exposed to similar market risks. Changes in market rates may change the fair value of our Revolving Loan as our loan bears interest at the greater of (1) the Prime Rate plus the applicable margin and (2) 3.25%. As of June 30, 2023, we had an outstanding balance of $43.0 million under the Revolving Loan. Based on our outstanding balance as of June 30, 2023, we estimate that a hypothetical 100 basis points increase in the Prime Rate would result in an increase in annual cash interest expense, excluding unused fees, of approximately $0.4 million and a 100 basis points decrease in the Prime Rate would result in a decrease in annual interest expense of approximately $0.4 million.

Changes in Market Interest Rates and Effect on Net Interest Income

~~Interest Rate Cap Risk~~

Risk Management

These factors could lower our net interest income or cause a net loss during periods of rising interest rates, which would harm our financial condition, cash flows, and results of operations. As of September 30, 2022, all of our floating rate loans have interest rate floors, and one loan is subject to an interest rate cap.

~~Interest Rate Mismatch Risk~~

We may fund a portion of our origination of loans, or of loans that we may in the future acquire, with borrowings that are based on the prime rate or a similar measure, while the interest rates on these assets may be fixed or indexed to the prime rate or another index rate. Accordingly, any increase in the prime rate will generally result in an increase in our borrowing costs that would not be matched by fixed-rate interest earnings and may not be matched by a corresponding increase in floating-rate interest earnings. Any such interest rate mismatch could adversely affect our profitability, which may negatively impact distributions to our stockholders.

Our analysis of risks is based on our Manager’s experience, estimates, models, and assumptions. These analyses rely on models which utilize estimates of fair value and interest rate sensitivity. Actual economic conditions or implementation of decisions by our Manager and our management may produce results that differ significantly from the estimates and assumptions used in our models and the projected results.

~~Market Conditions~~

We believe that favorable market conditions, including an imbalance in supply and demand of credit to cannabis operating companies, have provided attractive opportunities for non-bank lenders, such as us, to finance commercial real estate loans and other loans that exhibit strong fundamentals but also require more customized financing structures and loan products than regulated financial institutions can presently provide. Additionally, to the extent that additional states legalize cannabis, our addressable market will increase. We intend to capitalize on these opportunities and growing the size of our portfolio.

~~Risk Management~~

To the extent consistent with maintaining our REIT qualification and our exemption from registration under the Investment Company Act, we seek to manage risk exposure by closely monitoring our portfolio and actively managing the financing, interest rate, credit, prepayment and convexity (a measure of the sensitivity of the duration of a loan to changes in interest rates) risks associated with holding our portfolio of loans. Generally, with the guidance and experience of our Manager:

●

we manage our portfolio through an interactive process with our Manager and ~~generally~~ service our self-originated loans through our Manager’s servicer;

●

we invest in a mix of ~~floating-and~~floating-rate and fixed-rate loans to mitigate the interest rate risk associated with the financing of our portfolio;

●

we actively employ portfolio-wide and asset-specific risk measurement and management processes in our daily operations, including utilizing our Manager’s risk management tools such as software and services licensed or purchased from third-parties and proprietary analytical methods developed by our Manager; and

●

we seek to manage credit risk through our due diligence process prior to origination or acquisition and through the use of non-recourse financing, when and where available and appropriate. In addition, with respect to any particular target investment, prior to origination or acquisition our Manager’s investment team evaluates, among other things, relative valuation, comparable company analysis, supply and demand trends, shape-of-yield curves, delinquency and default rates, recovery of various sectors and vintage of collateral.

~~Changes in Fair Value of Our Assets~~Market Conditions

We generally hold our target investments as long-term loans; however, we may occasionally classify some of our loans as held for sale. We may carry our loans at fair value or carrying value in our balance sheet. As of September 30, 2022 and December 31, 2021, none of our loans held for investment were carried at fair value.

We evaluate our loans on a quarterly basis. We may use an independent third-party valuation firm to provide input in the valuation of certain of our unquoted investments, which we consider along with other various subjective and objective factors in making our evaluations.

Our loans are typically valued using a yield analysis, which is typically performed for non-credit impaired loans to borrowers. To determine fair value using a yield analysis, a current price is imputed for the loan based upon an assessment of the expected market yield for a similarly structured loan with a similar level of risk. In the yield analysis, we consider the current contractual interest rate, the maturity and other terms of the loan relative to risk of the borrower and the specific loan. A key determinant of risk, among other things, is the leverage through the loan relative to the enterprise value of the borrower. As loans held by us are substantially illiquid with no active transaction market, we depend on primary market data, including newly funded loans, as well as secondary market data with respect to high-yield debt instruments and syndicated loans, as inputs in determining the appropriate market yield, as applicable. Changes in market yields may change the fair value of certain of our loans. Generally, an increase in market yields may result in a decrease in the fair value of certain of our loans, however this is mitigated to the extent our loans bear interest at a floating rate.

Due to the inherent uncertainty of determining the fair value of loans that do not have a readily available market value, the fair value of our loans may fluctuate from period to period. Additionally, the fair value of our loans may differ significantly from the values that would have been used had a ready market existed for such loans and may differ materially from the values that we may ultimately realize. Further, such loans are generally subject to legal and other restrictions on resale or otherwise are less liquid than publicly traded securities. If we were required to liquidate our investment in a loan in a forced or liquidation sale, we could realize significantly less than the value at which we had recorded such loan investment.

~~Market Conditions~~

We provide loans to established companies operating in the cannabis industry which involves significant risks, including the risk of strict enforcement against our borrowers of the federal illegality of cannabis, our borrowers’ inability to renew or otherwise maintain their licenses or other requisite authorizations for their cannabis operations, and such loans lack of liquidity, and we could lose all or part of any of our loans.

We believe that favorable market conditions, including an imbalance in supply and demand of credit to cannabis operating companies, have provided attractive opportunities for non-bank lenders, such as us, to finance commercial real estate loans and other loans that exhibit strong fundamentals but also require more customized financing structures and loan products than regulated financial institutions can presently provide. Additionally, to the extent that additional states legalize cannabis, our addressable market will increase. While we intend to continue capitalizing on these opportunities and growing the size of our portfolio, we are aware that the competition for the capital we provide is increasing.

Our ability to grow or maintain our business depends on state laws pertaining to the cannabis industry. New laws that are adverse to our borrowers may be enacted, and current favorable state or national laws or enforcement guidelines relating to cultivation, production and distribution of cannabis may be modified or eliminated in the future, which would impede our ability to grow and could materially adversely affect our business.

Management’s plan to mitigate risks include monitoring the legal landscape as deemed appropriate. Also, should a loan default or otherwise be seized, we may be prohibited from owning cannabis assets and thus could not take possession of collateral, in which case we would look to sell the loan, which could result in us realizing a loss on the transaction.

While we believe the principal amounts of our loans are generally adequately protected by underlying collateral value, there is a risk that we will not realize the entire principal value of certain loans, particularly those not fully collateralized by real estate. In order to mitigate that risk, our loans are generally collateralized by other assets, such as equipment, receivables, licenses or other assets of the borrowers to the extent permitted by applicable laws and regulations. In addition, we seek to impose strict loan covenants and seek personal or corporate guarantees for additional protection. As of ~~September~~June 30, ~~2022, 96%~~2023, 74% of our portfolio is fully secured by real estate and 4%26% has limited or no real estate collateral. Our portfolio on average had real estate collateral coverage of 1.5x as of June 30, 2023, and all of our loans are secured by equity pledges of the borrower and all asset liens. As of June 30, 2022, 94% of our portfolio was fully secured by real estate and 6% had limited or no real estate collateral. Our portfolio on average had real estate collateral coverage of 1.9x as of ~~September~~June 30, 2022 and ~~substantially~~ all of our loans ~~are~~were secured by equity pledges of the borrower and all asset liens.

~~Credit Risk~~

Credit Risk

We are subject to varying degrees of credit risk in connection with our loans and interest receivable. Our Manager seeks to mitigate this risk by seeking to originate loans, and may in the future acquire loans, of higher quality at appropriate prices given anticipated and unanticipated losses, by employing a comprehensive review and selection process and by proactively monitoring originated and acquired loans. Nevertheless, unanticipated credit losses could occur that could adversely impact our operating results. For additional information regarding the credit risk associated with our loans and interest receivables, see “Risk Factors— Loans to relatively new and/or small companies and companies operating in the cannabis industry generally involve significant risks” in our Annual Report on Form 10-K for the year ended December 31, 2022.

Our Manager or affiliates of our Manager have originated all of our loans and intend to continue to originate our loans, but we may in the future also acquire loans from time to time. Our Investment Guidelines are not subject to any limits or proportions with respect to the mix of target investments that we make or that we may in the future acquire other than as necessary to maintain our exemption from registration under the Investment Company Act and our qualification as a REIT. Our investment decisions will depend on prevailing market conditions and may change over time in response to opportunities available in different interest rate, economic and credit environments. As a result, we cannot predict the percentage of our capital that will be invested in any individual target investment at any given time.

Credit risk will also be addressed through our Manager’s on-going review, and loans will be monitored for variance from expected prepayments, defaults, severities, losses, and cash flow on a quarterly basis.

Our loan portfolio as of ~~September~~June 30, ~~2022~~2023 and December 31, ~~2021,~~2022, was concentrated with the top three borrowers representing approximately ~~29.8%~~31.8% and ~~34.6%~~29.4% of ~~the funded~~ principal outstanding and approximately ~~28.1%~~29.7% and ~~31.9%~~27.9% of the total commitments, torespectively. As of and for the six months ended June 30, 2023 and 2022, the top three borrowers ~~respectively,~~represented approximately 30.3% and ~~approximately 28.8% and 9.7%~~27.8% of the total interest income, ~~for the nine months ended September 30, 2022 and the period March 30, 2021 (inception) through September 30, 2021,~~ respectively. The largest loan represented approximately ~~11.0%~~12.0% and ~~15.0%~~10.9% of ~~the funded~~ principal outstanding and approximately ~~10.3%~~10.9% and ~~12.8%~~10.2% of the total commitments as of ~~September~~June 30, ~~2022~~2023 and December 31, ~~2021,~~2022, respectively.

As of June 30, 2023 and December 31, 2022, our borrowers have operations in the jurisdiction noted within the table below:

As of June 30, 2023

Jurisdiction	Outstanding Principal		Percentage of Loan Portfolio
Maryland		64,401,652		20	%
Michigan		59,457,819		19	%
Florida		51,123,606		16	%
Illinois		24,579,796		8	%
Arizona		23,458,375		7	%
Pennsylvania		21,694,815		7	%
Ohio		18,328,322		6	%
Missouri		17,513,744		6	%
West Virginia		15,339,126		5	%
Massachusetts		15,083,830		5	%
Nevada		6,056,659		2	%
Oregon		940,000		0	%

		317,977,743		100	%

As of December 31, 2022

Jurisdiction	Outstanding Principal		Percentage of Loan Portfolio
Maryland		53,394,180		16	%
Michigan		58,823,506		17	%
Florida		51,421,128		15	%
Illinois		30,302,490		9	%
Arizona		19,266,104		6	%
Pennsylvania		34,606,585		10	%
Ohio		45,116,990		13	%
Missouri		17,337,220		5	%
West Virginia		11,640,004		3	%
Massachusetts		15,031,751		4	%
Nevada		6,089,376		2	%
Oregon		-		0	%

		343,029,334		0	%

Real Estate Risk

Commercial real estate loans are subject to volatility and may be affected adversely by a number of factors, including, but not limited to, national, regional and local economic conditions (which may be adversely affected by industry slowdowns and other factors); local real estate conditions; changes or continued weakness in specific industry segments; construction quality, age and design; demographic factors; and retroactive changes to building or similar codes. In addition, decreases in property values ~~resulting from macro-environmental or industry-specific factors may~~ reduce the value of the collateral and the potential proceeds available to a borrower to repay the underlying loan or loans, as the case may be, which ~~warrant an increase in the reserve for current expected credit losses or~~ could also cause us to suffer ~~losses on existing real estate secured loans.~~losses.

Item 4. Controls and Procedures

Evaluation of Disclosure Controls and Procedures

Disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act) are designed to provide reasonable assurance that information required to be disclosed in reports we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the forms and rules of the SEC and that such information is accumulated and communicated to management, including the CEO and Interim CFO, to allow timely decisions regarding required disclosures. Any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives.

In connection with the preparation of this quarterly report on Form 10-Q, our management, including the CEO and Interim CFO, evaluated the effectiveness of the design and operation of our disclosure controls and procedures as of ~~September~~June 30, ~~2022.~~2023. Based on that evaluation, our CEO and Interim CFO have concluded that our disclosure controls and procedures were ~~not~~ effective at the reasonable assurance level as of ~~September~~June 30, ~~2022 because~~2023 to ensure that (a) information required to be disclosed in reports we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the forms and rules of the ~~material weaknesses in our internal control over financial reporting that were previously reported in our Annual Report on Form 10-K for~~SEC and (b) such information is accumulated and communicated to management, including the ~~year ended December 31, 2021 (the “2021 10-K”). Such material weakness relates~~CEO and Interim CFO, to inadequate design and implementation of information technology general controls that prevent the information systems from providing appropriate segregation of duties, and delivery of complete and accurate information consistent with financial reporting objectives and current needs. Additionally, as previously reported in the 2021 10-K, a control deficiency in our internal control over financial reporting was identified which constitutes a material weakness relating to inadequate design and implementation of controls relating to the development of our allowance for current expected credit losses.allow timely decisions regarding required disclosures.

We have taken certain measures to address the material weakness related to information technology general controls described above, including hiring additional personnel, engaging an independent fund administrator, and designing and implementing formal user access controls. Additionally, we have engaged a third-party vendor and are in the process of implementing a new ERP system conducive to segregation of duties and a more robust control environment.

Additionally, we have taken measures to address the material weakness related to the Company’s development of its reserve for current expected credit losses. These measures include designing and implementing more robust procedures and controls over the preparation and review of risk ratings and the estimation of enterprise value of our borrowers, as well as over the preparation and review over the development of reasonable and supportable forecasts of the performance of our borrowers and the related loans.

While we believe that the efforts taken to date have improved the effectiveness of our internal control over financial reporting, additional remediation efforts are ongoing and will require additional time before management is able to conclude that the design is effective to address the risks of material misstatement and that such controls are operating effectively through testing of such controls. We may conclude that additional measures are necessary to remediate the material weaknesses in our internal control over financial reporting, which may necessitate additional evaluation and implementation time.

Notwithstanding the material weaknesses, the Company has concluded that the consolidated financial statements included in this report present fairly, in all material respects, the financial position of the Company as of September 30, 2022, and the results of its operations and its cash flows for the year then ended in conformity with accounting principles generally accepted in the United States of America.

Changes in Internal Control over Financial Reporting

There have been no changes in our internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) during the quarter ended ~~September~~June 30, ~~2022~~2023 that have materially affected, or that are reasonably likely to materially affect, our internal control over financial reporting.

PART II - OTHER INFORMATION

Item 1. Legal Proceedings

In the normal course of business, we may be subject to various legal proceedings from time to time. We are not party to any material pending legal proceedings required to be disclosed pursuant to Item 103 of Regulation S-K.

Item 1A. Risk Factors

In addition to the other information set forth in this report, you should carefully consider the factors discussed in Part I, “Item 1A. Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, ~~2021, and in Part II, “Item 1A. Risk Factors” in our Quarterly Report on Form 10-Q for the quarters ended March 31, 2022 and June 30,~~ 2022, which could materially affect our business, financial condition and/or results of operations. Except to the extent updated below or to the extent additional factual information disclosed elsewhere in this Quarterly Report on Form 10-Q relates to such risk factors, there have been no material changes to the risk factors described in the “Risk Factors” sections in our Annual Report on Form 10-K for the year ended December 31, ~~2021 and Quarterly Report on Form 10-Q for the quarters ended March 31, 2022 and June 30,~~ 2022. The risks described in our Annual Report on Form 10-K and subsequent Quarterly Reports on Form 10-Q are not the only risks facing our Company. Additional risks and uncertainties not currently known to us or that we currently deem to be immaterial also may materially adversely affect our business, financial condition and/or results of operations.

Recent macroeconomic trends, including inflation and rising interest rates, may adversely affect our business, financial condition and results of operations.

During the ~~nine~~six months ended ~~September~~June 30, ~~2022,~~2023, inflation in the United States has ~~accelerated~~remained at an elevated level and is currently expected to continue at an elevated level in the near-term. Rising inflation could have an adverse impact on any variable rate debt we may incur in the future, and our general and administrative expenses, as these costs could increase at a rate higher than our interest income and other revenue. The Federal Reserve has ~~recently started raising~~raised interest rates multiple times since March 2022 to combat inflation and restore price stability and ~~it is expected that~~ rates ~~will~~may continue to rise throughout ~~the remainder of 2022.~~2023. To the extent our borrowing costs increase faster than the interest income earned from our floating-rate loans, such increases may adversely affect our cash flows.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

None.

Item 3. Defaults Upon Senior Securities

None.

Item 4. Mine Safety Disclosures

Not applicable.

Item 5. Other Information

~~None.~~None of the Company’s officers or directors have adopted, modified or terminated trading plans under either a Rule 10b5-1 or non-Rule 10b5-1 trading arrangement (as such terms are defined in Item 408 of Regulation S-K of the Securities Act of 1933) for the three months ended June 30, 2023.

Item 6. Exhibits

Exhibit No.		Description of Exhibits
10.8***		Fourth Amended and Restated Loan and Security Agreement, dated as of June 30, 2023, among Chicago Atlantic Lincoln, LLC, Chicago Atlantic Real Estate Finance, Inc., the other Persons from time to time party thereto, as borrowers; and the financial institutions party thereto, as Lenders.
31.1*		Certification of Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
31.2*		Certification of Interim Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
32.1*		Certification of Chief Executive Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
32.2*		Certification of Interim Chief Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
101.INS*		Inline XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.
101.SCH*		Inline XBRL Taxonomy Extension Schema Document.
101.CAL*		Inline XBRL Taxonomy Extension Calculation Linkbase Document.
101.LAB*		Inline XBRL Taxonomy Extension Label Linkbase Document.
101.PRE*		Inline XBRL Taxonomy Extension Presentation Linkbase Document.
101.DEF*		Inline XBRL Taxonomy Extension Definition Linkbase Document.
104		Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101).

*	Furnished herewith
**	In accordance with Item 601(b)(10) of Regulation S-K, certain provisions or terms of the Agreement have been redacted. The Company will provide an unredacted copy of the exhibit on a supplemental basis to the SEC or its staff upon request.

SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

	CHICAGO ATLANTIC REAL ESTATE FINANCE, INC.

Dated: ~~November~~August 9, ~~2022~~2023	By:	/s/ Anthony Cappell
		Anthony Cappell
		Chief Executive Officer
		(Principal Executive Officer)

Dated: ~~November~~August 9, ~~2022~~2023	By:	/s/ Phillip Silverman
		Phillip Silverman
		Interim Chief Financial Officer ~~and Treasurer~~
		(Principal Financial and Accounting Officer)

4048

The difference between the Carrying Value and the Outstanding Principal amount of the loans consists of unaccreted original issue discount, deferred loan fees and other upfront fees. Outstanding principal balance includes capitalized PIK interest, if applicable. Weighted average remaining life is calculated based on the carrying value of the loans as of September 30, 2022 and December 31, 2021, respectively. Certain loans are subject to contractual extension options and may be subject to performance based on other conditions as stipulated in the loan agreement. Actual maturities may differ from contractual maturities stated herein as certain borrowers may have the right to prepay with or without a contractual prepayment penalty. The Company may also extend contractual maturities and amend other terms of the loans in connection with loan modifications. The aggregate loan commitment to Loan #4 includes a $10.0 million initial advance, which has a base interest rate of 15.00%, and a second advance of $2.0 million, which has an interest rate of 39%. The statistics presented reflect the weighted average of the terms under both advances for the total aggregate loan commitment. Loans with material collateral in multiple jurisdictions, namely multi-state operators, are disclosed as “various.” This Loan is subject to an interest rate cap. The aggregate loan commitment to Loan #1 includes a $4.005 million initial advance, which has an interest rate of 15.25%, a second advance of $15.995 million, which has an interest rate of 9.75%, and a third advance of $10.0 million, which has an interest rate of 8.50%. The statistics presented reflect the weighted average of the terms under all three advances for the total aggregate loan commitment. P = prime rate and depicts floating rate loans that pay interest at the prime rate plus a specific percentage; “PIK” = paid in kind interest. P&I = principal and interest. I/O = interest only. P&I loans may include interest only periods for a portion of the loan term. The aggregate loan commitment to Loan #3 includes a $15.9 million initial advance, which has a base interest rate of 13.625%, 2.75% PIK and a second advance of $4.2 million, which has an interest rate of 15.00%, 2.00% PIK. The statistics presented reflect the weighted average of the terms under both advances for the total aggregate loan commitment. The difference between the Carrying Value and the Outstanding Principal amount of the loans consists of unaccreted original issue discounts, deferred loan fees and other upfront fees. Outstanding principal balance includes capitalized PIK interest, if applicable. Subject to adjustment not below 2% if borrower receives at least two consecutive quarters of positive cash flow after the closing date. This Loan is subject to prime rate floor. As of September 30, 2022, the CECL Reserve related to unfunded commitments on loans at carrying value is recorded within accounts payable and accrued liabilities in the Company’s consolidated balance sheets. As of September 30, 2022, the CECL Reserve related to outstanding balances on loans at carrying value is recorded within current expected credit loss reserve in the Company’s consolidated balance sheets. false --12-31 Q3 0001867949 iso4217:USD xbrli:shares

	Common Stock					Additional Paid-		Accumulated			Total Stockholders’
	Shares			Amount		In-Capital		Earnings			Equity
Balance at March 30, 2021 (inception)		-		$	-	$	-	$	-		$	-
Issuance of common stock in connection with sale of unregistered equity securities		6,427			64		99,936		-			100,000
Balance at March 31, 2021		6,427		$	64	$	99,936	$	-		$	100,000
Issuance of common stock in connection with sale of unregistered equity securities		3,618,401			36,184		56,263,560		-			56,299,744
Dividends declared on common shares		-			-		-		(1,068,551	)		(1,068,551	)
Net income		-			-		-		1,068,551			1,068,551
Balance at June 30, 2021		3,624,828		$	36,248	$	56,363,496	$	-		$	56,399,744
Issuance of common stock in connection with sale of unregistered equity securities		4,415,594			44,156		68,179,213		-			68,223,369
Net income		-			-		-		4,067,521			4,067,521
Balance at September 30, 2021		8,040,422		$	80,404	$	124,542,709	$	4,067,521		$	128,690,634

Balance at January 1, 2022		17,453,553		$	173,551	$	264,081,977	$	(177,560	)	$	264,077,968
Issuance of common stock in connection with initial public offering and concurrent private placement, net of offering costs, underwriting discounts and commissions		302,800			3,028		4,478,528		-			4,481,556
Stock-based compensation		(3,750	)		-		120,940		975			121,915
Dividends declared on common shares ($0.40 per share)		-			-		-		(7,100,875	)		(7,100,875	)
Net income		-			-		-		7,803,952			7,803,952
Balance at March 31, 2022		17,752,603		$	176,579	$	268,681,445	$	526,492		$	269,384,516
Stock-based compensation		(313	)		-		122,525		207			122,732
Dividends declared on common shares ($0.47 per share)		-			-		-		(8,343,576	)		(8,343,576	)
Net income		-			-		-		7,463,839			7,463,839
Balance at June 30, 2022		17,752,290		$	176,579	$	268,803,970	$	(353,038	)	$	268,627,511
Stock-based compensation		(9,375	)		-		84,891		10,593			95,484
Dividends declared on common shares ($0.47 per share)		-			-		-		(8,339,170	)		(8,339,170	)
Net income		-			-		-		9,768,969			9,768,969
Balance at September 30, 2022		17,742,915		$	176,579	$	268,888,861	$	1,087,354		$	270,152,794

Loan	Location	Outstanding Principal(1)		Original Issue Premium/ (Discount)			Carrying Value(1)			Contractual Interest Rate(4)	Maturity Date(2)	Payment Terms(3)	Initial Funding Date
1	Various⁽⁶⁾		30,000,000		(287,746	)		29,712,254		10.07%⁽⁷⁾	5/30/2023	I/O	7/2/2020
2	Michigan		36,646,551		(182,125	)		36,464,426		P + 6.65%^(5)(11) Cash, 3.25% PIK	12/31/2024	P&I	3/5/2021
3	Various⁽⁶⁾		20,673,831		(444,457	)		20,229,374		13.91% Cash, 2.59% PIK⁽¹⁰⁾	11/29/2024	P&I	3/25/2021
4	Arizona		11,909,539		-			11,909,539		19.01%⁽⁸⁾	12/31/2023	P&I	4/19/2021
5	Massachusetts		1,500,000		-			1,500,000		P + 12.25%⁽⁵⁾	4/30/2023	P&I	4/19/2021
6	Pennsylvania		13,263,665		-			13,263,665		P + 10.75%⁽⁵⁾ Cash, 4% PIK⁽⁹⁾	5/31/2025	P&I	5/28/2021
7	Michigan		4,443,750		(5,558	)		4,438,192		P + 9.00%⁽⁵⁾	2/20/2024	P&I	8/20/2021
8	Various⁽⁶⁾		23,168,151		(242,929	)		22,925,222		13% Cash, 2.5% PIK	6/30/2025	P&I	8/24/2021
9	West Virginia		9,554,960		(121,586	)		9,433,374		P + 9.25%⁽⁵⁾ Cash, 2% PIK	9/1/2024	P&I	9/1/2021
10	Pennsylvania		15,536,102		-			15,536,102		P + 10.75%⁽⁵⁾ Cash, 3% PIK	6/30/2024	P&I	9/3/2021
11	Michigan		313,607		-			313,607		11.00%	9/30/2024	P&I	9/20/2021
12	Maryland		32,479,495		(714,967	)		31,764,528		P + 8.75%⁽⁵⁾ Cash, 2% PIK	9/30/2024	I/O	9/30/2021
13	Various⁽⁶⁾		20,000,000		(210,110	)		19,789,890		13.00%	10/31/2024	P&I	11/8/2021
14	Michigan		10,600,000		(22,487	)		10,577,513		P + 7.00%⁽⁵⁾	11/22/2022	I/O	11/22/2021
15	Various⁽⁶⁾		5,000,000		-			5,000,000		15% Cash, 2.5% PIK	12/27/2026	P&I	12/27/2021
16	Michigan		3,739,861		(56,096	)		3,683,765		10.50% Cash, 5% PIK	12/29/2023	I/O	12/29/2021
17	Various⁽⁶⁾		7,500,000		(56,267	)		7,443,733		P + 9.25%⁽⁵⁾	12/31/2024	I/O	12/30/2021
18	Florida		15,000,000		(293,989	)		14,706,011		11.00%	1/31/2025	P&I	1/18/2022
19	Ohio		30,602,729		(472,079	)		30,130,650		P + 8.25%⁽⁵⁾ Cash, 3% PIK	2/28/2025	P&I	2/3/2022
20	Florida		20,327,703		(84,518	)		20,243,185		11.00% Cash, 3% PIK	8/29/2025	P&I	3/11/2022
21	Missouri		17,204,978		(148,084	)		17,056,894		11.00% Cash, 3% PIK	5/30/2025	P&I	5/9/2022
22	Illinois		5,038,013		(84,390	)		4,953,623		P + 8.50% Cash, 3%⁽⁵⁾ PIK	6/30/2026	P&I	7/1/2022

Current expected credit loss reserve			-		-			(1,497,933	)
Total loans held at carrying value		$	334,502,935	$	(3,427,388	)	$	329,577,614

	Outstanding		Unfunded
Balance at December 31, 2021	$	134,542	$	13,407
Provision for current expected credit losses		48,296		3,047
Balance at March 31, 2022		182,838		16,454
Provision for current expected credit losses		1,020,586		25,079
Balance at June 30, 2022		1,203,424		41,533
Provision for current expected credit losses		294,509		12,375
Balance at September 30, 2022	$	1,497,933	$	53,908

	As of September 30, 2022			As of December 31, 2021
Non-vested		98,440			98,440
Forfeited		(13,438	)		-
Balance		85,002			98,440

	For the nine months ended September 30, 2022			Period from March 30, 2021 (inception) to September 30, 2021
Revenue
Interest income	$	35,478,178		$	5,295,812
Interest expense		(1,383,172	)		(41,918	)
Net interest income		34,095,006			5,253,894

Expenses
Management and incentive fees, net		3,266,487			-
General and administrative expense		2,410,151			13,531
Organizational expense		-			104,291
Provision for current expected credit losses		1,403,892			-
Professional fees		1,649,360			-
Stock based compensation		328,356			-
Total expenses	$	9,058,246		$	117,822

Net Income before income taxes		25,036,760			5,136,072
Income tax expense		-			-
Net Income	$	25,036,760		$	5,136,072

	As of September 30, 2022 (1)
Risk Rating	2022		2021		2020		2019		Total
1	$	-	$	20,542,981	$	29,712,254	$	-	$	50,255,235
2		93,424,139		79,819,303		-		-		173,243,442
3		30,130,650		77,446,220		-		-		107,576,870
4		-		-		-		-		-
5		-		-		-		-		-
Total	$	123,554,789	$	177,808,504	$	29,712,254	$	-	$	331,075,547

	As of December 31, 2021 (1)
Risk Rating	2021		2020		2019		Total
1	$	135,076,307	$	32,242,114	$	590,384	$	167,908,805
2		29,075,761		-		-		29,075,761
3		-		-		-		-
4		-		-		-		-
5		-		-		-		-
Total	$	164,152,068	$	32,242,114	$	590,384	$	196,984,566